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Health research plays a critical role in the development of low- and middle-income 
countries (LMICs). Accordingly, global efforts to strengthen health research capacity in 
LMICs have intensified in the past few decades, increasingly through consortia. Reports 
on health research capacity strengthening (HRCS) consortia have primarily focused on 
programme outputs and outcomes. Implementation processes and their implications for 
consortia goals have rarely been studied in depth. 
In this thesis, I examined how management processes and practices used by LMIC-led 
HRCS consortia influence the realization of broader research capacity outcomes. In the 
exploratory phase of the study, I used a qualitative approach to identify consortium 
management processes and factors influencing these processes. This was followed by a 
multiple case study design in which I examined in more depth the decision-making 
considerations in consortium management, factors that influenced consortia’s strategy 
choices, and how those strategies enabled or hindered capacity strengthening.  
Similar management structures and processes were used by the consortia studied, but 
consortia adopted different strategies in executing management processes. The findings 
demonstrate that decision-making in consortium management can be highly complex, as 
it involves tensions between compelling alternatives. Resulting trade-offs do not always 
align with capacity strengthening principles. Perceptions of research capacity and its 
strengthening, funder expectations, and both perceived and stated programme success 
indicators significantly influenced management decisions. Although consortium 
management processes are capacity strengthening mechanisms in their own right, this 
was not fully appreciated, planned for, or leveraged in the consortia studied. 
Drawing on these findings, I have presented a conceptual framework which lays out 
factors to consider in determining consortium management strategies that promote 
capacity strengthening. Considering the increasing investment in HRCS consortia, 
highlighting how consortium processes influence capacity strengthening is instructive for 
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CHAPTER 1:  INTRODUCTION AND OVERVIEW OF THE 
THESIS 
1.1  Introduction 
Strengthening health research capacity in low- and middle-income countries (LMICs) has 
been recognised as one of the most effective ways of advancing health and development 
1. If the health challenges of these countries are to be addressed in the most sustainable 
way, it is clear that LMICs need the capacity to be framers, producers and users of their 
own research 2, 3. Several calls for action have been made over the last three decades 3-6, 
resulting in increasing investments in health research capacity strengthening (HRCS) 
initiatives 7-9.  
The use of consortia has become a leading approach for facilitating HRCS in LMICs 10, 
11. Consortia typically consist of individuals and organisations from both high and low- 
and middle-income countries, with variable resources, expertise and experiences, 
working together to achieve collective gains 12, 13. Although there has been steady 
progress in strengthening health research capacity in LMICs, the gap between high-
income countries (HICs) and LMICs is still vast, and inequities and power imbalances 
persist in consortia which are often led by HIC partners 14. Indeed, the research and 
capacity strengthening agenda of these consortia are often set by HIC funders and 
partners2. To help address these challenges, there has been a rising trend of LMIC-led 
HRCS consortia implementing programmes such as The Wellcome Trust’s African 
Institutions Initiative and its successive Developing Excellence in Leadership, Training 
and Science (DELTAS) Africa Initiative; the USA National Institute of Health’s Medical 
Education Partnership Initiative (MEPI); and the European and Developing Countries 
Clinical Trials Partnership (EDCTP) Programmes. This approach is intended to enhance 
local RCS agenda setting, mitigate partner asymmetries and increase research capacity 
benefits to the local settings. Hence, it is essential to assess such LMIC-led initiatives to 
ascertain the effect of this approach on capacity strengthening efforts. 
The literature on HRCS consortia in general has focused on programme activities and 
outputs 15-17. Evaluation indicators mainly reflect outputs such as trained researchers, 
publications, and grant awards 18-21. However, more recently, evaluation thinking has 
begun to highlight the value of both outcome and process evaluations 22. Whereas 
outcome evaluations assess whether an intervention worked, process evaluations examine 
how and why the various outcomes were realized 23. Consortium processes involve a 
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series of steps and actions to establish and manage consortium activities and ultimately 
deliver the specified outputs, outcomes and goals. This thesis explores these processes in 
LMIC-led HRCS consortia to ascertain their role in the capacity strengthening efforts.  
 
1.2 Research Aim and Objectives 
The aim of this study is to critically examine the management processes and practices 
within health research capacity strengthening (HRCS) consortia, and the ways in which 
these activities feature in and contribute to broader capacity goals. 
 
The specific objectives are: 
1. To describe HRCS consortium management processes and factors that influence 
them 
2. To examine key HRCS consortium management processes and practices using a 
capacity development lens 
3. To explore how consortium management features in research capacity 
strengthening goals and mechanisms 
4. To identify and recommend strategies for managing HRCS consortia and the 
implications for their evaluation 
To address these objectives, I focus my study on consortia participating in the DELTAS 
Africa initiative. I employ a qualitative research strategy and conduct the study in two 
phases. I first take an exploratory research approach to gain a better understanding of 
management practices across all the DELTAS consortia and identify the most critical 
managerial issues. I then examine the highlighted issues in more depth using a case study 
approach involving three selected consortia.  
 
1.3 Research Justification 
The rationale for this study was informed by multiple factors. From a personal point of 
view, and as an African, I have long had a passion for the development of individual, 
institutional and systemic capacity in LMICs. With a background in international 
development and project management, my career began with implementing community-
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based development projects in low-income settings. I then transitioned into an academic 
setting where I focused on managing capacity strengthening programmes for health 
research, human resource for health, and broader research systems. Throughout the years 
in these roles, I was aware of the little attention given to the managerial component of 
research and capacity strengthening programmes, particularly in the LMIC setting. Thus, 
I was interested in exploring the role of the management function and its value in research 
capacity and the capacity development process.      
From the policy and practice perspective, continuous assessment of HRCS programmes 
by funders and practitioners is essential to enable programme improvement. This is 
especially important considering the increasing investments in these initiatives to ensure 
optimized impact and continued relevance. After three decades of HRCS investments, 
there is still little consensus on the best ways of designing and evaluating these 
programmes 24. The evidence base on what works under what conditions, and the means 
of assessing the effectiveness of HRCS programmes barely exists 14, 21. Major HRCS 
programme funders continue to express the need for quality data on existing health 
research capacities, the gaps at various levels, and effective evaluation frameworks and 
metrics 25, 26. It has become clear that in addition to identifying what works, it is vital to 
understand how and why specific outcomes are achieved, and the components of 
interventions that contributed to those outcomes, including managerial elements 27. This 
is even more crucial when assessing complex interventions like HRCS programmes, 
which often involve multiple actors and components operating at multiple levels over 
extended time periods 10, 23.   
From the theoretical perspective, very little has been published on consortia approaches 
to management processes. An essential element of HRCS consortia is their management, 
including how management processes and practices are enacted and feed into broader 
capacity strengthening goals. There are increasing efforts to improve consortium 
management practices in general such as one funder’s requirement to explicitly state 
consortium management outputs in the programme theory of change 28, and the 
publication of practice guides 29-31. However, initial exploration of this topic indicated 
that very little attention has been paid to empirical interrogation of consortium 
management processes, and how they contribute to achieving consortia outcomes. 
Additionally, there is little evidence of the conceptual basis for consortium management 
practice. Consortium management involves the coordination of multiple individual and 
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institutional partners, as well as scientific and administrative activities 32, 33. These 
activities are usually led by consortia leaders who are often primarily researchers 33. 
Empirical and conceptual understanding of consortium management practice is needed to 
provide direction and support to leaders navigating this multi-faceted function.  
To contribute to the HRCS evidence base, it is necessary to identify what consortium 
management and capacity strengthening entail, and then ascertain the role of management 
processes in the capacity strengthening process. This study empirically explores these 
issues.  
 
1.4 Capacity and Collaboration Terminology 
Different terms have been used to indicate capacity strengthening processes including 
‘building’ and ‘development’, and these terms are generally used interchangeably in the 
literature and in practice 21, 34. I discuss these terminologies in more detail in the next 
chapter. In this thesis, I have used both ‘strengthening’ and ‘development’ for a specific 
reason. The term ‘strengthening’ appears to be the preferred term in the health research 
domain, almost making ‘health research capacity strengthening’ (HRCS) a domain-
specific term. On the other hand, the term ‘capacity development’ has been used in the 
broader capacity literature to represent the mechanisms through which capacity change 
occurs; giving it a more technical meaning. I have therefore endeavoured to use these two 
terms in the specified contexts. As will be described in the next chapter, these two terms 
represent a similar concept and can be used interchangeably. 
Similarly, collaborations have been labelled with different names in the literature and in 
practice, including consortia, partnerships, cooperation, and networks 35, 36. There appears 
to be no standardised or widely accepted typology for this labelling and what they 
represent, and the terms are often used interchangeably. I have used the term ‘consortium’ 
throughout this thesis to represent collaborations that espouse common goals and shared 
responsibility and authority 37.  
 
1.5 Structure of the Thesis 
This thesis has eight chapters. In this first chapter, I have given an overview of the thesis 
including the research aim and specific objectives, and the broad justification for the 
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study. Following this introduction, I present two chapters which cover the literature 
review that has informed this study. Chapter Two presents an overview of the evolution 
of the global HRCS agenda. I then explicate the concept of capacity and the capacity 
development paradigms used in practice. The chapter also introduces consortium 
management phases and processes. In Chapter Three, I present the current published 
evidence on HRCS consortium management, identifying the key emerging issues and 
highlighting the gaps. Chapter Four focuses on the study design and methodology. I 
describe the two phases of my study and the approaches used for each phase.  
I present the empirical findings of the study in Chapters Five to Seven. In Chapter Five, 
I describe the management processes used by the consortia studied and factors that 
informed those processes. These formed the basis for a more in-depth examination of the 
highlighted management processes and strategies of three selected consortia in a case 
study. I present these findings in Chapter Six, where I explore the tensions that arise in 
consortium management practice and the underlying influences in consortium decision-
making. In Chapter Seven, I consider the effect of these management processes on 
participating individuals and institutions and discuss the role of consortium management 
in strengthening research capacity. Finally, Chapter Eight presents a discussion of the 
findings in relation to the wider literature, and recommendations for policy, practice and 




CHAPTER 2: APPROACHES TO HEALTH RESEARCH 




In this chapter, I present an overview of the approaches to the HRCS agenda with a focus 
on the consortium model. The chapter is structured into three main sections. I begin by 
highlighting the global HRCS efforts made over the years, particularly in LMICs. To 
provide the basis for applying a capacity development lens in assessing consortium 
management processes, I unpack the concept of capacity and its development in broader 
terms as well as within the research context. This is followed by an introduction to 
consortia as one of the main mechanisms for implementing HRCS initiatives. Finally, I 
discuss the nature of consortia and the processes involved in their establishment and 
management.   
 
2.2 Health Research Capacity Strengthening in LMICs 
Health research plays a critical role in the development of LMICs 9, 38, 39. However, there 
are huge research capacity gaps coupled with high disease burdens in many of these 
countries 6. These research capacity gaps, including low levels of expertise and 
infrastructure and a lack of enabling environments, continue to limit research outputs and 
use in LMICs 12, 40, 41. This situation is compounded by inadequate investments in research 
and development in these countries by national and global stakeholders 6, 42. The need to 
strengthen health research capacity has therefore been recognised as one of the most 
effective ways of advancing development in LMICs 1, 43.  
One of the key drivers of the HRCS agenda was the 1990 landmark report of the 
Commission on Health Research for Development (COHRED) which pointed out the 
need to build and sustain local research capacity to improve health and development in 
developing countries 4. Since this call for action, several global actors have continued to 
increase investments in HRCS initiatives 7-9. Funders have supported various HRCS 
mechanisms, including provision of technical assistance, overseas training of individuals, 
institutional capacity building, and collaborative research and training 33, 44. A 2015 
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mapping of the research capacity priorities of international funders documented 303 
HRCS programmes executed between 2004 and 2009 alone 45.  
Research capacity has been observed to operate at multiple levels - individual, 
institutional and environmental 46. The capability of researchers demonstrates individual 
level capacity; the organisational ability to conduct and administer research demonstrates 
institutional level capacity; and the broader context within which individuals and 
institutions operate demonstrates environmental level capacity (described further in 
subsequent sub-sections). Health research capacity strengthening initiatives often focus 
on formal short-term and degree training programmes 18, 20, 47 and joint research projects 
which are expected to enhance the skills of participants 48-50.  The goal of these 
programmes is to produce individuals who can conduct and disseminate research, 
demonstrate research leadership, train others and collaborate with peers in the wider 
global health arena 12, 51. In some cases, these individual-level training programmes are 
complemented with institutional-level capacity strengthening efforts, especially 
enhancing research infrastructure such as laboratories, and other research support systems 
18, 52. Most initiatives tend to focus on individual training efforts or institutional levels as 
opposed to the environmental 14, 46, 53. While there have been calls to pay attention to all 
the three levels to ensure effective and sustained research capacity, the “capacity-as-
training” approach is still the most prevalent means adopted for many HRCS programmes 
54, 55. Thus, capacity strengthening efforts have primarily focused on the skills and 
resources required for research production, and little attention has been paid to other 
elements of the research ecosystem such as research prioritisation, financing and use 46, 
54, 56.  
Generally, HRCS programme implementers have reported on outputs such as trained 
researchers, joint publications and conference presentations, single or joint applications 
for research funding (some of which have resulted in grant awards), new training 
resources, new or enhanced networks with access to member expertise and resources, and 
enhanced research dissemination 16, 18-20, 57. Programme and institutional actors have 
reported that enhanced capacities of individuals and institutions resulting from HRCS 
programmes have contributed to health and research systems and the ability to meet 
pertinent health needs in many LMICs 58, 59. The initiatives have also faced some 
challenges. These include uneven attention to capacity strengthening across diseases, 
specialities, and countries 60, 61; lack of long-term funding for sustaining HRCS models 
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32, 62; little funding support and ownership by LMIC stakeholders 32, 63, 64; lack of mentors 
62, 65; and challenges related to programmes involving several partners such as differences 
in interests and capacities 19, 66, 67.  
The experiences and lessons learnt by some HRCS practitioners have been shared to help 
improve the design and implementation of HRCS initiatives 9, 14, 40, 58. However, the global 
HRCS effort has neither been well mapped out nor coordinated, and much of the evidence 
is based on specific programmes 25, 42. Moreover, many of the HRCS programme reports 
and experiences have been output-oriented and very little has been done in terms of 
formal and systemic evaluations, particularly at the outcome and impact levels 26, 54. 
Hence, the actual picture of the collective HRCS effort and its effectiveness is not well 
understood. There have been some reflections on the modes and mechanisms adopted for 
HRCS programmes and their influences on capacity outcomes, and this has highlighted 
the limitation of inordinately focusing on individuals and research production 8, 14, 54. 
However, there is still little consensus on how research capacity strengthening (RCS) is 
understood, what capacities are important, and the best approaches to strengthening these 
capacities 54. The paucity of empirical evidence on the practice of RCS means that its 
effectiveness has not been fully established. To form a basis for determining the meaning 
of RCS and examining approaches to RCS, I explore the concept of capacity and its 
development next. 
 
2.3 The Concept of Capacity 
2.3.1 Defining capacity 
There is no single globally accepted definition of capacity 21, 68. While capacity and its 
development are applied beyond the international development domain, the sector 
appears to be a major contributor to the existing body of work on the subject. Even within 
this domain, the definitions, approaches, models and frameworks are numerous and 
diverse, demonstrating the multiple perspectives that currently exist. To illustrate, I 
present three varied definitions of capacity below: 
 “The emergent combination of individual competencies, collective capabilities, assets 
and relationships that enables a human system to create value.” 69 
“The ability of individuals, institutions and societies to perform functions, solve 
problems, and set and achieve objectives in a sustainable manner.” 70 
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“The ability of a human system to perform, sustain itself and self-renew.” 71 
An examination of the multiple definitions and perspectives on the concept of capacity 
reveals key characteristics of capacity which have been highlighted over time. I discuss 
these next. 
 
2.3.2 Capacity operates at multiple levels 
One of the most widely accepted characteristics of capacity is its presence and 
requirement at multiple levels (Figure 2.1). As indicated earlier, these are made up of the 
individual, organisational (institutional), and environmental (societal or systemic) levels. 
69, 72, 73. The recognition of capacity at these three levels is largely consistent across 
authors and practitioners. Individual capacity refers to the knowledge, skills and 
competencies of the people within a system; organisational or institutional capacity refers 
to the collective capability of an organised group of people and demonstrated through its 
structures, resources and functions; and environmental capacity refers to the context 
within which the individuals and organisations operate including political, legal, social 
and economic frameworks 53, 74, 75. The levels are interrelated, each level relies on or is 
enabled by the others to thrive, and capacity must exist at all three levels to ensure that 
the objectives of any system are met 73, 76, 77. 
 
Figure 2.1: Three levels of capacity 74 
 
2.3.3 Capacity is multi-dimensional 
Capacity is a multi-faceted phenomenon 71, and is only fully constituted when all its 
dimensions are at play. Capacity has been sectioned in various ways: tangible and 
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intangible 72, 78 hard and soft 79, 80, technical and managerial 81, or cognitive and practical 
82. These framings cast a more operational light on the phenomenon, making it easier to 
understand, develop and assess 83-85.  
In this thesis, I will highlight three frameworks from diverse viewpoints to demonstrate 
the multi-dimensional and complex nature of capacity and ways of framing and 
configuring capacity for practice. These three were selected based on their emergence 
from empirical evidence and practice and wide application in directing and assessing 
capacity strengthening efforts. These frameworks, as commonly observed with many 
capacity frameworks, interpret capacity at the organisational level, and act as bases from 
which the capacity requirements of the other levels are extracted.   
The first framework, presented by Kaplan 86 in his seminal paper “The developing of 
capacity”, posits that for capacity to exist in an organisation, a series of seven elements 
need to be present and interact with each other (Table 2.1). These interrelated elements, 
which are ordered in terms of priority and sequence, are context and conceptual 
framework, vision, strategy, culture, structure, skills, and material resources. Kaplan 86 
argues that an organisation must first understand its context, conceptualise its location 
and role within that context, and position itself to act in order to be effective and make an 
impact. It is only with this understanding and sense of responsibility will it be able to 
develop a vision, plan its programme of action, and translate this vision into an 
operational strategy. The organisation will then need to develop norms and values based 
on which organisational roles, functions and procedures will be clearly defined. 
Individual skills and abilities can then be developed, and the required material resources 
garnered to implement the organisational strategy. While acknowledging that these 
elements are rarely gained sequentially, Kaplan 86 noted that the intangible elements at 
the top of the hierarchy form the base on which the more tangible elements are built, and 
an organisation’s capacity arises out of the relationship between all the elements. It was 
observed that although the intangible aspects of an organisation’s capacity largely 
determine its functioning, organisations tend to focus on the more tangible aspects. This 
is emphasized in the quote below: 
 “Redesigning structures, building skills or securing resources are secondary to 
conceptual clarity, focused vision, coherent strategy and enabling culture; and 
organisational thinking which begins with structure, skills or resources will leave the 
organisation confused and incapacitated” 86 p.27. 
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Table 2.1: Elements of capacity 86 
Elements of capacity Description 
Context and conceptual 
framework 
Having a frame of reference and a set of concepts which 
allows the organisation to make sense of the world around 
it, to locate itself within that world, and to make decisions 
in relation to it. 
Understanding one’s context and having sufficient 
information regarding that context 
Vision Developing an organisational vision and a sense of purpose 
based on which the organisation plans and implements a 
programme of action 
Strategy Translating the organisational vision into an operational 
strategy which entails the development of specific 
methodologies of practice 
Culture Norms and values which are practised in an organisation: 
the way of life, the way things are done, habits, routines, 
and mindsets 
Structure Structuring the organisation and clearly defining roles, 
functions, lines of communication and accountability, and 
decision-making procedures 
Skills Growth and extension of individual skills, abilities and 
competencies 
Material resources Material resources such as finances, equipment and office 
space 
 
The second framework is the European Centre for Development Policy Management’s 
(ECDPM) 5Cs framework (Table 2.2). This framework was based on an in-depth study 
of 16 cases across different sectors, objectives, geographic locations and organisational 
histories which aimed to understand capacity development and performance 87. Five 
dimensions of capacity termed ‘core capabilities’ were determined to contribute to the 
overall capacity of a system or an organisation: the capabilities to commit and engage; to 
carry out technical, service delivery and logistical tasks; to relate and attract resources 
and support; to adapt and self-renew; and to balance coherence and diversity 69, 88. These 
capabilities were separate but interdependent and were considered to collectively produce 




Table 2.2: Five core capabilities for systems and organisational capacity performance 69, 
88 
Core capability Description 
To commit and engage • To be conscious and aware of one’s place in the world 
• To configure and create space for one’s self 
• To take ownership and be determined 
• To have motivation and commitment 
• To demonstrate agency; to choose and to act  
To carry out technical, 
service delivery and 
logistical tasks 
• To formulate policies and regulate activities 
• To carry out functions, deliver service and generate 
outputs 
• To sustain production over time 
To relate and attract 
resources and support 
• To relate and survive within the context  
• To develop, manage and sustain key relationships to 
leverage resources and actions 
• To build legitimacy in the eyes of key stakeholders  
• To deal effectively with competition, politics, and 
power differentials 
To adapt and self-renew • To cope with changing contexts and develop resilience 
• To reposition and reconfigure the organisation 
• To adapt and modify plans and operations as needed 
• To pursue continuous learning and growth  
To balance coherence 
and diversity 
• To develop clear vision and strategies 
• To manage diversity, paradox and tension 
• To achieve a balance between conflicting options 
• To integrate and harmonize plans and actions in 
complex multi-actor settings 
 
The third framework, though presented by Elloker et al. 89, was incrementally developed 
and based on the work of multiple authors 69, 72, 77. This framework (Figure 2.2) advances 
that organisational capacity requires a combination of ‘hard’ capacities such as 
infrastructure, technology and finances; tangible ‘soft’ capacities such as management 
knowledge and skills and organisational systems and procedures, and intangible ‘soft’ 
capacities such as capabilities to commit, engage, adapt, self-renew and relate. This 
framework highlights the role of elements such as power dynamics, values, norms, and 






 Figure 2.2: Framework for capacity 89 
 
The three frameworks, while presenting different sets of dimensions, collectively and 
consistently point out the key features of capacity: 1) capacity is made up of multiple 
elements; 2) capacity emerges out of an interaction between all the elements; and 3) there 
are tangible and intangible dimensions of capacity, and the tangible is largely driven by 
the intangible. 
 
2.3.4 Capacity is a systems phenomenon 
A system is “any group of interacting, interrelated, or interdependent parts that form a 
complex and unified whole that has a specific purpose” 90. Therefore, systems thinking 
denotes a holistic perspective which recognises that the different parts of a system and its 
broader context are interconnected and synthesized into an integrated whole 90, 91. 
Capacity is inherently a systems phenomenon 69. Its reliance on the interaction between 
its multiple components reveals that the essence of capacity is not in its parts but in the 
whole. Capacity dimensions such as the crucial role of context, and the ability to engage, 
relate, and adapt to changes, point out the relational nature and systemic perspective of 
capacity 71, 80, 92. Moreover, the interrelatedness and interdependence of individual, 
organisational and environmental capacities (Figure 2.1) reinforce this systemic 
characteristic. Individual competencies and the collective capabilities of an organisation 
need to interact with the environment to generate the required capacity to function 87. 
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2.3.5 Capacity is latent and dynamic 
Capacity is primarily a latent phenomenon which only becomes manifest when used to 
achieve results 69, 88. Van Deuren 92 theorises that this invisibility has contributed to the 
elusive nature of capacity and resulted in the multiplicity of perspectives. As a result, 
capacity is hard to induce, manage, track and measure 69. In addition, capacity has been 
recognised as a living and dynamic phenomenon 80, 82. It continuously evolves at all the 
levels as a result of both internal and external interactions 71.  
With these characteristics of capacity in mind, I discuss the meaning and approaches to 
capacity development in the next section. 
 
2.4 Capacity Development 
2.4.1 Understanding capacity development 
Similar to capacity, there is no widely accepted definition nor interpretation of capacity 
development 93-95. In this thesis, I adopt the OECD definition of capacity development 
due to its acknowledgement of the multiple levels and dimensions of capacity. This 
definition states that capacity development is: 
"the process by which individuals, groups, organizations, institutions and 
societies increase their abilities to: (i) perform core functions, solve problems, 
define and achieve objectives; and (ii) understand and deal with their 
development needs in a broad context and in a sustainable manner" 96 p.2 
The variety of definitions is exacerbated by the lack of consistency in the terminology 
used 97. Different terms for capacity changes (building, development and strengthening) 
have been used interchangeably in literature and in practice 21, 34, 82, 98. However, it has 
been pointed out by practitioners in the development and health fields that the differences 
between these terms are not just linguistic but conceptual, with each term representing a 
different development approach 14, 20, 73, 77, 92, 99. ‘Capacity building’ is seen as an erstwhile 
development paradigm characterised by a focus on external interventions, little 
recognition of existing capacities, carefully planned activities and predetermined outputs, 
enhancement of technical skills and capabilities, and a short-term outlook 73, 77, 92, 99. The 
concept of ‘capacity development’ has emerged more recently and focuses on the 
improvement of already existing capacities, internally driven capacity changes, local 
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ownership, broader systems-thinking approaches to individual and organisational 
learning, experimentation and learning, and an organic growth process towards long-term 
sustainability 73, 77, 92, 99. The term ‘capacity strengthening’ has been largely used in the 
same vein as ‘capacity development’, and emphasizes the enhancement of extant capacity 
and local participation in the process 14, 20, 21, 100-102. The conceptual differences in the 
terminology and the shift in thinking have not been consistently adhered to. A recent 
content analysis of capacity terms and definitions used in the literature found very little 
association between a used term and the content of its definition 21. The terms are still 
used interchangeably 73, 100, and so far, the distinctions have limited meaning in practice. 
 
2.4.2 Capacity development approaches 
Capacity development is an abstract and multi-dimensional concept 94, 103, and this has 
given rise to a wide range of interpretations and approaches 87, 88, 104. As a result, numerous 
theories, models and frameworks have been adopted in capacity development efforts. A 
review by Bergeron et al. 84 identified twenty-eight (28) theories, models and frameworks 
that had been used in public health capacity development interventions. One thing that 
has become clear is that there is no single formula for developing capacity 69, 77. However, 
irrespective of the approach used, the philosophy underpinning the approaches and the 
pathways through which the expected capacity changes occur have been categorised into 
three capacity development paradigms: planned, emergent, and incremental 68, 69, 105. The 
thinking associated with each paradigm serves as the strategy that informs capacity 
development interventions. I discuss each paradigm in turn. 
Planned paradigm 
The planned paradigm of capacity development is based on planning and control, and 
advances linear ‘cause and effect’ connections between inputs of an intervention and the 
resulting outputs, outcomes and impact 68, 69. There is an a priori assumption of what 
capacity is and what capacities are required, and thus capacity changes are planned and 
produced by pre-designed programme activities and the application of results-based 
management tools such as the logical framework analysis 69, 105. This strategy is based on 
the assumption that capacity development is driven by exogenous factors, and the process 
can be directly managed and externally controlled 69, 92. The paradigm also presupposes 
that the complexities of capacity can be reduced into constituent capacity components, 
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and the whole is equal to the sum of its parts 92, 105.  The planned paradigm has thus been 
termed as ‘technocratic’ and ‘reductionist’ 68. This strategy has been observed to be more 
appropriate for situations where there is a shared consensus on the intervention’s 
direction, and the objectives are more tangible and technical in nature 69. 
Emergent paradigm 
The emergent paradigm of capacity development is predicated on the complex nature of 
capacity and systems thinking 69, 73, 105. Capacity is perceived to emerge over time from 
multiple inter-dependencies and interactions among actors within the system, and allows 
for self-organisation and learning 88. Thus, capacity development is dependent on 
endogenous factors, and is a primarily ‘inside-out’ process which is often unpredictable 
69, 71, 95. Capacity changes are associated with multiple causes and effects, many of which 
are unplanned and unintended 68. Unlike the planned paradigm, this viewpoint 
emphasizes the less tangible and highly relational dimensions of capacity 71, 92.  
Incremental paradigm 
The incremental paradigm comes across as a middle ground between the planned and 
emergent paradigms as it reflects elements from both viewpoints. While this paradigm 
starts off with planned processes and predetermined capacity development objectives, it 
is open to changes and adjustments, and pursues what would work under different 
conditions 69. The strategy is based on the principles of learning, adaptiveness, and 
flexibility in implementation 69, 88. This paradigm has been observed to work best in 
unstable contexts where the capacity and performance needs and the prevailing 
constraints are difficult to predict, and the choice of strategy cannot easily be confirmed 
88. 
 
2.4.3 Capacity development in practice 
The planned paradigm is the most widely used, mainly due to accountability concerns 
and the pressure on both implementers and funders to provide tangible evidence 106, 107. 
However, practitioners are increasingly acknowledging that reductionist approaches do 
not provide a sound basis for capacity development interventions due to the complexity 
of capacity and the need for interaction among its multiple elements, 88, 107-109. Capacity 
development has been observed to be considerably non-compliant to “linear and neat ‘if 
this, then that’ thinking” 68. Systems thinking thus offers a better characterisation of the 
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capacity development process, and emphasizes the role of multiple elements and actors, 
relationships, internally-driven dynamics and long-term outlooks 80, 105. There is an 
increasing recognition that capacity development cannot be ‘done’ by outsiders, although 
external change agents may act as triggers and facilitators of the process 71, 77.  
While the systems approach is advocated as a better fit for capacity development, a 
blended approach incorporating elements of the different paradigms is recommended 71, 
73, 88. No single approach has the ability to change a complex system; different paradigms 
have worked at different times for different things and in different ways, and need to be 
combined to attain effective capacity development 69. McEvoy et al. 73 note that although 
capacity development practitioners can make use of planned management tools, this 
needs to be subsumed within the broader emergent paradigm. In practice however, the 
systemic perspective and the recognition of intangible capacities remain a challenge, and 
the planned and result-based strategies still dominate capacity development efforts 88.  
The multi-dimensional and systemic nature of capacity also reinforce the fact that no 
single element can constitute capacity, and it is only when individual competencies and 
organisational capabilities interact that capacity is created 73, 110. However, it has been 
recognised that, among the multiple levels and dimensions of capacity, neither the entry 
point nor the sequencing of capacity development interventions can be prescribed, as 
experiences differ 69, 81, 111 and human systems are continuously evolving 71. It has been 
considered more important to ensure adequate balance and interactions between the levels 
and dimensions for effective capacity development 69, 111.  
In addition, there has been much deliberation on whether capacity development is a means 
to an end or an end in itself 94, 112. As a means, capacity development is a process by which 
other development goals such as health outcomes are reached; as an end, capacity 
development is recognised as a development outcome in itself. While some may still 
consider capacity development as a means to an end 113, the thinking is shifting, and 
capacity development is widely considered as both a means and an end 69, 73, 80, 92, 103. This 
recognition is considered as fundamental to capacity development efforts 80, 95. When 
perceived as a means to an end, interventions focus on task achievements and 
performance results; whereas changes in capacity receive more focus when perceived as 
an end 92. 




2.5 Research Capacity Development 
2.5.1 Defining research capacity development 
Although initiatives to strengthen research capacity have increased over the years, there 
appears to be little consensus on the definition of research capacity, what capacities are 
important and how best to strengthen them 21, 54. There are still multiple assumptions and 
complexities associated with the concept 114, and there is a lack of consistent terminology 
115. The three capacity terms (building, development, or strengthening) are commonly 
used with respect to research; and in many cases, the conceptual differences described 
above (Section 2.4.1) are not acknowledged 21. Consequently, the concept of research 
capacity development has been open to interpretation, and the varied definitions reflect 
the range of perspectives of what research capacity entails 34, 75, 115. While some focus on 
the ability to carry out research tasks, others draw out the multiple dimensions of capacity. 
In this thesis, I adopt a broad definition of research capacity development: 
“The ongoing process of empowering individuals, institutions, organisations, and nations 
to: define and prioritise problems systematically; develop and scientifically evaluate 
appropriate solutions; and share and apply the knowledge generated.” 39 p.764 
This definition takes into account the continuous nature of the capacity strengthening 
process, the multiple levels of capacity, and the multiple stages of the research process - 
strategic and operational.  
Research capacity generally aligns with the characteristics of capacity discussed in 
Section 2.3. It exists at the individual, organisational and environmental levels, and 
constitutes multiple dimensions 54, 115, 116. These levels specifically refer to capable 
researchers (individual); institutional structures and processes with the ability to manage 
local research and retain researchers (organisational); and enabling political, resource and 
regulatory contexts at national or regional levels in which research is undertaken and used 
(environmental) 46, 75.  
While the levels are largely similar across the board, there are some variations in the 
classification of research capacity dimensions. For example, Cooke 116 and Kahwa et al. 
115 identified dimensions such as skills, infrastructure, linkages and collaborations, 
research applicability, and leadership in their research capacity evaluation framework. 
Dimensions identified by Zicker 98 included research systems and institutional 
frameworks, research leadership, management capacity, research skills, research 
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infrastructure, resource flow for research, and partnerships. Potter and Brough 117 
identified four main dimensions: structures, systems and roles; staff and infrastructure; 
skills; and tools. Many other authors frame their capacity components around the levels 
75, 118. A common observation is that both tangible and intangible components have been 
incorporated in many of these frameworks. 
For many years, research capacity development focused on strengthening the skills of 
individuals; and this was sometimes coupled with research infrastructure development 
115. However, the systems thinking approach to research capacity development is 
increasingly taking root 34, 54, 75, 115, 116. The systems approach recognises that research 
capacity is developed when multiple components at individual, organisational and 
environmental levels interact and act collectively; and no single component or level can 
deliver the required capacity 54, 75, 116. Hence, research capacity development is considered 
as a complex, holistic and long-term process 75, 119. It has become evident that 
interventions targeting one level or component require changes in the other levels and 
components to be effective and sustainable 34. The whole is greater than the sum of its 
parts 71, 119. While there appears to be no prescription of the sequence for the levels or 
components in interventions, multiple stakeholders have recommended a combination of 
strategies and concurrent capacity development at the different levels and in the different 
components to ensure a sustainable research system 34, 115, 120. 
 
 
2.5.2 Research capacity development paradigms 
There appears to be very little literature specifically detailing out the pathways through 
which research capacity is developed. However, the development of research capacity is 
not significantly different from the development of other kinds of capacity 121. Thus, 
research capacity development strategies also fall within the three paradigms described 
above (Section 2.4.2). The planned approach is dominant in research capacity 
development initiatives 34, 122-125. The systemic nature of research capacity has been 
widely recognised, but this does not appear to have led to the adoption of the emergent 
paradigm in research capacity development programmes 34, 125. The prevalence of the 
planned approach, particularly the use of results-based management methods such as the 
logical framework analysis is predominantly funder-driven 122. However, some funders 
are beginning to recognise that the research capacity development process is too complex 
to determine in advance the steps to be taken and the dynamics that would evolve 34, 125. 
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These funders have therefore recommended reflection, learning and continuous 
adaptation of interventions.  
 
 
2.5.3 Research capacity development: a means or an end 
Research capacity development has been recognised as both a means to an end and an 
end in itself 114, 116. As a means, it is a process through which “useful” research that 
informs policy and practice is produced as the output; as an end, the emphasis is on the 
development of skills, structures and the environment that will enable the conduct of 
research 116. As pointed out by Gadsby 54, capacity includes both the ability and power to 
perform. As such, in addition to the expectation of research performance (when research 
capacity development is perceived as a means), possessing the ability and power to 
perform research by itself is a legitimate outcome of capacity development interventions. 
Frameworks for implementing and measuring research capacity development should 
therefore capture changes that reflect both the ‘means’ and the ‘end’ perspectives 116, 125.   
In the next section, I focus on the consortium approach to research capacity development. 
 
2.6 The Use of the Consortium Model for HRCS Initiatives 
One of the main strategies proposed by COHRED for the ‘research for health’ agenda is 
the creation of international partnerships for research and capacity strengthening 4. The 
establishment of consortia has thus become one of the main mechanisms for 
implementing HRCS initiatives 10, 11. Health research capacity strengthening consortia 
connect individuals and organisations with variable resources, expertise and experience 
to work together to achieve a common goal and collective gains in health research 
capacity (albeit the level and type of capacity gain may vary across partners). Over the 
years, the most common HRCS consortia have constituted partners from both HICs and 
LMICs.  
Generally, the establishment of HRCS consortia has been deemed beneficial, and reports 
on their activities have highlighted several gains, including enhanced individual and 
institutional research capacity among partners, mentorship opportunities, increased 
research outputs, joint creation of teaching and research resources, and expanded 
networks 49, 126-128. Although experiences across consortia vary, many have also come 
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under considerable critique regarding issues of inequity and power imbalances, especially 
those involving HIC and LMIC partners 14, 16, 129, 130. Typically, HIC collaborators secure 
most of the funding for research and capacity building initiatives; thus, they determine 
the agenda and control the resources, leading to power imbalances 12, 131, 132. As a result, 
participation, especially at decision-making levels, tends to be unequal, favouring HIC 
partners, with priorities of international funders and HIC partners taking precedence over 
those of LMICs 12, 14, 131. Consequently, there have been increasing efforts to address these 
issues in consortia including the promotion of shared goals and ownership, mutual trust 
and respect, inclusion at all stages, and joint decision making 47, 133-136. Several practice 
documents and frameworks for partnership have been published to guide consortia and 
address some of the identified challenges 29, 30, 137, 138. In spite of these challenges, the use 
of consortia remains a favoured mechanism employed by funders and practitioners for 
strengthening research capacity in LMICs 7, 139. I discuss the nature and management of 
consortia next. 
 
2.7 The Nature and Management of Consortia 
2.7.1 The multi-dimensional nature of consortia 
A consortium brings together individuals and institutions and functions as an independent 
entity to achieve a collective goal. Consortia portray a combination of characteristics from 
different types of entities in structure and function. While consortia are primarily 
collaborations, they also appear to depict features of organisations and projects. 
Collaborative principles and practices are expected to be the mainstays of consortium 
operations. These include developing a shared purpose and common goals, promoting 
inclusivity and ownership, and ensuring mutuality and transparency 140-142. As such, it is 
valuable for consortia to use participatory approaches, consensus in decision-making, and 
collective problem-solving 143. To promote ownership and equitable benefits, consortia 
are expected to take partner needs, interests and unique contexts into account in setting 
their agenda 144.  
In addition to its collaborative characteristics, a consortium takes on an organisational 
identity to enable it to achieve its goals 142. For example, a consortium requires 
governance and management structures to ensure that it functions effectively 138, 145, 146. 
The design of an organisation mainly covers the organisational structure and coordination 
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147. The organisational structure is the way the organisation is configured; it determines 
the governance and management systems, authority relations, roles and responsibilities, 
resource sharing, decision-making processes, rules, and lines of accountability 147-150. 
While there are different categorizations of the types of organisational structures in the 
literature 151, some of the common types include: the simple or flat structure which has 
few levels and the decision-making authority is typically held by a single individual; the 
bureaucratic structure which is framed around functional departments; the divisional 
structure which splits the organisation into semi-autonomous units; and the matrix 
structure which is a combination of the functional and divisional structures 152. An 
emerging organisational structure is the network structure which places emphasis on 
formal or informal relationships between teams or related organisations; and facilitates 
resource sharing, international expansion, learning synergies and the ability to handle 
complex situations which cannot be handled by a single organisation 152. Generally, 
organisational structures can be tall or flat in terms of hierarchy 149, and centralised or 
decentralised 151. Once the organisational structure is established, coordination involves 
aligning the structures and bringing the constituent units together through leadership, 
communication, processes and practices to achieve the set goals 147. Consortia require the 
appropriate structure and coordination to function efficiently and effectively. As pointed 
out by Wolff 148, collaborations require organisational capacities to achieve their goals. 
In addition to these formal structures and processes, organisational management has been 
observed to have informal dimensions which – together with the formal dimensions – 
make up the organisational culture 153. Organisational culture refers to shared and learned 
assumptions, values, beliefs, ideas, behaviour and practices 154, 155. Consortia 
implementing HRCS initiatives are mostly made up of universities and other research 
institutions which have traditionally held a bureaucratic culture in terms of its 
administrative procedures and a collegiate culture in terms of the academic freedom 
exercised in knowledge production 155, 156. However, these cultures (particularly the 
bureaucratic) are changing; they also differ or exist to varying extents across different 
institutions 156. For example, universities and stand-alone research institutes are 
functionally different and often have different cultures 157, 158. Since the consortium 
management processes and practices are often embedded in the participating institutions, 
consortia may adopt aspects of these different host institutional cultures. Additionally, 
due to increasing globalization and reliance on research grants from international funders, 
especially by institutions in LMICs, cultures of external stakeholders (funders and HIC 
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institutions) have been incorporated in some aspects of the operations of these institutions 
155. Thus, when institutions participate in externally funded consortia, a research culture 
which is collaborative and creative but also focuses on quantitative measurement of 
research outputs, narrow concepts of ‘impact’ and intense pressure to deliver outputs, 
tends to dominate the management of consortia activities 159. As a result, consortia are 
likely to diverge from aspects of the host institutional culture and adopt management 
practices that align with the culture of the external stakeholders. All these multiple 
influences contribute to how consortia are managed.  
Furthermore, because consortia often rely on the availability of funded projects or 
programmes, they assume project-oriented characteristics which significantly influence 
how they are managed 148. Indeed, many consortia are formed to implement specific 
projects and disbanded upon completion of these projects 160. As a result, consortia tend 
to follow the project life cycle and adopt project management processes and practices to 
ensure delivery of project expectations, particularly with respect to time, budget and 
specifications 160, 161. The project life cycle is generally made up of five phases: initiation, 
planning, executing, monitoring and controlling, and closing 162-164. Project management 
processes are thus framed around these phases. Similarly, consortium phases and 
management processes are often organised using a similar structure 31, 165. Consortia 
which were established with a long-term outlook may close out projects but will usually 
continue the collaboration and transition into new projects 31. Project performance 
management approaches such as logical framework analysis (LFA) 166, 167, and project 
management tools and techniques such as Gantt charts, performance reports, planned-to-
actual comparisons, risk management tools, and monitoring and evaluation tools 168, 169 
are frequently adopted in consortium management. 
Hence, management approaches from collaborations, organisations and projects are 
drawn on in the management of consortia.  
 
2.7.2 Defining management 
There have been several definitions of management with a wide variation in scope. Over 
the years, definitions have reflected the evolving theories of modern management 170-173. 
Definitions of various management theorists have laid emphasis on different aspects of 
management including the setting of objectives, planning, division of work, coordination, 
control, efficiency, teamwork, shared power between management and workers, and 
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consideration of the interests and satisfaction of the wider society (Table 2.3). The 
emphases on different elements of management by different theorists and authors appear 
to be demonstrated in practice. While there are some commonalities across the board, 
different practitioners promote greater emphasis on some management elements over 
others. I focus on the management of consortia next. 
  
Table 2.3: Definitions of management  
Author Definition Key emphases 
Frederick W. 
Taylor 
Management is the art of knowing exactly 
what you want men to do, and then seeing 




Henri Fayol To manage is to forecast and to plan, to 
organize, to command, to coordinate and 
to control 175 
 
• Planning 
• Division of work 
• Coordination 
• Control 
George R Terry Management is a distinct process 
consisting of planning, organizing, 
actuating and controlling performed to 
determine and accomplish the objectives 
by the use of people and resources 176 
• Process towards objectives 
• Role of human and other 
resources 
Mary P. Follett Management is the art of getting things 
done through people 177 
• Role of people 
• Shared power between 
management and workers 




Management is the process of designing 
and maintaining an environment in which 
individuals working together in groups, 
efficiently accomplish selected aims 178 
• Collective goals 
• Teamwork 
Mary C. Niles Good management or scientific 
management achieves a social objective 
with the best use of human and material 
energy and time and with satisfaction for 
the participants and the public 179 
• Consideration of the 
objectives and satisfaction 







2.7.3 Consortium management processes 
As a result of the multi-dimensional nature of consortia, the approaches to management 
draw on collaborative, organisational and project-oriented management structures and 
processes. Consortium management processes are broadly categorised in four phases: 
pre-inception, inception, planning and implementation, and closure 31, 165, 180. During the 
pre-inception phase, management processes involve consideration of factors existing 
prior to the establishment of the consortium such as motivation for the collaboration, 
broader contexts within which the initiator(s) of the collaboration are embedded, history 
of collaboration among potential partners, and pre-requisites for the collaboration 142, 181. 
At the inception phase, management processes include deciding on and sharing the 
consortium’s aim and objectives, determining its structure and composition, and selecting 
partners 31, 165. The planning and implementation phase involves instituting operational 
procedures and norms, assigning roles, planning and implementing collaborative work, 
allocating resources, coordinating members and resources, and monitoring of processes 
and results towards achieving set objectives 182, 183. There is no definite demarcation 
between the pre-inception, inception and the planning and implementation phases of a 
consortium. In some cases, partner selection occurs or begins at the pre-inception phase. 
Similarly, discussions on governance, resource sharing, financial and administrative 
procedures, and approaches to consortia programmes often begin at the inception phase 
and are developed in more detail or refined during the planning and implementation phase 
29, 31. In the closure phase, programmatic, administrative and financial activities are 
wrapped up; and any contractual relationships are terminated 31. These phases and 
processes informed the development of the conceptual framework for this study which is 
presented in Section 4.2.   
  
2.8 Chapter Summary 
This chapter began by discussing the evolution of the global HRCS agenda as one of the 
most effective means of advancing development in LMICs. The concept of capacity was 
found to be multi-level, multi-dimensional and dynamic, characteristics that also held true 
for research capacity. It became clear that the pathways through which capacity changes 
occur usually fall within a planned, emergent or incremental capacity development 
paradigm. The planned approach appeared to have dominated research capacity 
development initiatives. Furthermore, the consortium model was identified as one of the 
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main strategies used in implementing HRCS programmes. Consortia demonstrate 
collaborative, organisational and project-oriented characteristics; and hence their 
management processes and practices were drawn from multiple management approaches. 
Consortium management processes were broadly categorised into pre-inception, 
inception, planning and implementation, and closure phases. In the next chapter, I present 
the current published evidence on management processes and practices adopted by HRCS 
consortia, and the factors influencing their operations and outcomes. 
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CHAPTER 3: MANAGING HEALTH RESEARCH CAPACITY 
STRENGTHENING CONSORTIA: A SYSTEMATISED REVIEW 
OF THE LITERATURE 
 
3.1 Introduction 
In the previous chapter, I presented an overview of the global HRCS agenda and identified 
the consortium model as one of the main mechanisms for implementing HRCS initiatives. 
In this chapter, I present a literature review on HRCS consortium management processes. 
I ascertain the scope and quality of the published evidence on HRCS consortium 
management and identify the management processes adopted. I also identify the critical 
management-related issues emerging from the experiences of consortia actors and 
highlight the knowledge gaps in the current evidence. This review has already been 
published in BMJ Global Health 184 (Appendix 1).  
 
3.2 Review Methods 
3.2.1 Type of review 
A systematised review of the published literature was conducted. This type of review 
models the systematic review process without strict adherence to the standard article 
selection criteria such as limitation to studies and adherence to quality thresholds 185, 186. 
This type of review was selected due to the dearth of HRCS research publications 21,  as 
it enabled the inclusion of a wide range of peer-reviewed literature irrespective of 
publication type or quality. In addition, relevant data extracted from selected papers were 
not only limited to findings, reflections, opinions or perspectives, but included all 
management-related descriptions. 
 
3.2.2 Search strategy and selection of papers 
An electronic search for peer-reviewed articles on HRCS consortia was conducted using 
PubMed and Scopus. The search terms used were 1) health AND 2) research AND 3) 
capacity AND 4) strengthening AND 5) consortium AND 6) low- and middle-income 
countries, together with relevant variants (Appendix 2). 
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In addition to the term LMIC, I included four specific geographic regions with the highest 
concentration of LMICs namely Africa, Asia, Latin America and the Caribbean, and 
Pacific, to balance sensitivity and specificity 187 and optimize the search. Search results 
were saved in an Endnote X8 library. The inclusion criteria for article selection were:  1) 
a focus on consortium-based HRCS initiatives (stand-alone or embedded in a broader 
initiative); 2) involved LMICs; 3) included descriptions, study findings or reflections 
related to consortium management processes, practices and outcomes; and 4) papers 
published up to December 2018 with the full paper available in English. I first screened 
the titles and abstracts of identified papers using the inclusion criteria. This was followed 
by an assessment of the full text of each retained article based on which a final inclusion 
decision was made. I also identified additional papers through a manual search which 
included checking the references and supplementary lists of identified articles and citation 
searching 188. 
3.2.3 Quality appraisal 
Although article quality was not an inclusion criterion, I assessed the quality of the 
selected articles to ascertain the calibre of the available evidence on HRCS consortium 
management.  I used the Mixed Methods Appraisal Tool (MMAT) due to its suitability 
for assessing multiple design studies: qualitative, quantitative (randomized, non-
randomized or descriptive) and mixed methods 189. It is particularly suited to “context-
dependent” and “process-oriented” complex interventions, and has been tested for 
reliability 190. The tool allows for initial screening to determine a paper’s eligibility for 
full appraisals. It constitutes a set of four assessment criteria per study design and metrics 
for scoring 191. Only the empirical papers could be assessed for methodological quality. 
To enhance rigour, a second reviewer conducted an independent appraisal of all the 
papers, and a third reviewer facilitated deliberations on any divergences. 
 
3.2.4 Data extraction and analysis 
Two sets of data were extracted from the selected papers. First, I extracted the 
characteristics of the HRCS programmes reported in the papers such as goals, activities, 
and geographic focus; and consortium characteristics such as structure, size and 
composition. For the empirical papers, I identified the study objectives and design, 
methods used in data collection, sampling and analysis, and any framework or guideline 
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used. Second, I elicited the findings from each paper which were categorised into three 
broad areas: 1) descriptions of management processes and systems adopted during the 
consortium’s establishment and implementation; (2) experiences and lessons learnt by 
consortium actors and (3) effect of the processes and experiences on the achievement of 
programme goals. I organised the data using the matrix method 192. This method involves 
structuring the extracted data in tables to facilitate a systematic synthesis of the data. The 
various categories of data were captured in columns, and each row represented an 
included paper. I carried out a thematic synthesis of the extracted data by eliciting 
descriptive and analytical themes from each column of findings while drawing out 
commonalities, divergences and associations across themes and papers.  
 
3.3 Review Results 
3.3.1 Description of included papers 
The electronic search resulted in 5378 papers, of which 1325 were duplicates (Figure 3.1). 
I screened the title and abstract of the remaining 4053 papers for initial eligibility, out of 
which 281 eligible papers were identified. Forty-six (46) papers were retained after a full-
text review of the eligible papers, and an additional nine (9) papers were identified from 
the manual search, resulting in the inclusion of 55 papers (18 empirical and 37 
commentaries) in the review (Appendix 3).  
The papers were published between 1994 and 2018 (Figure 2.2). Majority of the papers 
(47 out of 55) were published between 2010 and 2018, indicating a six-fold increase 
compared with the period before 2010. Only one paper was published before 2000, and 
the highest number of papers published in a year was eight (8). There were twice as many 
commentaries as empirical research papers (Table 3.1). Most of the empirical papers (14 
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Figure 3.2: Number and type of publications per year 
 
Half of the papers (n=28) had neither the first nor last authors affiliated to LMIC 
institutions, and in a fifth, there were no LMIC-affiliated authors at all (Table 3.1) Last 
authors (48 out of 55) were primarily affiliated to high- and upper-middle-income 
countries. Of the 18 empirical papers, only seven were scored in the top half of the 
MMAT quality range (Appendix 3) as they had clear research objectives, used data 
sources and analysis approaches relevant for addressing the research questions, and 
situated the findings within the study contexts.  
Overall, the papers evaluated or reflected on consortia operations and experiences, 
particularly on the activities and outputs. Only a third of the papers focused on the 
partnership experience of the consortia actors or assessed the successes, challenges and 
lessons learnt. Only two papers purposefully evaluated the consortia’s management 





Table 3.1: Summary of publication and programme characteristics 
HIC-High-income country, U-MIC-Upper middle-income country, L-MIC-Lower middle-
income country, LIC-Low-income country; RCS-Research capacity strengthening 
* Some programmes combined two or more categories 
 






Type of publication Empirical research 18 (33%) 
Commentary 37 (67%) 
First author 
affiliation 
HIC 36 (66%) 
U-MIC 4 (7%) 
L-MIC 6 (11%) 
LIC 9 (16%) 
Last author 
affiliation 
HIC 38 (69%) 
U-MIC 10 (18%) 
L-MIC 3 (6%) 





Geographic focus* Africa 37 (73%) 
Asia 12 (24%) 
Latin America and the 
Caribbean 
7 (14%) 
Pacific 1 (2%) 
Consortium 
leadership 
HIC 32 (63%) 
U-MIC 2 (4%) 
L-MIC 3 (6%) 
LIC 2 (4%) 
Led by both L-MIC and 
LIC partners 
2 (4%) 
Not indicated 10 (19%) 
Capacity 
strengthening focus 
Wholly or primarily RCS 23 (45%) 
RCS embedded in broader 
initiative 
28 (55%) 
Subject focus Disease or discipline focus 38 (74%) 
Generic 11 (22%) 
 Not indicated 2 (4%) 
Main activities* Training individuals 40 (78%) 




Developing collaborations 9 (18%) 
Knowledge translation 9 (18%) 
Infrastructure enhancement 4 (8%) 
33 
 
3.3.2  Description of reported consortia 
The 55 included articles represented 51 distinct HRCS programmes, as three programmes 
were reported in multiple articles. There was inconsistent use of terms in describing the 
collaborations, with 39 papers using two or more terms interchangeably, and one paper 
using five. The most commonly used terms were partnership (n=22), network (n=11) and 
consortium (n=10), and fewer uses of collaboration (n=4), alliance (n=2) and community 
of practice (n=2). Only five papers provided definitions of their selected term, which 
varied considerably 194-198. The sizes of the consortia ranged from 2 to 20 institutional 
partners from both LMICs and HICs. Africa was the geographical focus of most of the 
programmes (n=37). Of the 41 consortia that had reported on their leadership, 32 were 
led by HIC partners. Research capacity strengthening was the primary focus of almost 
half of the programmes (n=23), and an embedded component of broader research, 
educational or clinical care programmes in the rest (Table 3.1). The main capacity 
strengthening activities implemented by consortia were individual training (short term 
and degree awarding) and learning ‘on the job’ through conducting collaborative 
research.  
 
3.3.3 Consortium management processes and practices 
A range of management processes and practices representing both operational and 
relational aspects of consortium functioning were highlighted across papers (Table 3.2). 
The operational elements were related to the structures and procedures used in the pre-
inception, inception, planning and implementation, and closure phases of the consortia. 
The relational elements covered consortia experiences regarding behaviour and practice 
across the phases. I discuss these in turn.  
 
3.3.4 Operational aspects of consortium management 
The consortium management structures and processes reported across the papers have 
been broadly organised according to the pre-inception, inception, planning and 
implementation, and closure phases of the consortium cycle. The reported processes were 
neither the primary focus of the publications nor examined in detail, but were brief 




Table 3.2: Summary of management issues raised across papers 
Category Description No. of publications (%) 
               (N=55) 
Operational aspects of 
management 
Partner selection criteria 22 (40%) 
Determinants of consortia leaders 8 (17%) 
Partnership development phase 11 (20%) 
Types of collaborative agreement used 7 (13%) 
Governance structures 19 (35%) 
Coordination of consortia activities 21 (38%) 
Monitoring and evaluation of consortia 
activities 
22 (40%) 
Closure 3 (5%) 
Relational aspects of 
management 
Partner relationships 45 (81%) 
Equity and power 24 (44%) 
Role of leadership  20 (36%) 




Conditions in place prior to the inception of the consortia were only mentioned in passing. 
Pre-existing factors such as previous working relationships among consortia partners and 
cooperation at national and regional levels were reported to have facilitated consortia 
establishment. Similarly, the research strengths of potential partners that others sought to 
leverage 199 and common national challenges 200 motivated the formation of consortia. 
The most significant catalyst for consortia formation appeared to be funding 
opportunities, as almost two-thirds of consortia reported implementing funded projects, 
and specific reference to its influence was made in some cases 52, 201. Other drivers 
included global health interests 49, 66, 202, mutual research interests 134, 203-205, access to 
specific expertise in a specific area of need 200, 206 and a plan to establish a regional 
cooperation 207. These conditions indicated the context out of which consortia emerged 
and factors which influenced collaboration decisions. 
 
Inception Processes 
Consortia formation was often initiated by the principal applicant for the grant, except in 
one case 200 where an LMIC government representative initiated the process. The criteria 
for partner selection were discussed in 22 papers (Figure 3.3), and the most cited criteria 
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were previous individual and institutional working relationships (n=17), and expertise or 
experience in the research area (n=9). Many consortia (n=11) reported considering two 
or more criteria, but none reported any considerations for determining the number or type 
of partners. In 11 cases, consortia reported engaging in a partnership development 
process, also referred to as the ‘engagement phase’ 66, ‘inception phase’ 127, 208 or 
‘establishment process’ 209. This process was typically used to engage partners and other 
stakeholders, identify partner needs and expectations, and align partner goals; as well as 
initiate discussions on a plan of action, governance structures, and consortium guidelines 
and procedures. Consortia actors shared the benefits of this process, including promoting 
openness, trust and teamwork 209, and helping partners acknowledge and deal with any 
assumptions held 20. The importance of involving institutional stakeholders beyond 
consortium actors was also pointed out in a few cases where consortia had experienced 
negative consequences due to non-alignment of consortium and institutional interests and 
plans 19, 193. Only three papers 202, 205, 208 described the use of a framework or tool to guide 
this process, citing the Partnership Assessment Tool, the four-dimensional Appreciative 










Planning and Implementation Phase 
Only a third of the papers reported on the governance structures adopted by consortia. 
Governing and management bodies were similar across consortia and generally fell into 
four categories: advisory bodies that provided strategic advice 52, 134, 210, steering 
committees that made both strategic and operational decisions 193, 198, 210, executive teams 
responsible for the day-to-day management 19, 210, 211, and implementation teams that 
executed consortium activities 126, 134, 212. These bodies often comprised representatives 
from partner institutions. However, there were no discussions on factors informing the 
choice of governance structures or the effectiveness of these structures. Consortia were 
often led by researchers who had initiated the collaboration, had the required resources 
or were selected to fulfil funder requirements 52, 133, 195. The role of a project manager or 
coordinator was reported in only two cases 19, 210. The consortium management capacities 
of leaders and managers were neither mentioned nor discussed, although two papers 
pointed out the value of having both management and technical expertise in leading 
consortia 33, 200. 
In all, 21 papers described processes used in coordinating consortia activities, and 22 
indicated the incorporation of monitoring and evaluation elements. Activity coordination 
and progress monitoring were mainly done through consortium-wide meetings, 
management meetings, partner visits, and telephone and electronic communication. 
Factors reported to foster coordination and monitoring included regular communication, 
jointly determined goals and processes, previous working relationships, and the use of 
codes of conduct and guidelines 19, 213, 214. Lack of clarity about roles and guidelines 66, 
193, and difficulties in organising meetings due to physical distances, time differences, 
conflicting partner priorities, and poor internet connectivity were reported as barriers 
particularly in large-sized consortia 19, 135, 215.  
Consortium evaluations, whether internally or externally conducted, were mostly 
programmatic in nature and focused on assessing training and research outputs. Of the 18 
evaluations reported, only six involved the assessment of partnership successes and 
challenges. The use of frameworks in evaluations was reported in six cases. Frameworks 
used were the Swiss Commission for Research Partnerships with Developing Countries’ 
Guide for Transboundary Research Partnerships 16, 133, Mercer et al.’s 216 Guidelines for 
Assessing Participatory Research Projects 66, the Capacity WORKS Model 193, 
Kernaghan’s types of partnerships 194 and the realist methodology approach 200. These 
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frameworks are orientated towards examining research partnerships more broadly, with 




Activities related to consortia closure were barely reported. Only three papers made 
mention of how the consortia transitioned out of their current programmes. These 
included a consortium that was discontinued due to disagreements among the partners193, 
a North-led consortium that transitioned into a South-led consortium 52, and a third case 
where partners kept activities going by availing their time, expertise and access to other 
grants in preparation for generating a new collaborative identity133. There was very little 
detail on how these transitions were processed. As indicated earlier, most of the 
publications focused on consortia outputs and outcomes and not on the life cycle 
processes.  
 
3.3.5 Relational aspects of consortium management 
Four critical factors were identified from the range of consortia successes, challenges, 
enablers, barriers, and lessons learnt shared across papers. These were partner 
relationships, equity and power, leadership, and inclusion. Although interrelated, I 
present the data shared on these key factors in turn, returning to the potential interplays 
later in the chapter. 
 
Partner relationships 
The importance of fostering strong relationships among partners was reported as having 
the biggest influence on consortia success, with a majority of the papers (n=45) 
commenting on this. Consortia actors emphasized the value of informal networks and 
friendships among individual partners in consortium success 32, 127, 193, 215, 218. In addition 
to their influence on the achievement of programme deliverables and consortium 






“While these [courses and workshops] were the quantifiable outputs…, much of 
the experiences in capacity building are not measurable: these may focus on 
relationship dynamics, work and the learning experienced by the participants 
involved” 19 p.4 
 
“Many participants reported that new relationships developed during the project 
implementation were the most important outcomes” 19 p.5 
 
Partner relationships were fostered by principles such as openness, trust, mutual respect, 
transparency, shared commitment and recognition 127, 213, 219, 220; and practices such as 
establishing guiding principles and norms, joint planning and implementation processes 
and regular communication 198, 200. It was noted that recognising and leveraging the 
differences in partner needs, strengths, interests, objectives, expectations, contexts and 
culture was essential for nurturing partner relationships 200, 220-222. Almost half of the 
papers (n=21) reported encountering challenges when partner differences were not 
acknowledged and monitored 32, 49, 135, 200, 219-222. At the same time, the investment required 
(in time and other resources) and practical challenges of building relationships, 
particularly when partners were spread across continents, were recognised 49, 66, 100, 127, 199, 
212, 215. As demonstrated in one study, participants “found the process of establishing 
relationships and reaching consensus… laborious and at times, negotiation-intensive” 212 
p.4. One consortium shared their learning: 
 
All collaborators should be aware of the fluid and the initially challenging 
processes that are normal for group development. Partners should allow 
sufficient time for complex and consultative decision making 127 p.15 
 
Equity and Power 
Challenges with inequity and power imbalances among partners were discussed in 24 
papers, particularly regarding the inequitable division of resources, control and benefits. 
These were noted to have stemmed from pre-existing asymmetries between partners, as 
well as consortium design factors 100, 199. Pre-existing asymmetries were based on 
differences in partners’ resources, income levels and expertise, especially between North 
and South partners. These asymmetries predisposed consortia to power imbalances, 
39 
 
which were exacerbated by consortium arrangements such as access to funding, resource 
allocation and leadership 100, 199. ‘Lopsided’ consortium arrangements were reported to 
result in more-resourced partners taking up the conceptual roles and being perceived as 
capacity providers, and less-resourced partners becoming implementers and capacity 
receivers 199, 208, 219, 223, 224. Thus, unequal power relations were entrenched, and the ability 
of less-resourced partners to negotiate better terms were undermined. 
 
 
When the Northern partner serves as the primary grant recipient (and the 
Southern partner is subcontracted) a level of inequality is created that is difficult 
to overcome, no matter what provisions are made to make decisions equitably 100 
p.4 
 
…it is too often assumed that the more developed nation has more to offer. This 
erroneous perspective is a fatal flaw in the development and progress of such 
collaborative efforts and is usually accountable for a number of failed attempts at 
collaboration due to its skewed balance of power 196 p.101 
 
“partners with less funding (almost entirely LMIC partners) confirmed that they 
felt as though they had less influence in decisions 19 p.7 
 
 
Power imbalances were not limited to North-South collaborations, but also encountered 
among ‘bigger’ and ‘smaller’ Southern partners 135, 194, 199. Openly acknowledging and 
discussing these issues were deemed necessary in addressing this challenge in several 
papers 20, 32, 127, 197, 208: 
 
There are interests at stake among Southern universities just as there are among 
Northern universities… therefore power and interest dynamics are at play in 
South-South partnerships just as they are in North-South and North-North 
partnerships 194 p.146 
 
Without honest exchange, and an acknowledgement of the differential power at 
work in seeking to resolve tensions in perspective, the notion of ‘equitable 





Other recommendations included negotiating and instituting consortium agreements and 
structures that promote power-sharing, equal division of resources and benefits, and 
decision-making capacity 16, 100, 196, 212, 225. However, it was noted that these were not 
guarantees and sustained partner commitment to equal partnerships, mutual respect, trust, 
and reciprocity were still required 66, 100, 194, 205, 209, 219. 
 
Partner Inclusion 
The lack of inclusion of all partners, especially during the early stages was raised as a 
concern, mostly by Southern consortium actors. In a Bangladesh–British partnership for 
instance, the project proposal was mainly developed by the Northern partner, resulting in 
implementation difficulties 223. Another author noted: 
 
Many participants described their partnership experiences as more 
'incorporation' than 'collaboration', having been provided little to no opportunity 
to participate in priority-setting or in leadership roles 208 p.142 
 
Even in an LMIC-led consortium, decisions regarding a component that was led by the 
HIC partners were described as ‘top-down’ leading to some tension within the partnership 
127. Partner inclusion in all consortium processes, particularly in decision-making, was 
widely reported to engender ownership and commitment across both internal and external 
stakeholders 11, 196, 209, 212. It was also considered critical to include wider institutional 
actors and be cognisant of host institutional leadership and structures when determining 
and executing consortium processes 19, 198. In one consortium, the involvement of a wide 
range of stakeholders in conceptualising the HRCS project was seen to contribute to a 
“truly cooperative partnership based on trust and mutual respect” 219. In others however, 
the lack of alignment with institutional agenda was detrimental to the consortium’s 
success 19, 193. 
 
Role of Leadership 
Leadership emerged as a major determinant of consortium success or failure in over a 
third of the papers 200, 226. The critical role of leadership was demonstrated when 
leadership changes in some consortia resulted in operational challenges 19, 100, 193. As 




A successful partnership requires strong leadership to make decisions, take 
appropriate risks, and solve problems 227 p.6 
 
Leadership was deemed essential for providing direction, overseeing performance, 
demonstrating diplomacy, and ensuring that partners are engaged throughout the 
consortium’s lifecycle 126, 197, 212. In one consortium, leaders’ commitment to inclusive 
partnership was considered instrumental in overcoming initial reservations of less-
resourced partners in joining the consortium at all 224. 
 
3.3.6 Linkages between consortium management processes and programme 
outcomes 
Linkages between consortium management processes and programme outcomes were not 
clearly articulated, and only alluded to in a few recommendations made. Some consortia 
actors observed that HRCS programmes that focused on a range of human and 
infrastructural capacities 33, 128, 228 across micro-, meso- and macro-levels 100, 200, 206, 219 
produced synergistic interactions and more sustainable capacity. It was also noted that 
acknowledging existing capacities of each partner and according mutual respect promoted 
multidirectional capacity transfer 47, 49, 196, 200. Additionally, tailoring partners’ 
participation in consortia were noted to produce sustainable and contextually relevant 
outcomes 127, 222, 225, 226. 
The role and significance of consortium management in achieving HRCS outcomes are 
increasingly being acknowledged 33, 198, 219. Efficient management was named as one of 
four outputs in one consortium’s programme theory of change 127. Another paper 
identified the lack of management skills as a risk factor for consortia, criticising the 
reliance on the ‘learning-by-doing’ means of acquiring those skills as it often happened 
late in consortia leaders’ careers 225. The capacity strengthening role of management 
activities was recognised in a few cases as consortia actors noted that partner interactions 
at managerial levels generated the exchange of knowledge and skills 215 and provided 
opportunities for mentoring and ‘behaviour modelling’ 219. On the significance of 
management processes, one author pointed out: 
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What these [process] evaluation reports invariably facilitated was increased 
awareness of how underlying, often ignored or taken-for-granted processes 
influence project work and outcomes 33 p.141 
 
3.4 The HRCS Consortium Management Publication Landscape and 
Emerging Issues  
3.4.1 The HRCS consortium management evidence base 
This review set out to assess the consortium management publication landscape, 
specifically in the HRCS domain. However, the findings presented may not represent the 
entirety of HRCS consortia experiences for a number of reasons. All but one paper 
reported successful collaborations, and discordant leader and partner perspectives were 
only reported in one case, indicating the possibility of publication and social desirability 
biases, respectively. Indeed, one participant disclosed their consortium’s deliberate 
decision not to report their ‘dirty laundry’ in a peer-reviewed publication 194. Thus, 
experiences of unsuccessful consortia may exist but are unpublished, and authors and 
study participants of selected papers may have been cautious in their publications and 
responses to avoid potential tensions and maintain relationships. In addition, data from 
unpublished work or those published outside of peer-reviewed journals, or in languages 
other than English, or indexed in other databases, would have been excluded from this 
review. However, a systematic approach was used in carrying out the review to ensure a 
high level of rigour. Integrating diverse types of published literature also widened the 
range of included viewpoints.  
Regarding the available evidence base, there is a gradual increase in the attention being 
given to HRCS consortium management-related issues in recent years. Yet, yearly 
publication outputs remain low, and the evidence is weak both in terms of quantity and 
quality. Consortium management was not the focus for most papers, and there was little 
coherence in its discussion across papers. Authors from LMICs were absent in a 
significant proportion of publications, raising questions about the level of meaningful 
LMIC involvement and leadership in the LMIC-focused HRCS consortium management 
literature. Possible contributors to this authorship pattern include the dominance of high-
income partners in consortium leadership, and broader structural and contextual factors 
such as resource and expertise imbalances. The nascent nature of the management-
specific evidence reflects a similar trend in the broader HRCS literature, except that there 
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is a better representation of LMIC authors in the latter 21. These imbalances and their 
contributing factors need to be addressed, with a particular emphasis on correcting the 
under-representation of LMIC perspectives in the available evidence. 
Across the publications, terms for collaborations such as partnership, network and 
consortium are used inconsistently and interchangeably, a point also noted by others 198, 
229. Similarly, as noted in the previous chapter, the concept of ‘(health) research capacity 
strengthening’ has been inconsistently applied across the broader HRCS literature 21. 
Thus, it is not entirely clear how an HRCS consortium might differ from a traditional 
health research consortium or how a consortium might differ from a partnership or 
network. Although not discussed in the literature, the lack of standard definitions and 
delineation of terminologies could lead to challenges with multiple perceptions of the 
nature, level of engagement, and practices of a collaboration, as well as different partner 
expectations. Concerns about clarity in the use of terms contributed to efforts by Edwards 
et al. 229 to develop a typology of international health partnerships to facilitate evaluations 
by positing a classification according to the level of impact (individual or organisational), 
capacity strengthening approach and the type of relationship between partners. Beyond 
ensuring the use of appropriate comparators in evaluation 229, characterising 
collaborations and being explicit about the attributes of the collaboration and degree of 
involvement will promote consonance in partner thinking, approaches and expectations. 
 
 
3.4.2 Associations between the operational and relational aspects of management 
There appears to be a greater emphasis on the relational aspects of management in the 
reviewed literature than on operational factors. Relational aspects such as relationship 
building among partners, equity, power relations and leadership were identified as having 
the most influence on and requiring the greatest attention for successful HRCS 
consortium management. Although extensively mentioned, these elements were 
inadequately interrogated. Later in the thesis, I highlight the role of different approaches 
to leadership and power relations in the capacity strengthening context. The operational 
aspects of management, such as establishment processes, and governance structures and 
procedures, were given less attention in the reviewed papers. Given that the relational and 
operational aspects of collaborations have been identified as interdependent elements of 
consortium management 197, 230, 231, it is unclear why the operational aspects are relatively 
neglected, and the interdependency and interplay between the two largely ignored. Only 
44 
 
three papers hinted at any linkages 100, 197, 199. Van der Veken et al. 199 pointed out that 
inequity and power imbalances are as determined by consortium structures as they are by 
pre-existing contextual factors, and Vasquez et al. 100 noted that formalised consortium 
structures are not sufficient in themselves in addressing power differentials and ensuring 
equity without commitment to the appropriate principles. The lack of correlation between 
relational and operational elements in the literature is further evidenced in the linear 
nature of the partnership frameworks applied in the reviewed papers, which rarely elicited 
the relational complexities inherent in consortium processes. The importance of this 
interdependency between the operational and relational mirrors the need for both tangible 
and intangible elements of management as illustrated in the capacity framework by 
Elloker and colleagues (Figure 2.2). As earlier indicated, this framework highlighted the 
need to equally pay attention to strengthening organisational hardware such as finances 
and technology, tangible software such as management systems and procedures, and 
intangible software such as relationships and power 89, 232. As will become more evident 
from the empirical findings, the interrelatedness between the tangible and intangible 
elements of management is crucial if consortia outcomes are to be achieved, particularly 
in the capacity strengthening context.   
 
3.4.3 Role of management processes in research capacity strengthening 
Very little association has been made between HRCS consortium processes and capacity 
outcomes in the literature. There was almost no discussion in the reviewed literature on 
the ‘position’ of management in the HRCS agenda and whether it merely supports a 
capacity development process or is a capacity development mechanism or target in its 
own right. This gap may be a result of the prevalent focus on HRCS activity outputs such 
as individuals trained and publications which are widely used as proxies for capacity 83, 
and the apparent prioritisation of technical research skills over managerial expertise. 
Though HRCS activities focus more on technical research tasks than non-technical 
relational skills, issues raised in the HRCS consortium management literature emphasizes 
the latter. This could be an indication that consortium processes may be segregated from 
the capacity strengthening process and only perceived as a means to an end. Although 
there is a growing recognition of the role of management in HRCS consortia, its handling 
in the available published literature is rudimentary. Even where management is explicitly 
named as an output, the focus remains on programme efficiency with management as a 
facilitator of other programmatic outputs rather than a valuable capacity building output 
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in itself 127. Considering the philosophy underpinning HRCS consortia 4, capacity 
development needs to permeate both processes and deliverables, and it is essential that 
both technical and managerial components contribute to capacity strengthening 
outcomes. I empirically examine the role of management processes in RCS and will 
discuss the findings in Chapter 7. 
 
3.4.4 Implications of the evidence base for consortium management research and 
practice 
From this review, it is clear that although the consortium model has been widely adopted 
for strengthening health research capacity in LMICs, the evidence base to inform 
implementation is weak, and consortium actors lack the theoretical and empirical bases 
for framing their practice. Relational aspects of consortium management have been 
recognised as essential to HRCS programme success but have not been examined in 
depth. Operational processes have rarely been discussed, and it is unclear whether this is 
due to a lack of understanding or a lack of perceived importance. As a result, the interplay 
between operational and relational aspects of consortium management has not been well 
explored. The actual contribution of consortium management to HRCS outcomes is 
poorly documented, and the ‘position’ of management within the broader capacity 
strengthening agenda remains unclear. The gaps identified in the literature highlight the 
need to pay more attention to both theoretical and empirical investigation of consortium 
management processes, influencing factors, and their role in attaining the capacity 
strengthening aims of consortia. Such research needs to aim for more conceptual depth, 
making use of robust study designs and adherence to research reporting requirements to 
overcome the quality problems identified. Considering the growing investments in 
consortia implementing the LMIC-focused HRCS agenda, it is essential to advance 
evidence-based consortium management frameworks to underpin the effort. 
 
3.5 Chapter Summary 
This chapter presented a review of the published literature on HRCS consortium 
management processes. The review indicated that despite increasing efforts being made 
to publish HRCS consortia outcomes in recent years, there is a dearth of high-quality 
empirical research on consortium management. Relational elements of consortium 
management such as equity and power relations were considered essential for consortia 
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success but were not examined in depth. Also, operational management processes such 
as governance and coordination and their role in the achievement of capacity outcomes 
were rarely examined. These identified gaps highlight the need for increased empirical 
research that will strengthen the evidence base on the role and contribution of consortium 
management processes and practices to the HRCS initiatives. These review findings 
therefore informed my research questions and study methodology, which I present in the 




CHAPTER 4: RESEARCH METHODOLOGY 
 
4.1 Introduction 
In the previous chapter, I presented a systematised literature review which depicted the 
scope and quality of the published evidence on the management of HRCS consortia. It 
became clear that there is a dearth of high-quality research on consortium management. 
This finding further supported the case for conducting an empirical study on the 
management processes used by HRCS consortia and their influences on the achievement 
of consortia goals. In this chapter, I outline the approach and processes followed in 
conducting the study. I present the conceptual and theoretical frameworks, as well as the 
philosophical underpinning that guided the study. The study design and the methods used 
in data collection and analysis are also presented. I further discuss measures taken to 
enhance the study’s rigour, my positionality, and how I ensured reflexivity during the 
research process. I also outline the ethical considerations made and the study’s 
limitations.   
 
4.2 Conceptual and Theoretical Frameworks 
At the outset of a study, it is essential to set the study in a framework that clarifies its 
context and explains its structure and design233. This is done by determining the 
conceptual and theoretical frameworks of the study. A conceptual framework “lays out 
the key factors, constructs, or variables, and presumes relationships among them” 234 p.440 
in order to provide a complete understanding of the phenomenon. It is the researcher’s 
conception of what is “out there” with regard to the phenomenon which they plan to 
investigate 235. On the other hand, a theoretical framework “consists of the selected theory 
(or theories) that undergirds your thinking with regards to how you understand and plan 
to research your topic” 236 p.13. It presents the relevant theory underpinning the research 
and provides the lens through which the phenomenon of interest is examined 237, 238.  
To give direction to the study and facilitate a systematic and holistic investigation, I 
adopted both conceptual and theoretical frameworks. The conceptual framework (Figure 
4.1) was informed by the consortium phases and processes identified during the literature 
review and other related frameworks in the broader literature. I drew from frameworks 
on partnership processes and outcomes 142, dimensions of goals in collaborations 239, 
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organisational management elements 231, and dimensions of organisational capacity 72, 89. 
This initial framework therefore incorporates various elements of management processes 
of consortia, drawn from the collaborative, organisational and project-related processes, 




Figure 4.1: Conceptual framework for examining consortium management processes 
 
The conceptual framework focuses on management processes across the three consortium 
phases: pre-inception, inception, and planning and implementation (Figure 4.1). These 
phases and processes, drawn from the literature and presented in the conceptual 
framework, serve as a starting point for empirically examining the relevant management 
processes in HRCS consortia. At the pre-inception phase, factors that inform consortium 
establishment that need to be explored include the motivation for formation, the contexts 
within which the HRCS programme and participating institutions exist, partnership 
history and any programme pre-requisites 142, 181. At the inception phase, the processes 
and drivers for recruiting partners and establishing consortium structures need to be 
explored. For the planning and implementation phase, I have drawn out diverse 
dimensions of management deemed essential to collaborations and organisational 
effectiveness from the literature. These are strategic, operational, relational and 
performance management 197, 231. Strategic management of consortia involves processes 











resource allocation. Operational management involves processes such as planning of 
activities, assignment of roles and responsibilities, budgeting, coordination and activity 
implementation. Relationship management considers partner engagement, power 
relations, inclusivity, and equity. Performance management considers the development 
and implementation of monitoring and evaluation systems. As noted in the literature 
review, there is no clear-cut demarcation between consortium phases. For example, 
discussions on management structures and processes often begin at the inception phase 
and are developed further during the planning and implementation phase. Also, 
consortium processes continuously evolve as a result of feedback from phases and 
processes. The approach of each consortium to these management processes at each phase 
was investigated in the study, drawing out the factors influencing the different 
approaches. I also considered the influence of each management element on the different 
research capacity dimensions (tangible or intangible) and levels (individual, institutional 
or environment). This conceptual framework informed the study’s data collection and 
analysis. 
I applied the capacity development lens in examining each of the elements elicited by the 
conceptual framework (presented in Section 8.3.2). Applying a lens to a study makes 
explicit the viewpoint from which the researcher examines the phenomenon of interest 
and focuses the researcher’s attention to specific elements of the data being collected 240. 
Theories provide researchers with different lenses through which they could look at 
complicated problems, focus their attention on the relevant data and provide the 
framework within which to conduct analysis 238, 241. Due to the centrality of capacity 
development in HRCS consortia goals, it was crucial to assess consortia’s management 
processes from the capacity development perspective. The capacity development lens was 
therefore informed by the theories underlying capacity and its development. The literature 
review pointed out the various features of research capacity such as its multi-dimensional 
and systemic nature, and its development was shown to occur through fundamental 
mechanisms such as systems thinking and emergence (Sections 2.3 and 2.4). It is clear 
that capacity development is grounded in systems theories. I particularly drew on the 
complex adaptive systems (CAS) theory and the developmental systems theory to shape 
and inform this research due to their emphasis on the capacity and ability of a system to 
change through learning 242. The CAS theory advances that systems are made up of 
diverse components whose multiple interactions (between components and levels) 
produce emergent change towards self-organisation 69, 243, 244. The developmental systems 
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theory posits that human development occurs through a series of transformations 
produced by the interaction between individuals and their multi-level contexts 245-247. The 
common tenets across these systems theories include the interconnectedness of the units, 
the relation between individual units and their contexts, the integration of all levels of 
organisation, and the production of change as a result of the interactions; all of which are 
essential for the development of systems. The explication of these tenets shaped the 
perspective with which I examined the data and conducted my analysis, and enabled me 
to explain the relationships between consortium management processes and research 
capacity development.   
 
4.3 Philosophical Underpinning Guiding the Study 
Every research study is implicitly or explicitly underpinned by philosophical assumptions 
which shape the way the research is carried out 248. Identifying and articulating how a 
study’s philosophical underpinning aligns with its research question(s) and approach is a 
prerequisite for rigorous research 249. These philosophical assumptions, also referred to 
as research paradigms, represent the researcher’s perspective of the nature of what is to 
be known and how that knowledge can be gained 250. Several classical and contemporary 
research paradigms have been identified in the literature; the most common paradigms 
include positivism, post-positivism, critical theory and interpretivism (often combined or 
used interchangeably with constructivism) 251-253. In selecting the philosophical stance 
from which to approach this study, I considered the type of research questions I was 
seeking to answer and the potential means of generating the knowledge that would answer 
these questions 254, 255. My study sought to understand the consortium management 
actions, behaviour and experiences from the perspectives of the key actors, as well as 
their interpretations of the influence of their management processes and practices on 
research capacity strengthening 256, 257. Thus, this study is underpinned by the 
interpretivist philosophical assumption which asserts that multiple realities exist, each of 
which is socially constructed, and therefore individuals develop subjective meanings of 
their experiences 249, 258. The interpretive paradigm was therefore adopted due to the 
purpose of the study and the research questions.  
This philosophy was applied to my research at various stages. I selected a research 
strategy that would help draw out study participants’ views on what consortium 
management involved and their experiences in implementing management processes. I 
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adopted a two-step approach which allowed participants to bring out management 
elements they perceived as critical in the first step, which then guided the subsequent 
research. I also included a range of participants from various consortium partners to 
ensure that varied interpretations of consortium management experiences are captured. I 
present the study design in more detail in the next section. 
 
4.4 Study Design 
I employed a qualitative research strategy for this study due to its appropriateness for 
examining processes and understanding the experiences and perspectives of research 
participants within a natural setting 259, 260. The qualitative approach is also used in 
studying phenomena where little is known 259, making it the preferred strategy for this 
study.  
I also employed a two-phase research design for the study. Due to the dearth of 
consortium management evidence in the literature, the phased approach was adopted to 
provide preliminary information that will guide an effective investigation. In the first 
phase, I took an exploratory-descriptive approach to the research to gain a better 
understanding of what consortium management entailed and to identify the most critical 
issues that were relevant for the study. Again, I used an exploratory approach due to its 
suitability for research where there is little or no scientific knowledge about the group, 
process, activity, or situation of interest, and yet there is reason to believe that the 
phenomenon has insights worth discovering 261. This initial phase helped clarify the key 
research questions for the in-depth investigation in the subsequent phase.  
For the second phase, I took a multiple case study approach which involved three 
purposively selected cases. Case study research has been defined as “a qualitative 
approach in which the investigator explores a bounded system (a case) or multiple 
bounded systems (cases) over time, through detailed, in-depth data collection involving 
multiple sources of information (e.g., observations, interviews, audio-visual material, and 
documents and reports), and reports a case description and case-based themes” 262 p.73. 
Diverse approaches to case study research have been presented in the literature. Of note 
are the approaches advanced by the three most prominent contributors to the 
methodology: Shahan Merriam 263, Robert Stakes 264, and Robert Yin 265. There are 
differences as well as commonalities in the approaches of these three seminal authors. 
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The key differences lay in their philosophical orientation (pragmatic constructivist, 
constructivist/interpretivist, and postpositivist respectively), which in turn led to 
differences in their approaches to the case study design, data collection, and analysis 266-
268. Irrespective of the varied orientations of the different methodologists, some 
fundamental case study characteristics are common across the board. For example, a case 
study is seen as a holistic and in-depth investigation of a complex issue (phenomena, 
event, situation, organisation, program individual or group) in its real-life context, and 
which primarily answers ‘how’ and ‘why’ research questions 263, 265-267. 
I selected the case study methodology for several reasons. First, the complexity of 
ascertaining the effect of consortium management processes on capacity development 
required an in-depth investigation and multiple perspectives which are two key features 
of the case study methodology. Second, consortia are bounded and socially constructed 
organisations which provided the opportunity for a holistic examination of their 
organisational and managerial processes and practices 263-265, 268. Third, my study aimed 
to examine a contemporary phenomenon, specifically the interaction between the 
management of consortia in an active HRCS initiative and their research capacity 
outcomes in real-life contexts 265. Consortia are nested in real-life settings within wider 
institutional, regional and global contexts, which provided the opportunity to investigate 
the behaviour and decisions of participants without manipulating the consortia or their 
contexts 269. Fourth, this study sought to determine ‘why’ consortia adopted their specific 
management approaches and ‘how’ those approaches influenced the development of 
research capacity in those consortia. Finally, although case study research could be 
oriented from positivist through to constructivist/interpretivist perspectives, the latter 
commonly permeates its implementation due to its fundamental goal of understanding 
phenomena from the perspective of participants through in-depth and contextualised 
analyses 267. Considering the interpretivist underpinning of this study (Section 4.3), the 
case study methodology was considered as a suitable approach. I still drew on some of 
the methodology’s postpositivist elements such as measures for validating data 265, to 
further strengthen the study’s trustworthiness (discussed in more detail in Section 4.8).  
 
4.5 Study Population  
The Africa-led DELTAS Africa HRCS initiative was selected as the sampling frame for 
this study. This initiative is administered by the Alliance for Accelerating Excellence in 
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Science in Africa (AESA) platform of the African Academy of Sciences (AAS). The AAS 
acts as the funding agency, with funding support from the Wellcome Trust and the UK 
Agency for International Development. The initiative seeks to support Africa-led 
development of world-class research leaders in Africa. To achieve this goal, eleven 
programmes are implementing various HRCS activities across Africa (Figure 4.2). Of the 
eleven, one is not consortium-based and hence was excluded from the study. The 
remaining ten are consortia made up of lead and partner institutions from across Africa, 
Europe and North America. This study is nested within a Learning Research Programme 
(LRP) of the DELTAS Africa Initiative, led by the Centre for Capacity Research at the 
Liverpool School of Tropical Medicine (LSTM). The LRP constitutes four themes and 
involves working with all the DELTAS consortia to produce research-based learning on 
how to train and develop world-class researchers, foster their careers and collaborations 
and promote research uptake. This study, which is one of the four themes, was 
conceptualised to generate evidence using the DELTAS Africa initiative to address a 
recognised gap in HRCS practice. The DELTAS Africa initiative was also of particular 
interest as it represented new thinking regarding LMIC-led consortia, was going to be 
operational throughout the study, and is made up of a heterogeneous group of consortia 
with varying characteristics such as number of partners, level of consortium maturity, 
institution type (e.g. university vs research institution), geographical and research foci, 
and leadership experiences. This provided adequate diversity within this population and 
the opportunity to make use of varying contexts in examining the HRCS consortia 






Figure 4.2: Eleven (11) DELTAS Africa Programmes 
 
 
4.6 Study Phases, Sampling and Data Collection 
The data collection methods, participants and expected outputs of the exploratory and 
case study phases are presented in Figure 4.3. I describe these phases next. 
 
4.6.1 Phase 1 – Exploratory research 
The aim of this initial phase was to enable familiarity with the study context, and identify 
consortia’s characteristics, management processes and emerging management-related 
issues. The study context here refers to the environment within which consortia activities 
are implemented including the organisational settings and culture in participating 
institutions, policy frameworks at both institutional and initiative (DELTAS) levels, and 
existing research capacity in participating institutions 270. The data collection methods 
employed for this phase were document reviews and key informant interviews. The 
DELTAS team at the AAS acted as both gatekeepers and key informants for the study 256. 
Gatekeepers provide formal and informal access to targeted research participants 271 I first 









access to all the consortia by introducing me, as the researcher, and the study to the 
Consortium Directors. I recognised the implications of the gatekeeping role of the AAS, 
which is the funding agency, and took appropriate measures to minimize any potential 





Figure 4.3: Study phases 
 
The Phase 1 data collection process began with a review of the relevant consortium-
related documents. The document review preceded the interviews so that the textual data 
would help identify potential questions and improve the efficiency of the interviews. The 
documents were collected in two phases. Documents from the AAS, including the call for 
DELTAS proposals, funder terms and conditions, submitted proposals, consortia set-up, 
notices of award, and annual reports, were reviewed using a checklist (Appendix 4). Next, 
each consortium was given a template (Appendix 5) to provide relevant consortium data 
including composition, goals, governance and management structures and teams, 
functions, and activities.  
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I conducted twenty-four (24) key informant interviews involving the Directors and 
Programme Managers of all ten consortia, and four key AAS stakeholders. These 
individuals were identified as having first-hand knowledge of consortia’s establishment 
and management experiences and best placed to provide insights on the most critical 
management issues that had arisen over the period 272, 273. Each participant provided 
written informed consent (Appendix 6) after the study details and the interview process 
had been explained to them. I conducted four face-to-face interviews with the AAS 
participants, and twenty Skype and telephone interviews with the 10 Consortium 
Directors and 10 Programme Managers. All the interviews were conducted in English. 
The interviews were semi-structured, and I employed topic guides which were tailored 
for each type of participant (Appendix 7). I did not draw on any previously developed 
tools. The topic guides were informed by the conceptual framework and the literature 
review. The conceptual framework informed consortium management phases and 
processes to explore. The literature review highlighted the knowledge gaps in the 
consortium management literature which informed the areas of consortium practice to 
focus on for the empirical work. The interviews therefore focused on collecting data 
related to consortia history, management structures, overview of management processes, 
preliminary thoughts on how and why some of the processes were undertaken, and 
management successes and challenges. Each interview was audio-recorded and lasted for 
an average of one hour. I developed an interview summary after each interview. These 
summaries presented key information from the interviews, any emerging insights, and 
issues worth exploring in subsequent interviews. The summaries were also shared with 
my supervisory team to provide them with the key emerging data and to obtain additional 
insights to feed back into the data collection process.  
I then analysed the data from this phase (method described in Section 4.7). In addition to 
generating essential research evidence, the findings from this phase also facilitated case 
selection and prioritisation of emerging issues for in-depth investigation in the second 
phase. 
 
4.6.2 Phase 2 – Multiple case study 
The aim of this phase was to conduct an in-depth investigation into issues emerging from 
Phase 1 which were relevant to the study aim. Three (3) consortia were purposively 
selected as cases for this phase. Purposive sampling is widely used in qualitative research 
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to identify and select information-rich cases in relation to the study aim 274. Participant 
selection was done in three stages to select consortia, institutions within the selected 
consortia, and individual participants within the selected institutions (Figure 4.4). 
Elements of both theoretical and maximum variation sampling strategies were adopted in 
the selection of cases. Theoretical sampling is mostly used in the grounded theory 
approach and relies on the analysis of the initial data to guide decisions on “who to talk 
to” and “what to ask” 275. The maximum variation sampling strategy places emphasis on 
breadth and variation and seeks to capture different conditions in order to identify 
commonalities and differences across these variations 276. Hence, based on the Phase 1 
findings, I selected cases that would explore emerging concepts in more depth and capture 
diverse perspectives and contexts. For example, I sought to include consortia with 
different approaches to management processes such as resource allocation and partner 
management. Additionally, consortium characteristics including the size of consortia with 
respect to the number of partners, length of the relationship between partners, types of 
stated goals, geographical location, and language diversity, were considered in this 
process. Thus, I included consortia of different sizes, with both narrow and broad research 
foci, with partners from different regions of the continent, and a Francophone-led 
consortium. A more detailed description of the Phase 1 findings which informed case 
selection will be presented in Chapter 5. In addition to the above-mentioned criteria, there 
was a pragmatic element to the case selection process. Each of the four themes of the LRP 
involved case studies, and therefore the theme leaders were mindful of the potential to 
overburden consortia. As such, we (theme leaders) discussed our preliminary case 
choices, and when there was an overlap, the theme which had alternative consortia 
meeting their selection criteria made the required change. During my case selection 
process, I had identified more than three consortia that met my selection criteria. 
Therefore, although one of my potential cases was also selected by another theme, I had 
additional options and still identified three consortia that met all my criteria. Thus, the 
case levelling measures did not affect my selection of the type of cases I required to 
answer my research questions. After the selection of the cases, I selected institutional and 
individual participants within each consortium using the maximum variation strategy. For 
each case, I selected the lead and three partner institutions within the consortium to 
capture multiple perspectives. To facilitate the process, I consulted with the Programme 
Managers of each of the selected consortia to clarify the characteristics of all partner 
institutions. I focused on recruiting co-applicant institutions for this study, as generally, 
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it appeared they were more actively engaged in consortia activities compared to 
collaborators and would have more insight into the workings of the consortium. 
Moreover, considering that the roles and engagement levels of collaborators varied across 
the consortia, focusing on co-applicants was aimed at enabling the comparison of findings 
across consortia. I aimed for maximum variation among the co-applicant institutions and 
hence selected one each of the African partner institutions with relatively higher and 
lower levels of research capacity, and one HIC partner for each case. This selection stage 
also provided an opportunity to expand the overall geographical diversity of participants 
by increasing the number of represented countries and regions across the continent. The 
key criterion for the individual participant selection was participation in managerial and 
administrative roles in the consortium. 
I conducted individual in-depth interviews for this phase. Again, each participant 
provided written informed consent after being taken through the consent process. I 
interviewed forty-four (44) participants including Consortium Directors, Programme 
Managers, Partner Leads (leaders of consortia activities at the partner institutions), 
Finance Officers, and M&E Officers across the three cases (Table 4.1). Semi-structured 
guides were used during the interviews (Appendix 8). These guides were informed by the 
Phase 1 findings and the study’s conceptual and theoretical frameworks. Considering that 
Phase 1 was more exploratory, and Phase 2 was more explanatory, I used these in-depth 
interviews to dig deeper into some of the emerging Phase 1 findings. For example, Phase 
1 highlighted the management processes and approaches used by consortia. During this 
second phase I investigated in more depth the thinking behind and factors influencing 
these management decisions. The Phase 1 data also indicated the roles of various 
consortia stakeholders during management processes. This granted me the opportunity to 
explore different managerial elements with a wider range of consortium management 
stakeholders and to tailor my interrogation based on each participant’s role in the 
consortium. In addition, I explored the perceptions of participants of some of the concepts 




Figure 4.4: Three-stage participant selection process for case study 
  
As the sole interviewer for the study, I conducted visits to all the participating institutions 
over five (5) months to facilitate data collection. Thus, interviews were held at times and 
venues that were convenient for participants. I conducted face-to-face interviews with all 
participants during this phase. Each interview took between 60-100 minutes, and all 
interviews were audio-recorded after participant consent for recording had been granted. 
All participants granted consent for audio recording. Topics explored during the in-depth 
interviews included participants’ perspectives and experiences on what research capacity 
strengthening entailed, factors influencing management decisions regarding key 
management processes, implications of management decisions, and the effect of 
management processes on capacity development. Being the sole interviewer for the study 
granted me the opportunity to observe and capture both verbal and non-verbal 
communication from participants which facilitated more nuanced analysis of the data. 
Non-verbal means of communication used by participants included hesitations, facial 
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expressions, and hand gestures (for example, air quotes). These complemented the verbal 
data and were valuable for meaning making during data analysis. All but two of the 
interviews were conducted in English. The two interviews were conducted in French with 
the assistance of an interpreter. Prior to the interviews, I shared the interview guides with 
the interpreter, who is also a qualitative research assistant, and had a meeting to discuss 
the objectives of the study, the interview questions, the thinking behind the questions, the 
background of the participants and their contexts, and the expectations for the interview 
such as the need for both literal translation and conceptual accuracy 277. During the 
interview, sentence-by-sentence translations were done to enhance verbatim translations 
and limit potential compromises in the validity of the data. Additionally, I have basic 
knowledge in French, and so together with my observation of the non-verbal 
communication cues and behaviours of the participants, I was able to assess the 
translation to some extent in real time. I developed interview summaries after each 
interview.  
 
Table 4.1: Participant distribution across cases 
Type of Participant Case A Case B Case C Total 
Consortia Directors                        1 1 1 3 
Partner Leads 3 2 4 9 
Programme Managers                       2 2 1 5 
Finance Officers 2 4 4 10 
M&E Officers 1 3 1 5 
Other consortium support staff 2 1 1 4 
Graduates, supervisors, 
institutional staff 6 0 0 6 
HIC Partner Leads 1 1 0* 2 
Total 18 14 12 44 





4.7 Data Management and Analysis 
The audio recordings of all the interviews were transcribed into MS Word documents. 
The transcriptions for the first phase were done by a professional service provider, and 
those for the second phase (except for the two French interviews) were done by an in-
house data processing team. These decisions were based on the teams’ availability to 
ensure quick turnaround times for the transcriptions. Both the external and in-house 
transcribers have several years’ experience in transcribing similar qualitative research 
interviews. I transcribed the two French interviews due to the cross-language uniqueness 
of those interviews in order to reduce potential errors and misinterpretations and enhance 
the quality of the data. As part of the data cleaning process, I listened to all the audio 
recordings to check on transcription quality, make any corrections, and incorporate any 
missed data. This was a valuable process as it significantly contributed to my familiarity 
with the data. The transcriptions captured both verbal and non-verbal elements such as 
pauses, truncation of sentences, repetitions, and laughs. All consortium and participant 
identifiers were removed during transcription and data cleaning and replaced with 
descriptor codes (Table 4.2). I presented the data extracted from the document review in 
MS Excel spreadsheets to facilitate ease of reference and comparison across consortia.  
Table 4.2: Sample descriptor codes for study participants used in quotations 
Descriptor code Meaning 
Exploratory Research 
Director 1 Consortium Director in Consortium 1 
Manager 5 Programme Manager in Consortium 5 
Case Study 
Consortium A, Lead Institution, R1 A researcher based in Consortium A lead institution 
Consortium A, Lead Institution, M2 A manager* based in Consortium A lead institution 
Consortium B, Partner Institution, 
R3 
A researcher based in a Consortium B partner 
institution 
Consortium B, Partner Institution, 
M4 
A manager* based in a Consortium B partner 
institution 
*Managers include all non-academic study participants 
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In analysing the data, I used the thematic content analysis approach 278 and the framework 
analysis approach 279 in Phases 1 and 2 respectively. The selection of these methods was 
informed by the type of research conducted at each phase. The thematic content analysis 
method is appropriate for exploratory work as it involves a systematic categorisation of 
textual data to identify salient issues and recurrent themes emerging from respondents’ 
accounts 278. This method was therefore suitable for analysing the Phase 1 data. After 
reading through the transcripts and interview summaries to obtain a good sense of the 
data, I identified variables of interest from the data, a process described as coding 280. I 
adopted the ‘directed approach’ to content analysis, which incorporates some structured 
elements to the process 281. This involved starting off the analysis process with a few 
initial coding categories drawn from the study’s conceptual framework. Thus, both 
deductive and inductive approaches to the analysis were employed 282. The data from the 
document review supplemented the data from the interviews during this process. Next, I 
created broad categories to group the coded data. The coding and categorisation were 
informed by both the emerging codes and the conceptual framework. This was an iterative 
process as I repeatedly went back and forth between the raw data, identified codes, and 
categories in order to refine the outputs of the analysis. To make it easier to see all the 
distilled data in one location, I presented my categories and codes in an MS Excel 
spreadsheet 234. I also presented the data by consortia and type of participant to identify 
any patterns and facilitate comparison (see Appendix 9 for excerpts of the Phase 1 
analysis categorization). Finally, I identified the main themes emerging from the data.    
For the second phase of the study, I adopted the framework analysis approach 279. This is 
a matrix-based analytic method which involves summarising and classifying data within 
a thematic framework 278, 283. The framework approach was adopted for this phase for a 
number of reasons: 1) it is suited to policy- and practice-oriented research; 2) it is more 
appropriate in studies where a priori issues exist to serve as a starting point for the 
thematic framework (the Phase 1 findings served this purpose); 3) it enables associations 
within and comparisons between cases; and 4) it is comprehensive and systematic and 
helps maintain a transparent audit trail 279, 283. The NVivo 11 software produced by QSR 
International was used to organise and manage the data to facilitate the analysis. The 
framework approach involves five steps: familiarisation, development of a thematic 
framework, indexing (coding), charting, and mapping and interpretation 279. As a first 
step, I read the interview transcripts and summaries and the collated consortia documents 
to familiarise myself with the range, depth, and diversity of information gathered. During 
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this process, I took note of any initial coding ideas, meanings, recurring issues and 
emerging patterns. Next, I developed a thematic framework made up of themes and sub-
themes grouped into relevant categories (Appendix 10). This process involved identifying 
key issues and themes using both deductive and inductive approaches. Thus, both a priori 
themes from the research questions and Phase 1 findings and emerging themes from the 
data set informed the development of the framework. At this stage of the analysis, the 
themes are largely descriptive and literal. Next, I coded the data by systematically 
applying the thematic framework to each transcript using the NVivo software. This 
involved labelling sections of texts to the corresponding node (theme or sub-theme). The 
next step, charting, involved reading and summarising the data into thematic matrices. 
The summarised data were kept as close to the verbatim text as possible, and were also 
linked to the associated raw data in NVivo to enable referencing and facilitate an audit 
trail. A chart was then created for each category of themes, and the data was presented 
according to respondents and clustered into cases (see excerpts of summary charts in 
Appendix 11). The charts facilitated focused reviews of each category of themes as well 
as comparison between respondents and cases. The next stage of the process involved a 
closer examination of the themes and categories to enable more interpretive abstraction 
and association of emerging findings. This involved identifying concepts, eliciting 
meanings, and finding patterns and connections within and between themes. This process 
also involved identifying linkages between the findings and the research questions, 
existing literature and current practice.   
 
4.8 Enhancing Research Rigour 
Ensuring rigour in research is important for demonstrating the quality of the study, which 
includes the soundness of the methods used, the accuracy of the findings, and the integrity 
of the conclusions made 284. Lincoln and Guba 285 advanced four criteria that need to be 
met to demonstrate the trustworthiness of a qualitative study. These are credibility 
(whether findings represent participants’ original views), dependability (unvarying 
treatment of the data to arrive at the findings and interpretations), confirmability (whether 
findings and interpretations are grounded in the data), and transferability (the extent to 
which findings can be applied to other settings). To enhance this study’s rigour and 
address these criteria, I employed multiple strategies throughout the research process.  
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First, I utilised different types of triangulation to facilitate confirmation and completion 
of the data to enhance the credibility of the findings 286. I selected a wide range of study 
participants to obtain multiple perspectives on the topics of interest. This involved 
ensuring diversity among the types of participating institutions and selecting individuals 
at different levels who play different roles in the consortium. This was further 
strengthened by the use of a multiple case study design which facilitated an in-depth 
investigation of three different consortia. The combination of interviews and document 
review also made it possible to triangulate collected data between the two methods. 
Additionally, the two-phased study design and the fact that all the selected consortia for 
the case study participated in the exploratory phase, enabled me to validate some of the 
data collected in Phase 1 with participants during the subsequent phase. Furthermore, I 
consistently engaged with my supervisory team made up of experienced researchers who 
acted as ‘peer debriefers’ 287 throughout the entire research process. The team reviewed 
the interview summaries and provided feedback for subsequent interviews, as well as a 
range of the full transcripts when they became available. During the data analysis process, 
regular team meetings were held to discuss and refine the thematic framework and 
emerging findings. I also shared the preliminary findings and received inputs from social 
science researchers at a departmental seminar, as well as from a broader group of 
researchers working in multiple disciplines at an institution-wide seminar. All these 
measures contributed to maximising the credibility of the research process and findings. 
Second, to maximise the dependability of the study findings, I endeavoured to conduct 
the research systematically in line with widely accepted standards for the selected study 
designs, and data collection and analysis methods 288. I have thus provided the 
philosophical orientation and theoretical and conceptual frameworks guiding the inquiry, 
detailed documentation of each study process used, the rationale for methodological 
decisions, and how the findings were developed, to ensure a clear audit trail is maintained 
286, 289. The use of NVivo further enhanced the trail across the steps taken during the 
analysis as it enabled linkages to the raw data. Third, the audit trail and the peer debriefing 
were also meant to enhance and demonstrate the grounding of the findings in the data to 
maximise the study’s confirmability. 
Finally, I employed a number of measures to enhance the potential for transferability of 
the findings. It is worth noting that the responsibility of determining transferability of a 
study’s findings lies more with the person wanting to make the application in their setting 
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than with the original researcher 285. The researcher only facilitates the transferability 
judgment by providing sufficient descriptions of the participants and their settings and 
the research process 285, 288. Thus, to enhance this study’s transferability, I have provided 
detailed descriptions of the participating consortia and their contexts, as well as the study 
processes. In addition, I opted to use a multiple case study design representing three 
consortia with varying characteristics, and adopted a maximum variation strategy in 
sample selection within cases. These measures widened the contextual diversity 
represented in the findings and provide opportunities to explore replication of emerging 
findings from one case to the other 290.  
 
4.9 My Positionality and Reflexivity During the Research Process 
The researcher is the main data collection and analysis instrument in qualitative research 
291. Therefore, the positionality of the researcher, which encapsulates the different 
dimensions of their identity, such as background, biases, values, and beliefs, can affect 
the research process 287, 291. To ensure that these influences are minimised, and research 
findings are considered with these potential influences in mind, researchers are urged to 
exercise reflexivity 292. According to Sultana 293, reflexivity in research involves: 
“reflection on self, process, and representation, and critically examining power relations 
and politics in the research process, and researcher accountability in data collection and 
interpretation” (p. 376) 
Reflexivity has been noted to be crucial in ensuring that research is both rigorous 288, 292 
and ethical 293, 294. This therefore requires researchers to be consistently sensitive to and 
explicit about their positionality and its effect on the research process and outcome 292, 
294. Accordingly, I endeavoured to unpack my positionality in order to increase my 
awareness of the different types of influences that I could exert on the research process.  
I recognised that my affiliation with one of the DELTAS Africa programmes, Initiative 
to Develop African Research Leaders (IDeAL), and the inclusion of  IDeAL’s Director 
in my supervisory team could have influenced how I was perceived by participants (for 
example, one programme in the same initiative assessing the others). To start with, IDeAL 
was excluded from the study as it did not use a consortium model. Also, the research team 
was very mindful of this position and discussed ways to mitigate its effect on data 
collection and interpretation processes. Furthermore, the inclusion of this study in the 
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DELTAS LRP played a significant role. Therefore, as a researcher, I took on and 
projected an LRP identity, and consistently shared the aims of the LRP with participants 
to highlight the purpose of the study and my positioning in a neutral learning programme.  
In addition, considering that I was introduced to the Consortia Directors by the funding 
agency, and then to partner institutions by Consortia Directors, I was conscious of the 
perceived power relations that could result from these dynamics. My study could have 
been perceived as a consortium or partner evaluation exercise by participants. To mitigate 
these, I constantly reassured Consortia Directors and participants that the LRP neither 
represented the AAS nor any of the supporting funders, and the aim of the study was not 
to evaluate performance. I emphasized that the study sought to examine consortia 
processes and their perceived effect on capacity strengthening to generate learning and 
inform current and future initiatives. When introducing the study to Consortia Directors, 
the AAS had pointed out that participation was entirely voluntary without any 
consequences for decisions taken. I reiterated this throughout the data collection process. 
Consequently, I took a co-learning stance (and expressed this intention to participants) 
throughout the research process. This was aimed at minimising any perceived power or 
other disparity between myself and participants that may exist and facilitate active 
participation by consortium actors. 
Further, as a member of the DELTAS community, my regular participation in DELTAS 
activities accorded me the opportunity to engage with the directors and other members of 
the consortia, and this contributed to increasing cordiality and openness during the data 
collection process. This may have helped in reducing the ‘outsider’ distance that may 
have existed between myself and participants. Similarly, the two-phased approach used 
in this study turned out to be beneficial in this regard. During the Phase 2 interviews, 
consortia participants, particularly those I had interviewed during the first phase, were 
willing to share more in-depth information. Moreover, because I visited each participating 
institution to conduct the Phase 2 interviews, communication with consortia actors before 
my visits and the time spent on site helped in creating some level of naturalness during 
the interviews.     
Prior to the study, I had no relationship with the DELTAS Initiative or IDeAL. However, 
I had several years’ experience in managing HRCS programmes and consortia. In fact, I 
had previously engaged with two Consortia Directors, one Programme Manager, and one 
Finance Officer in other HRCS initiatives, a fact which further enhanced the level of 
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acceptability with those participants. Additionally, my experience from working with 
consortia and universities gave me some understanding of consortia activities and issues 
such as collaboration culture and formal and informal power relations. Therefore, as an 
African researcher who has been a practitioner in the HRCS field, I was aware that, to a 
certain extent, I shared a common identity and experiences with the study participants 
which gave me an insider status for this study 295. This status may have enhanced my 
understanding of participants’ experiences and granted me some unique insights into the 
research topic. Participants may also have been less ‘guarded’ in their interactions with 
me. On the other hand, I acknowledge that my background and the associated biases and 
assumptions from prior knowledge and experiences could have provided some personal 
and professional lenses with which I considered the data 296, and could have influenced 
the research process in general. The insider versus outsider debate in qualitative research 
continues to highlight the advantages and disadvantages of each status and the need for 
researchers to be aware of and take the appropriate measures to ensure research rigour  
297, 298 Thus, to limit any potential biases as a result of my positionality, I regularly shared 
and discussed the data and my preliminary ideas and interpretations with my supervisory 
team through the interview summaries and team meetings. For instance, the team always 
reiterated the need to ensure that interview questions and presentation of the data were 
value-neutral, and to consistently interrogate the different sides of any management 
orientation adopted by consortia. Further, considering that women occupy less than a third 
of leadership and management positions in global health 299-301, my positionality as a 
female researcher in the field may have resulted in a marginalized stance which could 
have influenced my approach to study participants and the data. The continuous 
involvement of my supervisory team (made up of two males and one female with different 
backgrounds) in the entire research process helped to ensure that any potential 
gendered/marginalised influences on the research process contributed to a deeper and 
broader understanding of the topic, rather than a blocking of ideas.   
Throughout the data collection process, I recognised that the different aspects of my 
positionality, and differences in study participants’ perception of me at different times, 
gave me a shifting insider-outsider status 302, 303. Hence, not only did I need to constantly 
negotiate these statuses in each situation, I needed to make efforts to maximise their 
advantages while minimising their disadvantages through some of the measures described 
above 298, 302, 303. I continuously noted the different ways in which my positionality was 
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likely to influence the study outcomes in order to ensure top-of-mind awareness of these 
influences and the timely adoption of appropriate mitigating measures. 
In addition to being aware of my own positionality, it was essential to be cognizant of the 
positionality of my supervisory team and the implications on the research process. The 
team was made up of an African biomedical researcher who is also a Consortium Director, 
an HRCS researcher with extensive experience in the African research context, and an 
Africa-based health systems and ethics researcher. As noted above, the team constituted 
two males and one female. The diversity of gender, backgrounds and research foci 
strengthened their collective role as peer debriefers due to the varied and complementary 
perspectives involved. 
 
4.10 Ethical Considerations 
This study was taken through an ethical review process prior to the data collection stage. 
Approval was sought and obtained from the Kenya Medical Research Institute’s 
Scientific and Ethics Review Unit (SERU), due to my affiliation with the KEMRI 
Wellcome Trust Research Programme (Appendix 12). This was appropriate as the AAS, 
host of the DELTAS Africa Initiative, is also based in Kenya. In addition, permission to 
engage with DELTAS participants was sought from the AAS, and approval for data 
collection was given (Appendix 13).  
Once all approvals had been received, the AAS provided an overview of the study to all 
the consortia leaders, and an invitation to participate. As noted earlier, it was particularly 
emphasized that participation was voluntary, and there were no consequences for any 
consortium or individual decision to participate or not. Subsequently, I communicated 
with each Consortium Director and provided further details of the study. I also enquired 
of their willingness to participate in the study, reiterating that participation was voluntary. 
Once a consortium agreed to participate in the study, I provided information on the data 
collection process and sought written consent from each individual participant before 
each interview (both for participation in the study and audio recording). The consent 
process included providing an explanation of the study aim and processes, and clarifying 
that participation was voluntary, and so participants were free to withdraw their 
participation at any time without consequences. An informed consent form (Appendix 6) 
was used for this process, and participants signed to indicate consent. All collected data 
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were kept confidential, and any identifiers have been excluded to protect participants and 
their respective institutions and consortia. Thus, in the transcripts, analysis, and 
presentation of study findings, participants have been identified by descriptor codes. The 
transcripts and audio recordings are securely stored in password-protected computers, and 
accessibility is limited to the study team.  
I am mindful of the fact that some of the information collected for this study presents the 
risk of potentially causing disagreements between partners. I also acknowledge that 
providing detailed descriptions of cases and their contexts to enhance research rigour, 
coupled with the limited number of participants playing specific roles (for example, there 
is only one Director per consortium) present the risk of potential case and participant 
identification, particularly by members of the DELTAS community. To minimise these 
risks, I carefully considered the details of consortia descriptions presented, and sought to 
attain a balance between providing adequate contextual depictions and protecting 
consortia’s identities. I have also shared some preliminary feedback and study findings 
with the DELTAS community through the DELTAS Annual Meetings and periodic LRP 
bulletins and reports, and these have been positively received. Through the feedback 
processes, participants were afforded the opportunity to raise any concerns regarding the 
findings or their identities. Participant feedback on reported findings was generally 
positive, and no objections were raised.  
 
4.11 Study Limitations 
There were some limitations of this study. First, only consortia from the DELTAS Africa 
initiative were recruited for this study. Considering the significant influence of initiative 
design and funder stipulations on how consortia are managed, the findings could have 
been framed by the peculiarities of the DELTAS Africa initiative. An investigation of 
consortia from other HRCS initiatives might identify different management processes and 
practices and throw more light on other influences on how consortia are managed. 
Second, study participants were limited to co-applicants. Inclusion of collaborators in the 
study may have drawn out management-related issues unique to this group of partners.  
A third limitation is the potential influence of social desirability biases on the findings. 
Social desirability bias is the tendency to present one’s self in a manner perceived to be 
socially acceptable even though it may not reflect one’s reality 304, 305. This is a limitation 
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in most qualitative research, and participants could have provided socially desirable 
answers for a number of reasons. As noted earlier, participants may have perceived the 
study to be an evaluation exercise aimed at assessing consortia performance. Also, 
participants may have been conscious of the need to avoid potential tensions within 
consortia and maintain existing relationships. To minimise this bias, participants were 
assured of measures being taken to enhance confidentiality and anonymity with regard to 
their data. I also ensured that interviews were private and conducted at venues that granted 
participants the space to communicate freely. A fourth limitation is the language barrier 
encountered in two of the interviews. Although measures were taken to reduce its effect 
on the quality of the data, the translation process could have compromised the fidelity of 
the data from those interviews. However, considering that these related to two out of 
sixty-eight (68) interviews, any effect was minimal.  
Fifth, an often-cited limitation of qualitative research is that the findings cannot be 
generalised to other populations and settings 306, 307. This concern is usually raised in 
reference to statistical generalisation, which refers to the inference of results from a 
randomly selected and representative sample to a wider population 308. As has been 
pointed out by many authors, statistical generalisation is not a goal of qualitative research, 
and other types of generalisations could be made from such studies 290, 309, 310. 
Accordingly, the goal of this study was not to attain statistical generalisability but rather 
to enhance transferability and analytical generalisability 309, 310. As discussed in Section 
4.8, detailed descriptions of participating consortia and their context have been provided 
to enhance the potential for transferability of the study findings. Analytic generalisability 
refers to the “extraction of a more abstract level of ideas from a set of case study findings 
- ideas that nevertheless can pertain to newer situations other than the case(s) in the 
original case study” 311 p.325. To attain this, higher-level concepts of the processes and 
experiences that are not unique to the cases being investigated are developed 310. I sought 
to enhance the potential for analytical generalisability of this study’s findings by taking 
several measures. I defined the research question in broader terms beyond the specific 
cases (how does consortium management influence capacity outcomes?) 312. Also, I 
aimed for replication through a multiple case study design to facilitate the investigation 
of consortium management in different contexts 310. Furthermore, I adopted theoretical 
sampling strategies in selecting the study cases as a means of further developing the 
themes that emerged from the Phase 1 analysis; and to enable the development of more 
conceptual ideas from the findings 311, 313. Lastly, the comparison of the emergent 
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concepts with existing literature and the application of a theoretical lens to the emerging 
themes enabled the conceptualisation process, which will further enhance the analytic 
generalisability of the findings 311, 314. Thus, the conceptual insights that have emerged 
from this study could potentially be applied to similar cases and contexts. 
 
4.12 Chapter Summary 
In this chapter, I discussed the approach taken in conducting this study. The study was 
underpinned by the interpretivist paradigm, which led to the selection of a qualitative 
strategy due to the purpose of the study. I also presented the conceptual and theoretical 
frameworks that guided the study. Further, I described the two-phase design I adopted for 
this study which involved an exploratory phase followed by a case study phase which 
involved three consortia as cases. Key informant and in-depth interviews were the main 
data collection methods in the first and second phases respectively, and were augmented 
by document review. I described the use of the thematic content analysis and framework 
methods used in analysing the data in the two phases. I also discussed the steps I took 
throughout the research process to enhance rigour, and described my positionality and the 
measures taken to mitigate its effect. Lastly, I discussed the ethical considerations I made 
and the study’s limitations. In the next three chapters, I present the findings from the two 
phases of the study.         
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CHAPTER 5: OVERVIEW OF CONSORTIUM MANAGEMENT 
STRUCTURES AND PROCESSES 
 
5.1 Introduction 
The findings of this study are presented in three chapters. In this first results chapter, I 
present the findings from Phase 1 of my study, which gives an overview of the 
management structures and processes used by the ten DELTAS consortia. The findings 
in this chapter are largely descriptive, providing a backdrop for the next two chapters, 
which are more explanatory and focused on the three selected consortia cases. I present 
the Phase 2 findings in Chapters 6 and 7. Chapter 6 examines the emerging tensions in 
consortium decision-making processes and the factors informing management decisions. 
Chapter 7 explores the role of consortium management processes and experiences in 
RCS.  
In this chapter, I provide an overview of the structures and processes involved in 
establishing and maintaining consortia and factors informing the choice of processes 
used. I highlight the similarities and differences in management practices among the 
consortia and identify some of the cross-cutting influences on consortium management 
practices. I also draw out the critical issues in consortium management which were 
explored further in the multiple case study. 
 
5.2 Consortia Characteristics 
Each of the ten DELTAS Africa consortia constitutes an African lead institution and other 
African and international partner institutions. Lead institutions are based in several 
countries across sub-Saharan Africa (SSA): three in Eastern Africa (one in Kenya and 
two in Uganda), four in Western Africa (one each in Cote d’Ivoire, Ghana, Mali, Senegal), 
and three in Southern Africa (two in South Africa and one in Zimbabwe). Led by seven 
universities and three research institutions, consortia sizes range from four to fourteen 
core institutions. Three consortia are led by francophone institutions with both 
anglophone and francophone partners, while only one of the anglophone-led consortia 




Table 5.1: DELTAS Africa Consortia 








1 Research Institute 13 2 Research Area 





14 6 Broad 
4 University 6 7 Research Area 
5 Research Institute 4 0 Research Area 
6 University 9 0 Research Area 
7 University 5 14 Subject Area 
8 Research Institute 4 18 Research Area 
9 University 8 2 Broad 
10 University 9 20 Research Area 
*These consortium numbers do not correspond with the numbering used in the participant codes 
 
5.3 DELTAS Africa Programme Strategies  
The DELTAS Africa initiative aims to support African-led development of research 
leaders. The initiative is hinged on four strategic areas which were recognised as essential 
for strengthening and sustaining health research capacity in Africa. These are scientific 
quality, research training, scientific citizenship, and research management and 
environment. Scientific quality and research training focus on prioritising quality in the 
selection of candidates, type of training programmes in place and scientific oversight 
provided throughout the process. Scientific citizenship focuses on developing researchers 
who take on leadership roles in scientific programmes, participate in regional and 
international collaborations, and engage with public and policy stakeholders. Finally, 
research management and environment focus on strengthening research management 
structures and physical infrastructure to support scientific research. The objectives of the 






The DELTAS programmes are driven by a Theory of Change (TOC) which maps out the 
interventions and expected outcomes as well as indicators for measuring these outcomes 
(Appendix 14). These form the basis for the monitoring and evaluation (M&E) of all the 
programmes, and each consortium’s performance is assessed by the funders and the 
consortia themselves using these indicators. Each consortium developed a programme-
specific M&E plan, taking into consideration the initiative-wide indicators as well as their 
unique goals and strategies.  
  
5.4 Consortium management phases and processes  
I have categorised the management processes used by consortia studied into the pre-
inception, inception, and planning and implementation phases (Figure 5.1). This was 
informed by the study’s conceptual framework (Section 4.2).  
 




Figure 5.1: Consortium management phases and processes 
 
As noted earlier in the thesis, the demarcation between the inception and the planning and 
implementation phases of a consortium is often blurred. In the DELTAS consortia, the 
planning process began at the inception phase, where major consortium management 
elements were broadly considered but were developed in more detail during the planning 
and implementation phase. To inform funding applications, consortia undertook high-
level planning for management elements such as goals and activities, partner roles, 
management structures and budgets. These provisional decisions were reconsidered once 
funding was obtained and programmes moved into the planning and implementation 
phase. The detailed planning was informed by greater certainty of partners and 
programme resources and greater clarity on funder expectations. 
Sometimes you write things when you are writing the proposal, and when you get the 
money, things change… when we were awarded the grant, we then had a theory of 
change workshop again, to then say “right, this is what we agreed we wanted to do 
when we were writing this proposal, are we still all on the same page?” (Director 2)  
Although the blurred distinction between the phases is recognised, I will describe the 
management processes used by the consortia for each phase. 
 
5.4.1 Pre-inception phase 
The period prior to the inception of consortia had an important bearing on management 
choices and experiences. Discussions on a potential consortium began at this stage and 









Pre-inception Inception Planning and Implementation 
• Goals and activities 
• Roles and responsibilities 
• Resource allocation 
• Governance structures 






• Size and Structure 
• Composition 




phase included the purpose and pre-requisites for consortium formation either from the 
consortia themselves or the funder. Motivations for using the consortium model, pre-
existing relationships existing among partners, and consortium leadership were also 
considered at this stage. These are discussed in turn. 
Purpose and pre-requisites for consortium formation 
The purpose of the DELTAS Africa initiative is to strengthen health research capacity on 
the continent. This was articulated in funder documents, and consortia leaders reported 
that the capacity strengthening purpose considerably informed consortium formation 
deliberations. Although the consortium model was not a pre-requisite for programmes, it 
was encouraged in the call for funding applications, and one of the four strategic areas of 
the DELTAS initiative focuses on fostering networking and collaborations with different 
stakeholders. Ten out of the eleven awarded programmes used the consortium model.   
The DELTAS application process involved two stages. At the first stage, preliminary 
applications were reviewed, and shortlisted applicants were asked to submit full 
proposals. After reviewing the full proposals at the second stage, qualifying applicants 
were selected for face-to-face interviews. During the interviews, applicants received 
recommendations for refining their programmes based on comments from the reviewers, 
and also provided any required explanations and clarifications. Reviewers made 
recommendations on issues such as the size and structure of consortia and partner 
responsibilities. These will be discussed in more detail later in the chapter.    
 
Motivation for formation of consortia 
The choice by consortia leaders to use the consortium model was motivated by several 
factors (Box 5.2). The presence of common challenges among partners, such as low levels 
of research capacity and similar epidemiological profiles, was one of the foremost factors 
which motivated decisions to form consortia. A consortium provided an opportunity to 
synergize, creating a platform for pooling individual resources and consolidating efforts 












For example, some consortia were formed to address diseases that were endemic across 
their respective countries (for example, malaria). Some consortia leaders noted that it may 
be futile to seek to address the problem on national bases as such diseases are 
transboundary, and many institutions in Africa lack the level of resources required to 
tackle these health challenges on their own. This made the consortium model the best 
approach if the burdens were to be tackled effectively.  
When you are dealing with a high priority issue that is affecting many countries or 
many locations, it makes sense to form a consortium… Joining forces for us makes 
sense, particularly in our environment in low and middle-income countries, because 
it is clear that none of the countries or the institutions has enough resources. 
(Director 5) 
Consortia formation were also motivated by the opportunity to share experiences and 
learning in research and capacity development. Shared learning expedited the ability to 
tackle health challenges at regional, continental or global levels. Additionally, the 
opportunity to capitalise on the diverse strengths brought on board by multiple partners 
was perceived as an advantage.   
Our institutions have worked on [Disease] for several years, but now we see that 
elimination is possible in some countries… so there is a real need to put all our 
strengths together, working together, sharing experiences… (Director 8) 
 
Box 5.2: Factors that motivated consortia formation 
• Common challenges among partners 
• Synergy (ability to pool individual resources and consolidating efforts) 
• Complementary capacities 
• Sharing of experiences and learning 
• Positive experiences in previous consortia 
• Strengthening regional and continental (South-South) collaborations 
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It was the recognition that they have complementary strengths. So, at the research 
institute, people are doing research all the time… and there are pretty good 
facilities… and then at the university, there are lots of bright young people… 
(Director 1) 
For most consortia, the aim was for partners to learn from each other through multi-
directional sharing of experiences and lessons. However, this was not always the case as 
sometimes leaders were motivated to be givers or receivers of capacities. In one 
consortium, the lead institution’s primary motivation for establishing a consortium was 
to gain assistance for their institutional goals, while another’s motivation was to provide 
capacity for the less capacitated partners.  
We had some capacity for [Research Area] whereas [Partner University] had very 
little capacity… so, the idea was to use the capacity available… and work with the 
university to put capacity there. (Director 1) 
As shown later in the chapter, these different stances influenced the management 
approach adopted by consortia. 
Additionally, some leaders adopted the consortium model due to positive experiences in 
previous consortia. The lessons learnt and first-hand experience of the benefits of the 
approach influenced the decision to take that route. 
It [previous collaboration] had been a very rich experience… and I thought that it 
was a really good model to sort of adopt for developing partnerships within sub-
Saharan Africa. (Director 4) 
Furthermore, there was a general desire to promote and strengthen regional and continent-
wide (South-South) collaborations. The opportunity to strengthen regional capacity, 
particularly for challenged institutions and the opportunity to break down language 
divides were additional motivations.  
We have very strong institutions in each country and really, we want to work 
together, having the same scientific objective… we have the same epidemiology in 
many of these countries. We also want to work in the trans-borders… We would also 




History of working together 
Most of the consortia were already collaborating prior to the DELTAS Africa initiative, 
while the rest took advantage of the funding opportunity to establish a consortium. In the 
case of the former, consortia had either previously implemented other programmes or 
existed as a form of network. In the case of the latter, partners had pre-existing linkages 
through individual and institutional relationships. These relationships were seen to have 
provided amenable contexts for the formation of the DELTAS consortia. 
 
Determining Consortium Leadership 
The initiators of most of the consortia and funding application processes became the 
leaders, and their institutions became the host institutions. Initiators were research leaders 
who pulled together potential partners, usually from their existing networks, to form a 
consortium. In only two of the consortia, the initiative was taken by a group who then 
nominated leaders based on their individual and institutional capacities.  
So, from those two meetings… we recognised that because the capacity was so 
limited, what we needed was to come together as partner institutions so that you are 
pooling together resources… So, that was the background of how we formed our 
consortium. And from that, I was made to lead the consortium because of how well-
placed my institution is in terms of resources and leadership in that discipline. 
(Director 6) 
These leaders then steered the funding application processes and subsequently became 
the Consortia Directors. All the Consortia Directors are established health researchers, 
mainly with biosciences and public health backgrounds. 
 
5.4.2 Inception phase 
Once the decisions to form consortia were made, leaders took the necessary steps to set 
up these consortia. These included determining the nature, size (referring to the number 
of partners), and geographical coverage. Leaders then identified and selected partners, 
and also determined the structure of the consortia. Although I discuss these steps in 
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sequence, in practice, leaders made multiple decisions concurrently, and different 
elements influenced each other as the establishment process unfolded. For example, 
decisions on geographical coverage influenced partners selected and vice versa.   
 
Determining the Nature of the Consortia 
Across all consortia, leaders mentioned that they did not deliberate on the type of 
collaboration being established. For many, the term ‘consortium’ was adopted because 
the funder had used that terminology and it did not connote any specific characteristics 
beyond representing a group of people working together.  
I think the consortium came out of the way the initial call came out… Because that’s 
what the funder wants, so you need to somehow fit into it. I really do not think that 
there is something really important that somebody should look at when considering 
that word consortium, because I think it was just a funder’s terminology. (Manager 
5) 
To be honest, we use those terms interchangeably. Sometimes we call it consortium; 
sometimes we call it a network; so, there’s no real value to any of those terms from 
our perspective. (Director 4) 
I think that’s just semantics really… I think the first word I would look for wouldn’t 
be consortium. Partnership is probably a better word. (Director 1) 
For the few who thought a consortium was a unique type of collaboration, definitions 
varied, and there were no specific characteristics that differentiated the terms.  
But consortium fits very well because it’s beyond collaboration, it’s beyond just 
networking. It’s not just working together. We also build the capacity of each other. 
We have common interests. (Director 10) 
It was evident that for most consortium actors, the label of the group did not matter, and 
there were no mentions of discussions regarding the type of collaborations being set up 





Determining the Size of Consortia 
With the exception of one consortium, leaders did not pre-determine the number of 
partners.  The number of partners appeared to be organically derived in most cases. Even 
in the single case where the consortium had a pre-determined number of partners, the 
leaders noted that there was room for subsequent additions if deemed strategically 
beneficial. A number of factors influenced consortium sizes. First, existing networks 
wanted to maintain their membership and hence tended to include all interested existing 
partners. In such cases, new partners were added where gaps existed, or additional 
expertise or demographics were desired. Second, some consortia were not as limited by 
size consideration as they were by other factors such as the expertise needed to deliver 
project goals and geographical spread. 
We thought a big consortium was better than a small consortium, and we wanted to 
have a spread across Africa… We wanted a mix of institutions, some are more-
resourced, and some are less-resourced, and we thought that that would be a good 
opportunity for south-south sharing. (Director 9) 
We basically looked at the partners we needed, and we brought them on board. So, 
our number was on the higher side. We got criticized a bit by the reviewers for that, 
but we thought that we needed all the partners bringing different things to the table, 
so that’s why we had that number. Basically, we had those we needed to deliver the 
project. (Director 3) 
On the other hand, some leaders purposed to develop smaller-sized consortia. The leaders 
in these consortia cited the desire to maintain close-knit and manageable collaborations. 
There were no specific definitions for ‘small’, ‘manageable’ or ‘big’; or the number of 
partners associated with those terms.  
There are still many people wanting to join, but beyond that, it becomes difficult to 
manage, so we decided to stop there. (Director 7) 
We’re trying now to focus on our ability to have a close-linked community of people 
working together. (Director 1) 
The sizes of the consortia were assessed as part of the application review process and 
were therefore influenced by the funding agency. Funders recommended that some 
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consortia reduce the number of proposed partners to avoid becoming unwieldy, and to 
enhance management and budget efficiency.  
But for the programme to cover all twelve members as co-applicants, the budget was 
too big. So, during the review process, the review committee told us to decrease the 
budget and to focus on a limited number of countries. (Director 7) 
One of the things that we knew was that the funder had always thought we were too 
big… we thought strategically that we should take into account what we’d heard 
from the funder. (Director 9) 
 
Deciding on Geographical Coverage 
Though all consortia had a primary focus on Sub-Saharan African countries, the 
geographical coverage of consortia varied. Some consortia were deliberate in their 
decisions on geographical coverage, while the coverage for others emerged as a result of 
other partner selection criteria. One consortium focused on a single country, and others 
focused on single or multiple sub-regions. Reasons given by consortia with specific 
geographical choices included leveraging regional commonalities or diversities such as 
language and epidemiology.  
 
We wanted them to be [Region] institutions… we thought we should start small in a 
way by having a Consortium within [Region] because we knew this region better 
than other places; that there was commonality of language which would make it 
easy… and the fact that countries were part of the regional community… (Director 
5) 
Selecting Partners 
Partner selection was one of the most critical activities during this phase and was initiated 
by consortia leaders once the decision to establish a consortium had been made. Several 












Consortia leaders often fell on their existing formal and informal networks when 
establishing a consortium. Even when new members were included, the foundation 
members were often known to the leaders, and the networks of the known members 
became the source for further partner recruitment. Generally, leaders reached out to 
potential partners with similar interests or initiated consortium discussions at relevant 
meetings. 
Basically two-fold, first is that they are existing partners of the centre already, and 
then two, we got in one or two others whom we needed to bring in for their expertise. 
(Director 3) 
So, it was really a snowball. So, you know this person, and we get those contacts 
from the various people who were in the initial contacts, and then we used those 
contacts to be able to make contacts with partners institutions. (Director 6) 
 
Consortia leaders also considered the level of the scientific and managerial capacities of 
potential partner institutions. Some consortia strategically chose institutions with strong 
or complementary research and management capacities, while others chose to work with 
a mix of institutions with varying levels of capacity. Partners with higher levels of 
capacity were selected for delivery of programme outputs and for mentoring while less-
capacitated partners were primarily brought on board for capacity strengthening 
opportunities.  
Box 5.3: Partner selection criteria 
• Pre- existing formal and informal working relationships 
• Similar interests 
• Level of scientific and managerial capacities 
• Past performance in previous programmes 
• Geographical coverage 




We thought about research infrastructure because what we wanted was partners who 
can make a contribution, and then we also thought that we have different strengths 
as sites. (Director 4) 
For consortia which existed before the DELTAS initiative or partners who had previously 
worked together, past performance often influenced recruitment decisions. Partner 
performance in preceding programmes was used as an indicator of programme 
management capability. 
We definitely had to think through how we have been performing and which 
institution had issues. “If we leave out this one, can we survive?” And [Partner] was 
dropped because it was very difficult to get information from them. (Manager 5) 
Partner selection decisions were not always straightforward. Sometimes leaders had to 
decide between institutions with varying capacities in different areas. This was illustrated 
in one consortium where potential partner institutions had disparate scientific and 
managerial capacities, and leaders needed to decide which type of capacity to prioritise 
in their selection. 
We tried to find the strongest PIs and the strongest centres also in terms of 
management. We had to look into this and find the right mix of science performance 
and management performance. It doesn’t always match, science and management 
performance of certain centres, so we have to decide on what we want. (Manager 
10) 
Some consortia had more complicated situations as they tried to balance multiple factors 
which were not always aligned. The quotation below demonstrates a consortium’s 
difficulty in trying to balance ‘stronger’ and ‘weaker’ institutions, previously known and 
newer partners, as well as geographical and language considerations.  
So, we have decided… strong institutions, and then we also brought in other partners 
who we consider as weaker institutions and needed to strengthen their capacity… To 
have a long-standing partnership, we cannot start this with some institution we don’t 
know. And, one of the criteria was that we wanted to breach or to fill the gap between 
geographical regions... and also to break the language barrier, so we wanted 
Anglophone and Francophone countries. (Director 10) 
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These challenges point to the dilemmas consortia leaders faced as they made management 
decisions, a phenomenon I explore further in the next chapter.  
As noted earlier, considerations of geographical coverage also informed partner selection 
decisions. Some consortia aimed to either restrict or diversify the geographical coverage 
of the consortium. The motivation for geographical coverage varied among consortia. For 
some, the aim was to restrict or diversify the language for convenience and inclusivity 
respectively. For others, the aim was to leverage on existing wider regional structures 
such as country alliances. For others still, particularly consortia with a focus on a specific 
research area, the aim was more research-driven. Leaders sought to attain research 
synergies with partners with similar or diverse research contexts.   
We wanted to cover much of the diversity of the continent, so we purposely wanted 
to have a representation of the different parts of the continent that is interested in 
[Research Area]. We know that the epidemiology is changing; not only is it changing, 
but it’s different. The transmission is different, and people are different. So, we went 
and looked for collaborators that can add more diversity to what we are doing. 
(Director 7) 
These considerations highlight the fact that though these are HRCS consortia, research-
oriented motivations affected partner selection decisions in some cases. This brings to the 
fore some of the underlying drivers of management decisions and how consortia perceive 
HRCS programmes, issues I discuss in more detail in the next chapter. 
 
Determining the Consortium Structure 
All consortia had two-tier structures, a practice which was largely influenced by the 
funding agency. As mentioned above, funders recommended the formation of smaller 
consortia during the funding application review process to promote management 
efficiency. This resulted in the categorisation of partners and the development of two-tier 
consortia structures. Consortia were made up of ‘institutional partners’ or ‘co-applicants’ 
in the first tier and ‘collaborating partners’ or ‘collaborators’ in the second tier. These 
terms and the functional differences between the two categories were also mainly 
determined by the funding agency. Co-applicants had part-ownership of the programme, 
made strategic contributions and significant intellectual inputs, were allocated some of 
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the awarded funds or received sub-awards, and had programmatic responsibilities 
towards delivering the outputs of the grant. The collaborators added intellectual and 
scientific value to the programme but played a minor role in delivering programme 
outputs. They did not typically receive grant funds, but costs related to activities 
undertaken by individuals from these institutions were covered by the lead institution. 
Consortia had to categorise their partners into these two groupings to adhere to the 
funder’s recommendations while retaining all their members, albeit with different 
statuses.  
We decided that the group was important, and we put a lot of work into keeping the 
group together… so, we used those agreed criteria to say, “okay we don’t want 
anyone to leave… we went with the institutions who met the criteria that the partners 
themselves had defined. The others stayed on as collaborating partners… And that’s 
the way that we tried to get two ends to meet. The one end was the expectations 
expressed by the funders, and the other was our commitment to the consortium as a 
whole. (Director 9) 
In categorizing partners, consortia leaders recognised the funder’s emphasis on 
excellence and its potential role in funding decisions and used that as a key criterion for 
determining the core partners.   
The review committee told us to decrease the budget and to focus on a limited number 
of countries that are more likely to deliver because the issue of excellence was 
already part of the criteria. They wanted us to focus on the places which are already 
capable of delivering. So, we had to take that advice and resize the programme. 
(Director 7) 
Thus, in structuring many of the consortia, ‘stronger’ partners were made co-applicants 
while ‘weaker’ ones became collaborators in response to the funder recommendations. 
Co-applicants had programmatic and budgetary responsibilities and were required to have 
the necessary resources and systems to manage and deliver on these responsibilities. 
Experience and past performance in previous programmes were used as indicators of 
partner capacity.  
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These sites were the ones that were considered to be very strong in terms of having 
strong environments for research and for grant management, and that would help 
the other sites. So, that was the main consideration. (Director 4) 
So, it’s more of the level of engagement and the level of productivity and performance 
by the respective institutions. That was the best in distinguishing between 
collaborators and partners [co-applicants]. (Manager 9) 
For our first phase… we put all the institutions at the same level, but reporting, 
administrative issues and the deliverables were very difficult for some of the 
institutions. So, we have decided this time to take such strong institutions as the co-
applicants… and the collaborators are the institutions that have a researcher 
involved in one of the topics or the institution where a fellow will be registered or be 
working at. (Director 10) 
One consortium even instituted an application process where partners applied to become 
co-applicants, and selections were made in a transparent manner based on criteria pre-
determined by the whole group. 
So, there were criteria on how to select the co-PIs, and it was sent to all partners and 
those who wanted to, applied to be a sort of partner institution… We looked at the 
resources of that particular institution… human resources for the discipline, whether 
they have established programmes that can be used to enhance the other partners 
within the network… and then the past experiences in terms of capacity building and 
research. (Director 6) 
All consortia adopted a hub-and-spoke management model, where the lead institution 
functioned as the hub of all consortia activities. All other partners were then connected to 
this central point. There were two variants of this model due to the two-tiered structures, 
the single and multiple hub models (Figure 5.2). In the single-hub model, all partners 
related directly with the lead institution irrespective of their tier. All partners received 
resources from and reported to the lead institution. In the multiple-hub model, the lead 
institution related mainly with co-applicants, who in turn related with the collaborating 
institutions. Co-applicants functioned as second-level hubs and thus received resources 









The single-hub model was the most commonly used structure with only one consortium 
employing the multiple-hub model. The hub-and-spoke model was prescribed by the 
funder. In this way, the funder related to and held only the lead institutions accountable 
for the consortia’s resources and deliverables. 
We deal mostly with the lead institution. Now that was a very deliberate decision we 
made. So, what we’re promoting is a hub-and-spoke model of consortium 
management… As the lead institution, you’re the hub. You take charge and 
responsibility for the resources that we give you on behalf of the entire consortium. 
You’re responsible for accounting for every dollar that goes to the consortium.  You 
will provide leadership not just for the science but also for managing the people, 
managing your partners, managing the resources… so our expectation is that we are 
not directly managing the sub-grantees who are their partners. (Funder 
Representative 3) 
 
5.4.3 Planning and Implementation Phase 
The main processes undertaken by consortia in the planning and implementation phase 
included developing goals and activities, assigning roles and responsibilities, instituting 
governance and management structures, allocating resources, establishing partner 
management structures, and coordinating and monitoring. These are discussed in turn. 
 
Developing Goals and Activities 
Consortia goals and activities were mainly based on the DELTAS Africa strategic areas 
as well as partner priorities. Processes for developing consortia goals were reported to be 
mostly participatory, either through a bottom-up or top-down approach. In the bottom-up 
approach, partners considered their strengths and needs and proposed their goals and 
activities. These partner-level goals and activities were discussed in line with the strategic 
areas, and the consortium goals were then formed. In the top-down approach, consortia 
leaders started the development process and proposed consortium goals and activities to 
partners for wider discussions and partner level inputs.  
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When we were writing the proposal, we sat down, and we said, right, what are the 
needs for [Partner A]?... [Partner B] has the greatest needs in the whole consortium. 
How can we support? (Director 2) 
Goals for the consortium are negotiated. We’ve agreed on zeroing in on three main 
strategic classes… The thing is that the needs across the African universities are very 
similar… All these things are mooted at the secretariat, then in the partners’ forum, 
they are presented and critiqued, and then we come up with a final product. 
(Manager 9) 
In some cases, consortia emanated from existing networks and hence their goals were 
based on common research interests or previously determined research objectives.  
We knew what the problem was. Actually, before we applied to this, we had a position 
paper which was published… where we really went into much depth to think about 
what we want to do and actually put it down on paper and to publish it. So, we already 
had a road map. (Director 9) 
In other cases, goals were informed by partner strengths as consortia leaders perceived 
that leveraging partners’ strengths would ensure a more competitive application and 
better delivery of grant outputs. 
We asked ourselves, “what would be the strengths of our network in applying for this 
grant”. Part of it was informed by what we thought were the most important scientific 
questions… and what was the strengths of the sites in terms of being able to deliver 
on those goals. (Director 4) 
 
Assigning Roles and Responsibilities 
The lead institution had oversight responsibility for all consortium activities. Even when 
that responsibility was delegated in the multiple-hub structure, the lead institution was 
still ultimately responsible to the funder. Roles within consortia were primarily 
determined by partner strengths and gaps at both individual and institutional levels. For 
example, a partner institution with the capacity (human and infrastructural) to host and 
lead training sessions was assigned that role. Similarly, partners with institution-specific 
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gaps took up the responsibility for driving those components of the programme. Roles 
were mostly assigned through discussions among partners.  
There are people who train… so they already know who has the capacity to teach… 
We sort of know that for the MPhil, [Partner X] already has an MPhil programme 
running, so they’re sort of in charge of the MPhil programme. And then for the PhD 
programme only [Partner Y] had a PhD programme already running, so they sort of 
give guidance to everybody else. (Manager 2) 
We actually came together to discuss these issues and we sort of laid down who is 
most likely to be able to do what. So, we took the strength and weaknesses of the 
various institutions and the various PIs, and then we took into consideration issues 
like gender balance and things like that. (Director 7) 
Co-applicants and collaborators were differentiated by their roles and responsibilities. 
However, there were similarities as well as differences across consortia in the roles 
assigned to the different categories. Whereas only co-applicants participated in governing 
boards in some consortia, this role was open to both categories in others.  
Those co-PIs form part of the Executive Committee of the consortium, while others 
are simply partner institutions where our programmes are being executed. So, the 
co-PIs also have programmes being executed, but on top of that, they are also 
members of the Executive Committee. (Director 6) 
The collaborators are stakeholders that contribute to the overall running of the 
programme, and there are places where they can contribute students. So, their 
students are eligible for applying to the programme, and they are part of the 
management of the programme, but they don’t receive a budget. (Director 7) 
In all but one consortium, only co-applicants had programmatic and fiscal responsibilities 
and had budgets while collaborators had only scientific responsibilities. This was because 
co-applicants were generally seen as jointly accountable for the funding together with the 
lead institution, whereas collaborators were not. 
For the co-applicants, their institutions have specific institutional budgets, but for 
the collaborators, they basically do not have any budgets allocated to them, that’s 
basically the difference. (Manager 5) 
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The co-applicants are responsible for everything with the funder… with the 
deliverables. (Director 10) 
 
Instituting Governance and Management Structures 
Though each consortium determined its own governance and management structures, all 
consortia aligned to similar levels, with only slight naming variations. Four main levels 
of governance and management were established across most consortia: advisory, 
steering, executive, and technical; though a few consortia make use of only the first three 
levels (Figure 5.3). Advisory level bodies provide high-level strategic oversight and 
constitute individuals with the requisite expertise and a wealth of experience. The steering 
bodies were generally made up of partner representatives and provide strategic direction 
for the programme. This included developing policies and processes, allocating resources 
and monitoring the progress of the consortium. The executive teams are responsible for 
overall programme management and day-to-day coordination of consortia activities. The 
executive teams operated from a Secretariat at the lead institutions and were made up of 
Programme Directors, Programme Managers and other support staff such as 
administrative, finance, M&E and communication personnel. The technical level groups 
were responsible for coordinating components of the programme, such as training or 
M&E. 
 




Governance and management levels 
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The funding agency required each consortium to have an external and independent 
advisory board. The decisions to use the other levels were made by the consortia 
themselves. These decisions were influenced by the desire to ensure transparent and 
inclusive decision-making, and facilitate coordination, monitoring and accountability. 
Previous experience of consortia leaders and lessons from other consortia also informed 
these structures.   
I think even at the beginning the funders said we should have an advisory board. 
(Director 1) 
We have always argued that there should be a representation from each partner 
institution on whatever committee so that the partners are in the know with what is 
going on, and then they participate in the decision-making. Governance will then be 
open, transparent and inclusive. (Director 5) 
I think previous experience; having participated in a large consortium like that, you 
know you need to have governing bodies, you need to have counsel so that when you 
start getting lost, they can put you on the right path. (Director 7) 
Consortia were also learning as they went along, and some of these governance and 
management bodies became necessary as consortia grew and learned lessons from their 
experiences. Thus, leaders adapted and introduced different levels based on the need.  
I guess again it’s an evolution type of thing… we started off with four PhD fellows 
and two postdocs… it gradually mushroomed, and we got more money, and there 
were more things to do… The implementation teams sort of budded out of the 
executive because it was too much for one committee to just manage everything. 
(Director 1) 
Allocating Resources 
Budgets were developed at the funding application stage based on planned activities. 
Consortia mostly maintained their budgets after the grant was awarded, although any 
activity changes were reflected in a post-award budget. Fund allocations to partners were 
done in two ways. First, because training was central to the DELTAS initiative, most of 
the funds were allocated to various training levels and were apportioned based on the 
targeted number of graduates. What differed among consortia was the mode of 
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distribution of training fellowships among partners. Most consortia followed a merit-
based system where potential trainees applied for fellowship opportunities and awards 
were centrally made to the most competitive applicants. A few consortia used a quota 
system where each partner was given a pre-determined number of fellowships. The merit 
system was based on open competition, and the quota system was based on equal 
distribution or partner capacity. For both the merit-based system, which was centrally 
managed and the quota-based system, which was managed at the partner level, the 
selection was competitive. The difference was the level of competition each system 
created. Consortia leaders admitted that the decision on which approach to adopt was 
challenging as each option had its pros and cons.  
Regarding other consortia activities, fund allocations were based on budgets submitted 
by partners either for institution-specific activities or assigned consortium-wide tasks. For 
example, in one consortium, partners had to go through an application process to receive 
funds for institution-based activities.   
What we do is we decide as a group, i.e. the partners together, on which functions 
will be managed centrally, and so we put money into that central pool…  we know 
we are going to be training PhDs and postdocs, but the selection is going to be a 
competitive process… The core budget does not belong to the lead or any partner 
institution; it’s in the central pool.  Then we have allocations that are institutional in 
nature. In the beginning, we decide on how much will go to this institution and the 
other institution depending on their needs to some extent but also the kind of plans 
that they have. (Director 5) 
Naturally, partners with bigger roles and responsibilities who were usually co-applicants 
ended up getting more resources than collaborators.  
They [co-applicants] get a bigger budget compared to collaborators, and that is 
linked to their involvement. For example, [Co-applicant X] was hosting a training 
activity… we supported them to build…  So, partners [co-applicants], as I’ve 





Establishing Partner Management Structures 
Partner management was done at three levels. At the strategic level, each partner was 
represented on the steering committee, creating a ‘peer-management’ system, and 
ensuring multi-directional accountability among both lead and partner institution. As 
noted in Section 5.3.3, one of the factors that influenced this type of structure was a desire 
for transparency within consortia.  
At the operational level, partner management mainly covered programmatic and financial 
oversight. Programmatic management involved monitoring the implementation of 
activities at both consortium and institutional levels. Financial management involved 
monitoring partner expenditure and reporting on allocated funds. While some consortia 
took a primarily centralised approach to partner management others took a more 
decentralised approach. For the primarily centralised approach, partners were directly 
managed by the secretariat. For instance, all fellowship funds were managed at the 
secretariat; and the expenditure for activities executed by partners was either directly 
made by the secretariat where possible, or partners received funds for specific activities 
for local payments. They subsequently submitted reports on the activity and the disbursed 
funds. One reason given for this approach was the need to avoid bureaucracies in partner 
institution that tended to slow down consortium operations. Another reason was trainee 
affiliation to multiple institutions in some cases which created complicated institutional 
arrangements, making it easier for the lead institution to manage all expenditure.  
It’s mainly bureaucracy, and bureaucracy can have a very serious impact on 
facilitating a fellow… slowness in processing and long procedures of procurement, 
where procurement is involved, kind of complicates the whole scenario. Yet here in 
the secretariat, this is the job we are employed to do… So, it’s not a matter of 
controlling others, but it’s more of facilitating the fellows. (Manager 9) 
If you see the way fellows are recruited, you will see that there is a problem of funds 
allocation. They can be in one institution doing research and registered to another 
institution; you see how the money flow will be complex… we have decided that the 
co-ordination centre should handle the fellowships. (Director 10) 
For the primarily decentralised approach, partners received annual sub-awards based on 
their work plans and budgets. Quarterly disbursements of budgeted funds were made 
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based on the work plans, and corresponding reports were submitted to the secretariat. 
Consortia adopting this approach cited the need for partner involvement in management 
as part of capacity strengthening, and to facilitate partner-level activities.  
The money comes to us, and then we have to disburse the money to our various 
partner institutions. So, to do that, we need to go into sub-contract with these partner 
institutions. They have to sign the contract, and then after everything is agreed upon, 
we send the funds. (Director 6)    
Once again, leaders needed to work through these different options and determine bases 
for their partner management strategy decisions. Finally, at the technical level, many of 
the consortia formed various committees with representatives from each partner 
institution to coordinate specific portions of consortia activities. For example, a finance 
committee was made up of finance personnel from all partner institutions. Hence, the 
‘peer-management’ system was replicated at this level.   
 
Coordinating and Monitoring Activities 
The executive team based at the secretariat led the coordination and monitoring of 
consortia activities. Partner Leads were responsible for all activities at their respective 
institutions. Annual reports from all partners were consolidated into a consortium report 
for onward submission to the funder. Coordination and monitoring were facilitated 
through multiple channels, including e-mails, telephone, and online and face-to-face 
meetings. Consortium-wide annual general meetings (AGM) were also organised by all 
consortia, providing a platform for leaders, partners, and trainees to meet and offer 
feedback on both scientific and managerial activities. Advisory and steering committee 
meetings were usually held alongside the AGM. Additionally, the executive team 
periodically visited partner sites for monitoring, learning and partner engagement 
purposes. The monitoring of consortium activities and outputs was based on the DELTAS 






5.5 Similarities and Differences Across Consortia 
There were some similarities as well as differences in management practices across the 
consortia studied (Table 5.2). Generally, there were similarities in the consortium 
structures made up of co-applicants and collaborators, the hub-and-spoke model, 
governance and management structures and processes, and coordination and monitoring 
processes. 
 
Table 5.2: Similarities and differences in management practices across consortia 
Similarities 
Management Structure/Process Description 
Consortium structure Hub-and-spoke models 
Partner categories Co-applicants and collaborators 
Governance and management 
structures 
Advisory, steering, executive and technical 
levels 
Coordinating and monitoring Reports, meetings, and site visits 
Differences 
Management Strategy for: Range of strategies 
Selecting partners • Prioritising partners with different levels 
of capacity 
• Focusing on different research and/or 
geographical areas 
Determining goals and activities • Top-down or bottom-up approaches 
• Focusing on partner strengths or gaps 
Assigning roles and responsibilities • Based on partner strengths or gaps 
• Different roles for co-applicants and 
collaborators 
Allocating resources • Merit-based or quota-based 
Managing partners • Centralised or decentralised systems 
 
The similarities across consortia appear to be unplanned. As indicated earlier, although 
the consortium structures were influenced by the funder, the governance and management 
structures and coordination and monitoring processes were mainly determined by the 
consortia themselves. The only exception was the requirement from the funder for all 
consortia to have an independent advisory committee. Therefore, the use of similar 
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structures and processes could have been because those had been frequently used by 
collaborations over the years and were the most known. Consortia leaders acknowledged 
that they applied learning acquired from experiences with other consortia.  
Differences in consortia approaches included strategies used for the various processes, 
including when determining goals and activities, assigning roles and responsibilities, 
allocating resources, and managing partners. For instance, some consortia used a top-
down approach in determining goals and activities, while others used a bottom-up 
approach. In the same way, consortia had two categories of partners, co-applicants and 
collaborators, but the levels of participation accorded the latter varied among consortia. 
While the categories were clearly differentiated in some consortia in terms of the roles 
and access to resources, there was very little distinction between the two in others. As 
noted earlier, resource allocation (particularly in awarding fellowships) and partner 
management approaches also differed.  
Due to the unique ways in which consortia approached their management processes, there 
were no obvious ways of categorizing consortia in clear groups. Even when consortia 
appeared to use a similar approach, such as the merit-based resource allocation approach, 
this was operationalised differently among consortia. For example, elements of the quota-
based systems were incorporated into merit-based resource allocation approaches in 
different ways, making it too complex to place consortia in distinct categories. Any such 
categorization may fail to depict the true picture of each consortium’s management 
approach as it will miss the intricate distinctions across consortia. This highlights the 
unique, contextualized, and nuanced nature of management approaches and demonstrates 
that consortium management approaches cannot easily be formularized.    
 
5.6 Cross-cutting Influences on Consortium Management Processes 
Exploring the management processes of consortia highlighted some key factors that 
influenced the different consortia practices. I present these factors next, which include 
funder expectations, perceptions of RCS, motivation for formation of consortia, previous 




5.6.1 Funder recommendations 
The role of the funder in consortium management decisions seemed paramount, as their 
preferences, advanced through recommendations and instructions, were often taken up by 
consortia. The funders’ influence in many of the management decisions, including size 
and structure of consortia, criteria for partner selection and categorisation, and 
governance structure was demonstrated across consortia. As noted above, funders 
recommended the formation of smaller consortia during the funding application review 
process to promote management efficiency. Additionally, the funder’s emphasis on 
excellence and preference for supporting stronger institutions was inculcated in consortia, 
which shaped their decision-making procedures. Thus, institutions with strong research 
and programme management capacity were prioritised in the selection of core partners, 
almost making existing capacity a pre-requisite for participation in the initiative.  
DELTAS is kind of unashamedly an elitist concept… We made a decision that we’re 
going to base the development of DELTAS around excellent science, and so we don’t 
see it as one of our roles to support very early stage and weak environments (Funder 
Representative 1) 
This raises questions about the capacity strengthening aim of the DELTAS programme 
and how that is manifested in the programme requirements and consortia processes. These 
questions will be discussed later in the thesis.  
 
5.6.2 Perceptions of research capacity 
Although the focus of all consortia was RCS, it became apparent that research interests, 
compared to strengthening research capacity, were a driving factor for many management 
decisions including partner selection and development of goals and activities. While it 
may be argued that there is substantial overlap between conducting research and 
strengthening research capacity, it appeared that often, consortia actors equated the two. 
Hence in many cases, management decisions appeared to be more research-oriented than 
capacity-strengthening-oriented. Additionally, there was more emphasis on technical 
research capacity than the managerial aspects of research capacity. As will become clearer 
in the next chapter, several factors influenced these orientations, which in turn had 
implications for management practices and capacity outcomes.  
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5.6.3 Motivation for Consortium Formation 
The motivations for establishing the consortia appeared to influence the management 
structures and processes that were eventually adopted.  For example, consortia that were 
motivated by opportunities to conduct research were more research-oriented in their 
decision-making, such as when prioritising goals and activities. In one of the consortia, 
the Director noted that the main motivation for establishing the consortium was to provide 
capacity for the other partners. This consortium's governance and management structures 
and processes were strongly built around lead institutional stakeholders, with few formal 
opportunities for the participation of the other partners. This approach suggests possible 
influences: 1) the consortium subscribed to a centralised approach to management, 2) the 
other partners were perceived to have little managerial capacity, or 3) the capacity 
strengthening goals of the consortium and process for achieving them were limited to 
technical research capacity and excluded managerial capacity. Again, this points to 
consortia actors’ perception of research capacity and its influence on management 
processes. A second consortium was motivated by the host institution’s quest for 
assistance in strengthening its research capacity. Hence, the main role of the partners that 
were brought on board was to help the lead institution achieve its goals. The management 
structures for this consortium were also strongly built around lead institutional 
stakeholders. 
We have an implementation committee that’s made up of representatives from the 
lead institution… We do not necessarily have a steering committee… we have a 
partner representative on our Advisory Board and a partner representative on our 
implementation committee. (Manager 3) 
It appears that the strengthening of partners’ capacity was not a primary goal for this 
consortium, and this appeared to reflect in the type of management structure used. Thus, 
the motivations that drove consortia formation appeared to consequently drive how 
leaders approached the management of the consortia.  
 
5.6.4 Previous partner relationships and consortia experiences 
It became clear that previous experiences played a huge role in management decisions 
throughout consortia processes. Consortia mostly opted for ‘the known’ such as previous 
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partners, new partners recommended by previous partners, and geographical areas which 
existing networks represented. It was noted that many of the management processes and 
practices were considerably informed by consortia actors’ previous experiences in various 
consortia; thus, these processes and practices appeared to be replicated from consortium 
to consortium.   
 
5.6.5 Intentionality and emergence 
Many of the adopted management structures, processes and practices were continuously 
refined as consortia went through the inception and planning and implementation phases. 
Although consortia proposed initial ideas on their management in the applications, these 
planned management frameworks were refined at the various stages as inputs were made 
by various stakeholders. Funder recommendations during the application review process, 
programme requirements, and partner inputs informed this refinement process. In many 
of the consortia, steering committees established during the planning stage deliberated on 
and agreed on the management processes. The degree of intentionality or emergence with 
regards to management processes varied across consortia. Some consortia were 
intentional about some elements such as geographical coverage and having inclusive 
steering committees which were upheld throughout consortia processes. Decisions on 
who took up the role of Consortium Director, which were made at the inception phase 
also remained unchanged across the board. On the other hand, the number of partners, 
consortium structure, and governance and management levels were some of the 
management-related elements that changed for some consortia during the application and 
award process. Generally, management processes and practices continued to be refined 
throughout all the consortium phases as even feedback from the implementation stage 
informed this process. 
 
5.7 Chapter Summary 
This chapter has presented a description of the consortia's management structures and 
processes at the pre-inception, inception, and planning and implementation phases. The 
findings indicate that similar management structures and processes were used across all 
the consortia. However, differences were observed in the approaches adopted by 
consortia in executing each management process. 
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Factors that influenced the choice of approach included leaders’ motivation for 
establishing the consortia, funder recommendations, and consortium actors’ perception 
of research capacity. Other strategic reasons such as maintaining existing networks and 
diversifying geographical and language reach also informed consortia decisions. It 
emerged that decision-making regarding management processes was not always a 
straightforward process as it involved navigating different options and balancing multiple 
influences on the process. There were indications of various dilemmas that consortia 
leaders faced in the process. For example, consortia leaders needed to consider whether 
to select partners with higher levels of research capacity or those with the greatest need 
for the opportunities that consortia sought to offer. Leaders also needed to make decisions 
between options such as decentralized and centralised partner management, and between 
quota-based and merit-based resource allocation approaches. These reveal the complex 
nature of decision-making in consortium management and the tensions that leaders have 
to negotiate in the process. It was evident that these tensions and the factors that 
influenced management strategy choices were critical to consortium management and 
merited a closer examination. These findings formed the basis for Phase 2 of the study 
where I conducted a more in-depth examination of the highlighted issues in a case study 
with three selected consortia. In exploring the management practices of the ten consortia, 
the different institutional, historical and programmatic contexts within which the 
consortia operated, their characteristics such as size and diversity, and the various 
management approaches used were highlighted. Hence, the three study cases were 
selected based on these factors, with the aim of leveraging the variations among consortia. 
The case study focused on examining in more depth the factors that emerged as critical 
in consortia management and outcomes. Thus, the cases enabled a closer interrogation of 
the processes and considerations in determining consortium management strategies and 
the effect of selected strategies on consortia operations and capacity strengthening. In the 








In the previous chapter, I described the management processes used by ten DELTAS 
consortia. I highlighted the similarities and differences among consortia and some of the 
key factors that affected their management processes. It became evident that differences 
among consortia lay in the management strategies used and consortia leaders encountered 
tensions in their decision-making processes as they were often faced with dilemmas when 
determining the management approaches to use. Tensions were revealed right from 
consortia’s inception stages, and the emerging tensions revealed the complex nature of 
managing consortia. Hence, it was important to unpack the processes involved in 
determining management strategies to uncover the nuances and drivers of consortium 
management practices. To further understand consortium management processes and 
approaches, and their determinants, I examined the decision-making considerations and 
influences in more detail in three case study consortia. In this chapter, I present the 
tensions encountered as these case consortia planned for and executed key management 
processes. I discuss the considerations made by leaders as they made choices between 
different potential strategies to adopt, factors which influenced their decisions, and the 
management outcomes when these strategies were implemented.  
 
6.2 Study Cases 
As indicated in the previous chapters, the three consortia were purposefully selected based 
on the following criteria: 1) consortium characteristics and contexts such as size, range 
of subject focus, and geographical and language diversity; 2) management approaches 
such as the use of centralised or decentralised partner management systems; and 3) type 
of lead institution such as university or research institute. 
Consortium A is hosted by a research institute and made up of fourteen (14) co-applicants. 
These constitute universities and research institutes from Africa and HIC. The African 
co-applicants are based in anglophone countries spread across three Sub-Sahara African 
regions. The consortium had previously implemented a capacity strengthening 
programme before the DELTAS initiative. Consortium B constitutes eight (8) co-
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applicants, is hosted by a University, and has both African and HIC partners. The 
consortium was established as a regional consortium, and hence all the African partners 
are based in a single sub-region and from anglophone countries. Consortium B has both 
universities and research institutes as partners. This consortium had also implemented a 
capacity strengthening programme prior to the DELTAS initiative. Consortium C is made 
up of eight (8) co-applicants. The consortium is hosted by a university and has both 
university and research institute partners, mostly from Africa. This consortium emanated 
from an existing network, though new members were added for the DELTAS programme. 
Partners are based in all four Sub-Saharan African regions and have different primary 
languages though communication in the consortium is in English.  
 
6.3 Tensions Encountered and Mitigating Strategies Adopted for Key 
Management Processes 
There were similarities in the tensions faced by all three consortia. However, the 
management strategies adopted across the cases differed, either by type of strategy or in 
how the strategy was implemented. I discuss the main tensions encountered by consortia, 
strategies adopted, factors that influenced those decisions, and how selected strategies 
worked out. 
 
6.3.1 Addressing individual or collective interests 
Consortia leaders had to deal with diverse interests of individual partners as well as any 
collective interests. Partners differed in capacities, interests, priorities and expectations, 
and consortium goals were not a simple amalgamation of the diverse partner goals. These 
inclinations were influenced by each partner’s level of research capacity, perceived 
capacity needs, and the value placed on the different capacity components. Budgetary and 
time limitations also meant that consortia needed to develop an acceptable set of goals 
and activities for their DELTAS programme. These goals had to be based on both partner 
and shared interests to ensure that the collaborative ethos was maintained.  
You are dealing with different people, different backgrounds with different resources 
and you always have this fine line to find between the interest of the group and each 
one’s interest… that’s where the leadership role of the leader comes in. If you are 
not careful, you will break the group. (Consortium C, Lead Institution, R1) 
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What I recall is the dilemma… given the breadth of interpretation [of research 
capacity] and the resources available. Of course, it’s difficult to cover the entire 
breadth with the resources available. And so, whereas ideally, you’ll like the capacity 
development to extend and cover all these different aspects, we had, in the 
application, to limit it. (Consortium B, Lead Institution, R2) 
A very dramatic example… We said, “what level of training should we focus on for 
researchers, postdoc, PhD, Masters, interns?” And of course, different people seated 
around the table, representatives of different institutions, had their views… One of 
those would even bang the table to say, “we are not interested in postdocs first of all, 
because we don’t have PhDs… that’s not our priority. If our institution is to move 
forward, we want Master’s training”, with a bang on the table. And you can see that 
was an interest driven by the peculiarities of the institution. (Consortium B, Lead 
Institution, R2) 
Although each consortium experienced and addressed this tension slightly differently, 
consortia’s interpretation of RCS and their respective foci served as the foundation and 
mould which shaped their decisions on goals and activities. Consortium A largely worked 
within its existing framework of individual-level training of researchers which had been 
established prior to the DELTAS programme.  
We must remember that a lot of the consortium ethos and thinking was already there. 
So, we took that thinking which was already aligned with a lot of our institutional 
goals (Consortium A, Partner Institution, R5) 
Similarly, because Consortium C had emerged from a research network, it had an existing 
road map for strengthening capacity in their research area of focus. Consortium C 
therefore tackled this tension by incorporating a wide range of goals in this road map, 
which provided each partner with the opportunity to work towards goals that were tailored 
to their needs. Their goals ranged from the training of individuals to building a continental 
network of research infrastructure.    
The consortium goals have been built to take into account the breadth of those 
needs… some have just MScs, because that’s where their needs are, and others have 
MScs and PhDs, and others have MScs, PhDs and postdocs, and others have a bit of 
all of that and also require sophisticated infrastructure… so we have been sort of 
providing for the whole array of needs. (Consortium C, Lead Institution, R1) 
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Consortium B had to juggle several interests and hence experienced more tension in this 
area. Consortium leaders were committed to identifying and addressing research capacity 
needs of the region as a whole. In addition, leaders were committed to a broad approach 
to research capacity strengthening that aimed to tackle both individual and institutional 
as well as technical and managerial capacities. Partner institutions also had their own 
priorities: 
There was a difference in the way our individual institutions looked at the need, 
which in some ways is not surprising… because you define your need based on where 
you are and what level you are at. You say, “I want to go there” while the one which 
is at a higher level at the beginning will say, “but that is too low a level, we want to 
go much higher”. (Consortium B, Lead Institution, R2) 
As a result of these considerations, it was essential for Consortium B leaders to address 
both individual and collective needs. In addressing this tension, two sets of goals were 
developed: consortium-wide and partner-specific. The former incorporated the 
consortium’s collective capacity strengthening goals, while the latter advanced partner 
institution’s capacity strengthening goals. Consortium leaders reasoned that:  
If institutions are going to be very interested in being part of the consortium, they 
must see benefits that relate to their own institutions… We also want to function as a 
consortium, and we have to strengthen the consortium (Consortium B, Lead 
Institution, R2) 
Hence, each consortium adopted a different approach in addressing this tension which I 
have termed as the ‘common goal’ (A), ‘two-level-goal’ (B), and ‘goal menu’ (C) 
approaches respectively. The two latter approaches appeared to provide opportunities for 
incorporating partner-level needs in consortia’s stated goals for the imminent programme. 
The former approach appeared to work with a common focus which is in line with a pre-
determined consortium direction.  
 
6.3.2 Prioritising efficient programme delivery or effective capacity strengthening  
Another major tension that consortia faced was between prioritising efficient programme 
delivery or effective strengthening of partners' capacity needs. This tension was 
experienced during several management processes starting from partner selection through 
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As indicated in the previous chapter, leaders were torn between selecting partners who 
had the capacity to perform or those who needed their capacity strengthened. Leaders 
were aware of the need to demonstrate competitiveness by partnering with ‘stronger’ 
institutions in order to successfully win the grant. Leaders reasoned that ‘stronger’ 
partners would result in high-performing consortia which would then be more 
competitive in future funding applications. On the other hand, consortia were aware of 
the programme’s capacity strengthening aim and the need to build up less capacitated 
partners on the continent. Leaders described deliberating on this dilemma considerably.  
Should we go for second-tier, third-tier, or first-tier universities? Should we go for 
universities that have a lot of funding and resources or should we go for universities 
which have nothing? We spent a lot of time in identifying our partners (Consortium 
A, Lead Institution, R2) 
It is a tricky situation because you want to present a proposal that is competitive 
against others and so you are debating… if you want a very competitive application, 
take the best institutions. Of course, everything else remaining equal, those are likely 
to be winners over a worst-case scenario where you’ve got just the not-so-strong 
institutions as a consortium. But when you start bringing in other considerations, 
you want to bring the weaker ones; you want to all move together; then the situation 
becomes a little tricky (Consortium B, Lead Institution, R2) 
Consortia took different approaches. While recognising the capacity needs of ‘weaker’ 
potential partners, Consortium A prioritised partner performance in their selection of 
partners. Consortium leaders reckoned that by selecting partners with adequate resources 
and capacity, the consortium would produce significant results: 
We are only dealing with first-tier universities… We were very deliberate about that 
because we don’t want to start from 100 kilometres. At least they were already 
running so let’s run with those… If you started with [University X], where do we 
even start? Do they even have fellows? Do they have faculty to train, maybe they 
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don’t? …and it’s not that [University X] doesn’t have gaps, but they don’t have the 
resources and infrastructure yet… So, it was strategic… if you want results, you have 
to pick and choose. Where do you want to invest your time? Sometimes you can push 
the mountain and move it one inch, but you would rather go for this mountain and 
move it one metre. So, it was deliberate. (Consortium A, Lead Institution, R2) 
Consortia B and C aimed for a balance by involving partners with varying levels of 
capacity. Both consortia had specific capacity strengthening goals. Consortium B leaders 
aimed to raise the level of the region’s collective research capacity through networking 
institutions across the region. Consortium C leaders aimed to address capacity gaps in 
their research area on the continent through linkages between institutions with existing 
research capacity and those with lower levels of capacity. Both leaders thus established 
consortia made up of a mix of ‘stronger’ and ‘weaker’ partners with the expectation that 
they would have the ability to both win and implement the grant and also strengthen the 
less capacitated partners.  
The Director said, ‘okay this is the map of Africa… we need to be wide and to cover 
the different regions of Africa and also the different languages, to bring everybody 
together” …We started with people who were interested in [Research Area] and 
already working on that topic, and then the second layer, also a bit. But the third 
layer was more from countries that were not doing much research (Consortium C, 
Partner Institution, R3) 
Opting for a mix of institutions with different levels of capacity was not without its 
challenges, and Consortium B leaders acknowledged that it involved the risk of delivering 
suboptimal results. However, the leaders reasoned that it was worth taking that risk in 
order to achieve the consortium’s primary aim of strengthening capacity. 
We wanted a mix of ‘stronger’ institutions and some which were not so strong in 
research… Without that consideration, we would have gone for just the strongest 
institutions. We would go with that because we know they’ll deliver, and capacity 
will be enhanced to a much higher level, and so to the viewers or observers, we will 
have a great output.  But we took the risk and said, “let’s have the less-strong in 
order to build their capacity”. Our interest as a network was to pull everybody up as 




It is clear that across the three cases, consortia leaders selected partners in alignment with 
their unique prioritised aims for the programme. 
 
Determining Goals and Allocating Resources 
As noted in their partner selection approach, Consortium A’s primary aim was to deliver 
programme outputs. Therefore, in determining goals, leaders focused on what one 
participant termed as “low-hanging fruits” and concentrated on activities that would 
quickly produce measurable outputs as stipulated by the programme’s evaluation 
indicators. Consortium leaders argued for investing more in individual fellowships than 
in institutional systems, reasoning that the former produced more results with less 
investment. Thus, in addressing the tension between efficient delivery of outputs and 
more effective capacity strengthening of partners, Consortium A prioritised the former 
and focused efforts and resources on training individual researchers. 
It’s easy to start with fellows… I don’t like low-hanging fruits, but maybe it’s a low-
hanging fruit. It’s easy; you can easily organize something and count. Data systems, 
for instance, are hard to count, but what is a good data system, how many can you 
set up, maybe 10? For the same amount that you can use to train 500 fellows, maybe 
you can set up 10 data systems. (Consortium A, Lead Institution, R2) 
Although Consortia B and C paid slightly more attention to strengthening institutional-
level capacity, all three consortia allocated most of their resources to individual researcher 
training. The effect was that other RCS activities such as the strengthening of institutional 
training programmes or infrastructure that may have benefitted less capacitated partners 
were allocated minimal or no resources. The emphasis on trainees appeared to have been 
influenced by perceived funder expectations. Although the DELTAS programme covered 
four strategic areas, evaluation indicators appeared to prioritise the training of 
researchers, which significantly influenced consortia decisions. The emphasis on 
quantified indicators was reported to have influenced consortia priorities. 
DELTAS has got those pillars of the theory of change… Of course, there’s a lot of 
emphasis on numbers; you know publications, amount of funding, and so forth… I 





Determining Partner Management Systems 
The tension between efficient output delivery and effective capacity development 
processes was also very evident as consortia determined strategies for managing partners. 
As was identified in the previous chapter, partner management systems were either 
primarily centralised or decentralised. Consortium A chose a primarily centralised partner 
management system, while Consortia B and C used decentralised approaches. These 
decisions were influenced by multiple factors. Consortium A leaders noted that an 
assessment of the partner institutions conducted during inception phase indicated gaps in 
institutional management systems and varying capacities across partners. Leaders argued 
that attempting to deal with these grant management gaps in partner institutions would 
adversely affect the consortium’s ability to deliver on its primary aim of training fellows.  
We knew that the financial systems were really problematic, and we didn’t want to 
be dealing with financial issues as opposed to dealing with the primary functions of 
the consortium. So, we said, let’s first push and get out the fellows… that process 
alone is capacitating to the partner institutions… We didn’t feel like at that point it 
would be wise. Otherwise, we would spend 50 percent of the time chasing money… 
because you know the bureaucracy of the Universities… can be problematic, so we 
wanted to remove that. We didn’t want people to say, “I can’t finish my PhD”. 
(Consortium A, Lead Institution, R2) 
Regarding the decentralised systems used by Consortia B and C, leaders noted that the 
main factor that influenced the choice was its value in capacity strengthening. Consortia 
leaders pointed out that establishing consortium management processes at the partner 
levels would strengthen additional capacities at these levels. Consortium B leaders noted 
that the consortium had a wide-range approach to RCS and subscribed to strengthening 
both scientific and managerial capacity at individual and institutional levels. Leaders 
noted that the decentralized system was employed because it was in line with that 
approach. 
We used that strategy because… we are interested in building capacity of individual 
researchers, individual research administrators and also capacity of institutions. 
And we think that if you decentralise, you give opportunity to institutions, because 
they are managing those funds, to build their own capacity in the process. 
(Consortium B, Lead Institution, R2) 
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The tension inherent in this decision was demonstrated when Consortium B leaders had 
to justify the choice of the decentralised system to actors within their own institution to 
allay fears of potential inefficiencies at partner institutions and the effect on consortium 
performance.  
The process included getting people to understand how the decentralised approach 
is going to work… explaining to some of my colleagues why you need to take that 
long approach… On the one hand, because of the bureaucracy, it kind of delays how 
fast you want to do things, but on the other hand sometimes that’s the price you’ll 
have to pay if you are going to build capacity. You’ll have to be patient with the 
systems. (Consortium B, Lead Institution, M2) 
Similarly, Consortium C leaders maintained that sharing management responsibilities 
with partners was not only a way of improving coordination but an effective way of 
sharing the capacity strengthening benefits of management with partners.  
We decided to share the responsibility, to share the workload and to share the 
resources so that the project runs better because it will be too much for just the lead 
institution… And it’s also a way of improving the capacity in these places… they 
have to be involved not just as participants, but playing a more active role in running 
an aspect of the programme, and in that process, it also improves their own 
capacity… in the specific deliverables that they have and also in project 
management…  So, having this decentralised system, sort of spreads or… contributes 
to the overall lifting of the research environment in these places. (Consortium C, 
Lead Institution, R1) 
There were many reactions to the centralised and decentralised partner management 
strategies from both consortia leaders and partners. Regarding the centralised system, 
Consortium A actors noted that there were fewer challenges with reporting requirements 
as leaders did not have to deal with systemic challenges in partner institutions. The lead 
institution had greater control of operations which averted risks and maintained the 




Centralising consortium funds is great, simply because different universities have 
different bureaucracies; and from experience and what I have seen, bureaucracies 
in different universities have delayed certain systems. Therefore, when you put it here 
[at the partner institution], you are likely to have mismanagement of those funds, not 
because they are mismanaged, or they are not doing the work, but quality control is 
missing (Consortium A, Partner Institution, R3) 
Both leaders and partners acknowledged that the main disadvantage of the centralised 
strategy is the missed opportunities for strengthening partners' capacity.  
We have noted that the disadvantage of the centralised system is that the partners do 
not really grow. They are dependent on the capacity of the lead institution… The 
capacity is still at minimal levels. (Consortium A, Partner Institution, M2) 
When we think about the next phase of the consortium, we think about how to 
strengthen this. We are sort of trying to see how to replicate the secretariat in all the 
partner institutions so that they do most of the work themselves. Because after ten 
years, maybe 15 years… we should have strengthened the institutions themselves to 
keep this thing moving (Consortium A, Lead Institution, R2) 
Consortium A partners also felt quite detached from the management of the consortium, 
engendering a diminished sense of ownership of the consortium’s activities and limited 
institutional embeddedness.  
We are not seriously looking at the consortium as a programme… That’s the main 
disadvantage… You seem like you are just supporting other than being a main 
player… because it’s centralised (Consortium A, Partner Institution, M2) 
When it comes to activities you want them to participate in that are not really 
financially tied, then you do a lot of lobbying… It’s more of a lot of negotiation that 
has to take place, and so one has to be very patient when dealing with the partner 
institutions… When it comes to other aspects that touch on finances, then there is a 
greater commitment, and it’s a more manageable way of dealing with the consortium. 
(Consortium A, Lead Institution, M1) 
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The tension between efficiency and effectiveness was not only faced by consortium 
leaders but also by partners who were still torn between the two options. 
There will be some partners that will be weak, and some will be strong. It’s good to 
build that capacity within the institutions so one can argue that. But I know after I’ve 
managed programmes where you sub-contract to people, it’s usually a nightmare 
sometimes to report. So, there are pros and cons of having a centralised system. 
(Consortium A, Partner Institution, R5) 
Similarly, the decentralised approach also had its advantages and disadvantages. 
Delegating managerial responsibilities through sub-awards gave partners the power to 
make decisions and control the grant at their levels. Partners were empowered to tailor 
their processes and plans to suit the local context, a process which facilitated capacity 
strengthening. This practice promoted partner ownership of the consortium’s goals and 
activities and helped sustain the built capacity.  
It helps when you give institutions some sort of power… you are building a system 
that will last other than having everything run from the lead institution… I think that 
also brings in some bit of ownership because the institution feels like oh, there is 
some money that comes here. (Consortium B, Lead Institution, M3) 
We’re building their capacity to move on beyond the current consortium grant… 
There are partners who’ve actually come back to us and said, “We are getting less 
money from the consortium, but we’ve actually learned a lot which has enabled us 
to go on to bigger grants”. (Consortium B, Lead Institution, M2) 
In addition, there is multi-directional peer learning as lead institutions also learnt from 
partners and partners learnt from each other. Lead and partner institutions learnt more 
about the unique contexts within which others operated. 
It’s good because this gives us a new experience to manage money, and it is a good 
experience… we are discovering new procedures, we are discovering new things… 
that is the benefit of the management of co-applicants. (Consortium C, Lead 
Institution, M2) 
On the other hand, consortia leaders were faced with delayed reporting and responses to 
information requests from partners which led to delays in the drawdown of funds from 
the funder and onward transfer from lead to partner institutions. Reporting delays resulted 
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from differences in institutional management systems, lack of clarity on what is required 
from partners, and bureaucracies inherent in partners’ institutional systems.  
Sometimes, the co-applicants are very late to send the report… if we have a big 
delay… we can’t have the money on time to do our activities. Sometimes, the bank is 
very slow to send the money to co-applicants… and sometimes the co-applicants and 
lead have different management procedures… it’s difficult to harmonize because a 
lot of countries are anglophone and we are French, and sometimes we have 
differences between the national procedures. (Consortium C, Lead Institution, M2) 
When the money has been released to the institution, it has to go through another 
process of the internal accounting system. That takes another period of time, and 
therefore we actually lose time… But that’s mainly the bureaucratic system within 
our own institution. (Consortium B, Partner Institution, M6) 
Generally, the orientation of some consortia actors towards efficiency over effectiveness 
reinforced the primacy of performance and competitiveness in consortia decision-making. 
Another key observation was that tensions between efficiency and effectiveness existed 
because of the perceptions and means of evaluating capacity strengthening outputs. 
Outputs such as persons trained were recognised as valuable deliverables, whereas efforts 
to enhance institutional systems were considered encumbrances to delivering these other 
outputs. Attention is thus drawn to how consortia perception of research capacity 
influenced the management strategies adopted. 
 
6.3.3 Focusing on excellence or equity 
Tensions between attaining excellence or equity were encountered during partner 
selection and resource allocation processes. As was observed in the previous chapter, 
when determining which partners to include, consortia leaders had to consider choosing 
institutions with higher levels of capacity or equitable representation of institutions from 
across existing networks or region(s) of focus. More significantly, equity also meant that 
leaders had to consider involving potential partners with lower capacity levels who 
needed the RCS opportunities the most. 
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The DELTAS always talk about excellence, and even at the onset, they wanted to start 
with institutions that were excellent. So, if we were to form the consortium in the 
spirit of DELTAS, then we probably would have a smaller consortium where we 
would just bring those who are already high up there. In our situation, we didn’t 
want to leave people behind because they were not excellent. (Consortium C, Lead 
Institution, R1) 
The conflict between excellence and equity was most evident in resource allocation 
decisions. As was highlighted in the previous chapter, leaders employed either a primarily 
merit-based or quota-based approach for allocating consortia resources. Leaders of all 
three consortia acknowledged the tensions they encountered as they deliberated on, 
selected and implemented strategies for allocating resources, particularly in awarding 
training fellowships. Consortia leaders were torn between the pursuit of excellence which 
prescribed the merit-based system and the desire for equity within consortia which 
supported the quota-based or balanced distribution among partners such as allocating 
more resources to partners with the greatest need. DELTAS Africa funders had 
emphasized the need for excellence in the initiative which consortia aimed to adhere to. 
Leaders were also keenly aware of the importance of equity not only to ensure that those 
who needed the capacity most received it, but to ensure good collaborative practice within 
the consortia.  
I have seen the scientists have a similar problem even when it comes to recruiting 
fellows into the program. And that question keeps coming up, is it merit or is it equity. 
It’s one that never gets answered. (Consortium B, Lead Institution, M2) 
For capacity building, there is a tendency to say we know the people we want in our 
institutions and so we can select them at the institutional level to meet our needs. And 
yet at the consortium level, you are saying no, in order to have a product which is 
the same high quality, let’s select them centrally using the same criteria… and that 
creates a tension. (Consortium B, Lead Institution, R2) 
All three consortia studied adopted the merit-based approach. This was influenced by the 
consortia’s prioritization of programme performance and positive funder evaluations. 
Some leaders also argued that although ‘weaker’ partners had greater needs, they often 
could not deliver training outputs even when given the opportunity due to their limited 
capacities such as limited pools for recruiting fellows and supervisors.  
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Allocation of resources is one where you know that at the end of the grant period you 
must deliver quality and show that you used the grant to deliver… It’s clear that if 
you put too much in the weaker institutions, it’s not going to be absorbed easily. So, 
in the governance discussions… should we allocate equal opportunities finance-
wise… should we say equal number of PhDs for different institutions? And arguments 
can go either way. The weaker institution will say we have a greater need therefore 
we should have more PhDs… it’s a valid argument… and remember we are looking 
at the finishing line, that we are going to be judged by whether we have achieved. 
(Consortium B, Lead Institution, R2) 
To address any imbalances in allocated resources that the merit-based system often 
created, each consortium incorporated various measures to promote a level of fairness 
among partners and minimise potential conflict. Consortium A capped the number of 
fellowship awards that a partner could receive, while Consortium B ring-fenced resources 
for partner-specific needs such as Masters training. Consortium C incorporated a system 
for levelling out geographical and gender disparities during the latter stages of the 
selection process. 
So, what we’ve done is put lots of specific guidelines… we don’t want one partner to 
have ten fellows… so that some universities don’t end up without anyone and then 
all the places are hogged by the ones which are already far ahead in terms of 
capacity (Consortium A, Lead Institution, R2) 
The procedure was well laid out… they look at the data and decide the cut-off point. 
But there is also the need for affirmative action for gender… So sometimes when we 
have just one or two female Africans, we definitely just push them once the 
applications are standard enough. Then there is also the need for having regional 
representation… you can’t give everything to one country. You have to still find a 
way of balancing things out and ensure there is a regional spread and the gender 
issues are taken care of. (Consortium C, Partner Institution, R4) 
Beyond the training awards, funds were allocated to other partner specific activities to 
attain some level of equity among partners, though this formed a small percentage of the 
consortia’s funds. In Consortium A, partners could apply for small grants from the 
secretariat for institutionalising some of the training initiatives to address local needs. 
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Consortium B allocated funds to partner-specific goals in line with its ‘two-level-goal’ 
approach.  
The excellence-equity tension manifested whenever issues of benefits to partners arose. 
Naturally, resource allocation to partners corresponded with assigned activities and 
responsibilities. While partners agreed with the principle of matching resources with roles 
and responsibilities, partners noted that it was crucial to ensure equitable distribution of 
benefits across the consortium.  
You would want people to move almost at the same level, you would want the benefits 
to be close, may not be exactly the same but it should be close… I don’t think that the 
consortium just wants to fund some universities better than the others. But I would 
think some universities have been more active, so that needs to be taken note of and 
then the gaps need to be closed (Consortium A, Partner Institution, R4) 
If you want to keep the group together and make it sustainable, then bear in mind 
that everybody wants something out of it, and the whole group wants to move. 
Everybody wants to move. You need to always be aware of that and take that into 
your decision-making and in how you orient resources and participation 
(Consortium C, Lead Institution, R1) 
Most partner reactions to the realities of the merit-based resource allocation strategy 
reinforced this concern. Generally, a partner’s satisfaction depended on the extent of 
benefits received.  
 I think we have probably the second or third largest cohort… so, the merit-based 
system has worked for us… some member institutions are starting to propose a 
different way when they see that things may not work well for them in the current 
system. (Consortium A, Partner Institution, R6) 
It has worked pretty well. Because the procedure was well laid out… but you have 
this silent incommunicado type of communication that should let you know that things 
didn’t go right for this person... I remember a couple of people who said that there 
are too many candidates from [Country]… and that’s why I said it works fairly well. 
Notwithstanding that, there has been no cause for a row… Everything was 
acceptable. (Consortium C, Partner Institution, R4) 
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Some partners still expressed support for the merit-based system irrespective of the 
awards received. For example, one partner institution had received no fellowships, but 
still supported the approach and advocated for maintaining standards irrespective of the 
inequities. 
There are standards, because if you start to implement, you are all bound by the same 
standard. Unfortunately, we have missed out in some of those because we couldn’t 
meet those standards. We didn’t get postdocs; we didn’t get PhDs. (Consortium B, 
Partner Institution, M1) 
Everything should be competitive. I know the disadvantages, yes, but in our days, we 
were all equal, and we competed very well, and I believe they can still do it 
(Consortium B, Partner Institution, R1) 
Generally, partners were not opposed to the principle of using merit to recruit trainees but 
recognised the need for implementing the strategy more equitably. Some argued that merit 
requirements appeared to favour trainees from some disciplines and backgrounds more 
than others.  
We decided that we would go for merit… It so happened that the criteria, that was 
the metrics we used to measure merit… turned out to be favourable to people who 
were in the medical sciences. (Consortium B, Partner Institution, R2) 
The other sites or members are already involved in [Discipline], so the profile of 
their students was more suitable to the requirements of the fellowship application… 
It was not the selection process, which for me I find simple, but it was the application 
requirements or the kind of students… it’s like the requirement for application were 
designed for those already trained (Consortium C, Partner Institution, R1) 
It is clear that perceived funder expectations and consortia’s pursuit for competitiveness 
propelled consortia to lean towards excellence. While appreciating merit-based trainee 
selection and the levelling measures in place, partners emphasized that it was necessary 
to ensure a more equitable distribution of benefits among partners even within the 




6.3.4 Prioritising shared power or greater control  
Consortia leaders faced tensions between sharing power among consortia partners or 
aiming for greater control as they established and operationalised governance and 
management systems. Sharing power within the consortia meant promoting inclusive 
decision-making and good collaborative practice; while greater control meant opting for 
the most efficient decision-making processes. These two approaches were not always 
aligned. While acknowledging the essence of shared power in consortia, the pressure of 
accountability heightened leaders’ need to have greater control over decisions. It is worth 
noting that there were basic levels of both shared power and control inherent in consortia's 
governance and management structures. The participation of partners in decision-making 
boards ensured that some levels of power-sharing existed in consortia. Simultaneously, 
the Consortium Director positions, with the responsibility of leading day-to-day 
operations, ensured that consortia leaders had some level of control. In some cases, 
Consortium Directors also chaired the steering committees.  
The degree of power-sharing varied across the three consortia. Consortium B actors 
reported that leaders made significant effort to ensure equal partner representation in 
governance structures and execution. Participants agreed that more than just having 
representative structures, substantial efforts were made to ensure that governance was 
inclusive in function, with negotiation and consensus-building as crucial elements. This 
ensured everyone was heard, promoting ownership of the consortium and its goals. 
There is a lot of consensus-building within the steering committee, and virtually 
every institution is represented whenever we have a call… The secretariat puts in a 
lot of effort to make sure that although it’s virtual, we have the right tools for it to 
function well. (Consortium B, Partner Institution, R2) 
We see it as a participatory approach to governance as opposed to a talk-down 
directive. There is a kind of negotiation-based governance, in that at any given time 
nobody is completely so wrong to be rubbished out. People would have to listen and 
then will still give good feedback… so that kind of negotiation, building the team, 
and building partnerships. (Consortium B, Partner Institution, M6) 
Consortium B leaders however, noted that this approach had risks and was not always 
easy to pursue. Leaders could only advocate for courses of action and had to accept 
partner decisions even if it could potentially lead to sub-optimal consortium results. This 
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is demonstrated in the quote below, which presents the Consortium Director's response 
to partners as they deliberated on goals and activities.  
If the institution feels strongly that they should delay getting involved with scientific 
citizenship, I’ll respect their decision. But on the day of judgment, they may have 
nothing to show. (Consortium B, Lead Institution, R2) 
Consortium B’s experiences draw out the risks and sacrifices associated with good 
collaboration practice which is sometimes achieved at the expense of consortium 
performance. Again, it also illustrates the efficiency-effectiveness tension faced by 
leaders. 
Consortium A leaders reported that they sought to attain a balance between shared power 
and control. The realities of their governance and management structures and processes 
appeared to prioritise control and efficient decision-making more than shared power and 
inclusion. The leaders reasoned that including all the partners at the steering level would 
result in a large body which will adversely affect decision-making efficiency. The 
consortium therefore established a smaller management board and created another forum 
which was open to all partners. The management board which met quarterly included 
members of the executive team and a few partners who represented all the partners. This 
pre-determined number of partner representatives were elected to sit on the board for a 
fixed term of office after which newly elected representatives took their place. All 
partners, however, participated in the wider forum which was held annually. Propositions 
are tabled by the executive team and first discussed at the wider forum before being 
forwarded to the management board where the final decisions are made.  
Consortium A partners expressed concerns about this system, noting that they still felt 
removed from decision-making processes and less like partners. 
I’m a co-applicant for the DELTAS, but I basically don’t have any serious influence 
in decision making… I can go into the parliament, i.e. the partners’ forum and say 
my views but I’m not on the management board… So, it’s like you are a co-applicant 
on that, but you don’t have a voice in it, that’s where the dilemma comes in. 




One of the few things that I have seen is, as partners, you are not much embedded. 
You don’t feel the grant as a partner; I don’t think the university feels the consortium. 
The only way you feel it is in the training of the students. But for the management bit 
and decision-making and who selects what, I think the university as a partner is not 
seen as much. (Consortium A, Partner Institution, M2) 
While pointing out concerns with the established management systems, partners 
continued to grapple with the tension between shared power and control as demonstrated 
in the quote below.  
There are some sort of influential people, and I suppose… they are doing it in the 
right capacity; these are the Directors. So, they are quite influential in terms of 
making decisions, although they have to justify them very well… There are sometimes 
a bit of, what can I say, executive decisions being made. But again, you know when 
you think of any organization, if it’s completely 100% democratic, decisions are 
made very slowly, and sometimes there is not a lot of accountability for them. So, you 
need some bit of executive decision-making where the buck stops, and I’ve seen that 
happen in the management board. (Consortium A, Partner Institution, R5) 
In the case of Consortium C, all partners were included in the management board. The 
board was made up of representatives of both co-applicants and collaborators and chaired 
by a representative from a collaborating institution. Yet, Consortia C actors reported 
greater control by the lead institution in practice. Partners recognised that although shared 
power among partners was essential, the Director had the ultimate responsibility to 
deliver on the consortium’s obligations and so required some control.  
The thing is, everything relies on the PI [Director]. He can take or not take advice. 
There is no written rule that in all this thing, we [management board] must enforce 
them, no…  I think it’s meant to guide. It’s meant to make sure that things are going 
well. So, he still has some room to manoeuvre, which for me is good, it’s not bad. We 
cannot have more than one person being ‘responsible’ for stuff; then things will never 
get done. (Consortium C, Partner Institution, R4) 
Indeed, partners trusted the Director’s leadership and recognised it as mentorship and 
training, particularly by the early and mid-career stakeholders. This was also because the 




The leadership of the Director is well-known and well recognised. Because people 
trust his leadership, they are on board and want to follow. He always ensures things 
are mostly done equitably… The Director listens to everybody. He has his mind set 
on some ways he wants to go, but he is able to change it, and this is very good. 
(Consortium C, Partner Institution, R3) 
The Consortium leaders also pointed out that power-sharing is inherently built into the 
governance structure, which puts some power into the hands of the partners. 
The leader is there to lead [laughs], so we sort of are responsible for executing what 
we said in the grant we are going to do. But we have a way of balancing that power 
by having the partners being members of the governing board… so, they actually, in 
reality, are the ones that set the pace of what the lead does... So, we as a lead tell 
them, “do this”… But what we are telling them to do has actually been dictated by 
them through the board, and if we don’t do it well, they feedback to us through the 
board. (Consortium C, Lead Institution, R1) 
 
6.3.5 Relying on tangible or intangible aspects of management 
The pull between reliance on the tangible or intangible aspects of management surfaced 
in consortia. This was not a tension that was explicitly considered by consortia, and 
decisions for one or the other were not expressly made. However, it appeared that there 
was greater reliance on tangible management elements such as structures and processes 
than on the intangible elements such as power dynamics, to produce the desired consortia 
outcomes. For example, although the right governance and management structures had 
been established in consortia to ensure inclusive decision-making, the level of partner 
participation in management was not always as expected. In Consortium A, leaders had 
envisaged that management structures that promoted participatory decision-making 
would result in enhanced partner engagement and proactiveness in driving local activities. 
However, this did not materialise. Partner engagement was not ideal, and Partner Leads 
needed constant prodding and pushing to get tasks accomplished.   
We have tried really hard to accommodate partners to feel like it’s a partnership… 
we’ve tried to put so many mechanisms to have participation in decision-making… 
but in the end, we still do the heavy lifting… Even things we expect the partners to 
take up, they don’t (Consortium A, Lead Institution, R2) 
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It appeared that a lack of incentive for active participation contributed to this situation in 
Consortium A. Partner Leads maintained that the over-emphasis on individual capacity 
strengthening activities produced minimal benefits for them and their institution. 
Additionally, they had very little control of consortium activities as they lacked proper 
sub-awards and did not directly manage their trainees.  
One Consortium A participant also pointed out that intangible elements such as individual 
agency were responsible for the varied influences in decision-making and not necessarily 
the structures put in place.  
I think that when it comes to influences in the board of management, there is no real 
inequity issue there apart from that related to the individual characteristics of the 
representatives on the board. I don’t know how well you know them, but some of the 
representatives are very powerful, and that’s not a system question it’s an individual 
person question. (Consortium A, Partner Institution, R9) 
Consortium C had established the most inclusive management board among the three 
consortia and had a partner management manual which laid out some of the required 
processes. However, several limitations affected some partners’ participation in decision-
making and partner engagement in general. First, partners with less research capacity and 
experience felt it was appropriate to defer to those with more capacity and experience 
during discussions:  
Some people are more influential because first they have more experience in certain 
areas, so it’s mostly because of that. I think it’s based on the experience and also 
what they bring on board… So, for me, I totally understand that their voice is louder 
than mine (Consortium C, Partner Institution, R3) 
Second, partners with little or no expertise in the sub-speciality that the consortium was 
focusing on felt inhibited and inadequate, thus hindering the full participation of these 
partners in decision-making.  
For example, I am not a [Discipline] researcher… it was not of interest for me to be 
involved in the practical training of the students… It depends on the subject. Some 
may not be interested in some subjects, and they do not participate even if they are 
supposed to participate (Consortium C, Partner Institution, R1) 
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Third, partners who joined the consortium in the latter stages perceived themselves as 
fringe partners and hence participated less in decision-making. This was because the older 
partners were already involved with the consortium’s activities or in the pre-existing 
network and had built working relationships which newer partners were now easing into.  
I think when the network started, there were only four, five people and then they 
invited more. So, there is a first layer, second layer and the third one. So, I would 
say the core and the second layer are always hands-on and always available. But 
maybe the third layer… it’s a bit more complicated to get them involved. (Consortium 
C, Partner Institution, R3) 
Fourth, the language diversity in Consortium C meant that not everyone was fluent in the 
consortium’s lingua franca which is English, a factor that was pointed out as a major 
hindrance to participation in management deliberations. Even for the non-anglophone 
partners who could generally communicate in English, holding consortium discussions in 
English was still a significant challenge and this limitation induced a feeling of exclusion. 
This was raised by both anglophone and non-anglophone participants.   
It’s a disadvantage for individuals who are not fluent in English… Most of the time 
during meetings, you can speak, or you can give your opinion, but you can’t make 
major inputs… you are never sure that you will give your true opinion… Sometimes 
I lose some words, so I can’t really participate in the discussion… When it’s time to 
give my opinion, I cannot give it because, for example, I did not really understand 
what those sentences or words meant… In the way of improving the English, it’s 
good, but in the way of communication, this is not really good… it is not efficient, 
and some individuals find themselves excluded. (Consortium C, Partner Institution, 
R1) 
The management board, I think it’s been good… people are willing to contribute, but 
the main sticky point is the French-English thing… where people want to talk but… 
particularly the French, articulating yourself in the meeting becomes difficult 
(Consortium C, Partner Institution, R4) 
The situation became more complicated when a partner was faced with two or more of 
these limitations. The compounded effect made it even more difficult to overcome the 
constraints. For example, partners with less research capacity and language challenges 
who joined the consortium at a later stage found it extremely challenging to fully 
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participate in consortium discussions. Although partners believed that it was possible to 
exercise agency and overcome such limitations, it rarely happened. For instance, the same 
constraints made it difficult for such partners to request for special considerations such as 
language translations that could have helped them overcome some of the challenges.   
If you take [Partner X] for instance… if their interaction isn’t that massive, you don’t 
hold them responsible, because they are not a mainline [Discipline] person… that’s 
why it has to have that link with your career… So, your individual motivation, your 
passion for what we are doing, your language barriers, your institutional capacity 
and strengths… all these things affect your full participation. (Consortium C, Partner 
Institution, R4) 
You are not a specialist in the main research… But you are also not fluent, so it’s a 
disadvantage. Though this disadvantage should not stop you, it’s true that it’s a 
disadvantage. And it’s true that you accepted to be part of this network. Of course, 
you will not ask the PI and everybody to improve or to translate everything for you, 
so you also have to make some efforts. (Consortium C, Partner Institution, R1) 
The interaction between the tangible and intangible was again demonstrated in the 
assignment of roles and responsibilities and resource allocation. Stronger partners were 
assigned more responsibilities and received more resources to fulfil these responsibilities, 
which naturally, resulted in their receiving disproportionate benefits from the consortium. 
However, it was pointed out that the proactiveness of less-capacitated partners could 
prompt some changes in some of these consortia structures.  
And I have even realized that [Partner X] seem to have benefited much more from 
the consortium. I am not saying there has been a foul play, but you need to be active 
or proactive (Consortium A, Partner Institution, R4) 
The partners also feel that the secretariat does a lot of heavy lifting, but in a way, 
it’s also disadvantageous because you don’t build capacity for certain things. So, 
there was a lot of… I would say, demand and pressure for devolving some of these 
things. (Consortium A, Lead Institution, R2) 
These experiences draw attention to the roles and varying reliance on tangible and 
intangible elements of consortium management. In many cases, although the tangible 
structures were in place, their proper functioning was limited by factors that were less 
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tangible such as perceived lack of power-sharing and feeling of inadequacy. Equally, 
intangible measures such as communication and agency were required to adequately 
identify and address these limitations. In some cases, the functioning of these structures 
also generated various responses which included feelings of dissatisfaction and inequity. 
Some consortia leaders noted that the intangible aspects of consortium management are 
even more critical than the tangible.  
It’s one thing to agree on how to move forward. When the reality comes and when 
the rubber hits the road as they say, then people start developing all sorts of feelings, 
“No, we should change that”, “But we agreed at the beginning” … these are all 
governance issues. So, the challenge is not so much the structure of governance but 
the real issues and the functionality. The structure can be discussed and agreed on 
fairly easily. (Consortium B, Lead Institution, R2)   
Intangible elements such as leadership styles played an enabling role when Consortia 
Directors consistently made efforts to ensure partners felt included in management and in 
the consortia more broadly. The consortia experiences point out the essence of both 
tangible and intangible elements in consortium management. 
 
6.4 Approaches to Management Decisions and Implementation 
The strategies used in addressing emerging tensions across the management processes 
and the cases appeared to fall in seven categories (Table 6.1).  
The identified categories of management strategies were not mutually exclusive in 
practice. Often, a single management strategy was multi-dimensional and exhibited 
characteristics of multiple categories. For instance, the decentralised partner management 
strategy made use of structural systems, was a means of aligning with the consortium’s 





Table 6.1: Categories of consortium management strategies 
No. Category Examples of how this was applied in consortia 
1 Balancing options  
Balancing the merit-based approach to resource 
allocation with measures such as capped awards 
and gender and geographical levelling to mitigate 
its effect 
 
Combining consortium-wide and partner-specific 
goals as a means of addressing both individual and 
collective interests 
2 Output-driven decision-making 
Choice of stronger partners and a focus on 
individual levels in order to deliver the most outputs 
 
Use of a centralised partner management system to 
avoid the effect of partners’ institutional challenges 
on consortia performance 
3 Structural systems 
Establishing the roles of Consortium Director and 
Lead Institutions in consortia structure provided 
clarity on who was accountable to the funder  
 
Instituting management boards with representation 
from partners was intended to enhance inclusive 
decision-making  
4 Combining the tangible and intangible  
Supporting representative management boards with 
individual agency from both leaders and partners to 
enhance inclusive participation in decision-making 
5 Aligning with consortia philosophy 
Consortia leaders’ commitment to collaborative 
principles such as inclusion and equity informed the 
use of representative decision-making bodies 
 
Leaders’ commitment to capacity strengthening 
resulted in strategies such as decentralised partner 
management despite the risks to consortium 
performance 
6 Strength-based strategies 
A decision to focus on individual researcher 
training based on the consortium’s existing training 
strengths 
 
Allocating most of a consortium’s resources to the 
strongest partners 
7 Short- or long-term strategies 
Selecting the shorter-term strategy of training 
individual researchers only compared to the longer-





Consortia leaders did not always explicitly lay out all the available options when tensions 
were encountered or provide the principles or drivers behind the decisions they made. 
Additionally, it became apparent that tensions were not only tackled during inception and 
planning but needed to be continuously considered during implementation. Deepening 
understanding and changing needs continued to shape the preferences of consortium 
actors. Consortia were thus confronted with shifting stances on strategy decisions taken 
of both leaders and partners as realities unfolded, particularly when faced with 
unfavourable situations. 
Initially, we had said we were just going to rank people based on performance. Then 
we realized that some partners might get no one… so those were the very first things 
we confronted and then we said, ok we are going to put some checks and balances to 
make sure there is some kind of equity (Consortium A, Lead Institution, R2) 
Adaptability therefore became essential, and the value of dynamic management was 
highlighted as leaders continued to reassess and revise strategies as activities unfolded. 
This approach required continuous engagement and consensus-building throughout the 
implementation phase. 
 
6.5 Tensions and Emerging Consortium Management Issues 
The emergence of tensions and how they were handled highlighted some of the more 
relational aspects of management such as power relations, inclusion, equity, and 
leadership. 
Each emerging tension highlighted some of the ways that power dynamics in consortia 
materialise. For example, tensions related to the adoption of centralised or decentralised 
partner management systems demonstrated power dynamics related to the control of 
resources. Several sources of power were brought to the fore across the consortia 
including existing capacity, position and responsibility (consortia leaders), access to and 
control of consortia resources, ownership of goals, expertise, English language capability, 
and research and grant leadership experience. Partners who had less of these indicated 
that they felt they had less power within the consortia. Further, having less of multiple 
sources of power compounded partners’ feeling of inadequacy and further deepened the 
power imbalance. It also became clear that although some tangible measures to address 
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power imbalances such as instituting inclusive management boards, these power 
dynamics still persisted due to differentials in some of the intangible sources of power 
indicated above which were often not identified, explicitly acknowledged or purposefully 
addressed.   
Tensions and decision-making considerations also highlighted issues of inequity in HRCS 
consortium management. Identification of the different sources of power demonstrated 
the range of inequities in consortia. Capacity, geographical, language, disciplinary, and 
gender inequities were most highlighted within the consortia. Some of these inequities 
were not only drivers of tensions (for example efficiency vs effectiveness and shared 
power or greater control) but also influenced the strategies that were adopted (for example 
using decentralised systems and balancing measures in merit-based approaches). 
Capacity and gender inequities were more acknowledged by consortia, seen as important 
HRCS goals, and featured in consortia decision-making considerations. Capacity 
inequities were visible in both consortium management processes and capacity 
strengthening decisions, and so played a significant role in consortia decisions such as 
adopting varying partner management strategies and taking measures that promote less-
capacitated partners. Gender inequities in research capacity influenced some of the 
management strategies such as promoting gender equality in the award of training 
fellowships. Regarding leadership, only two out of the ten DELTAS consortia were led 
by women. Within consortia, measures such as promoting consortia roles taken up by 
women (such as partner and programme component leadership roles) were adopted to 
help address the prevalent gender inequity.  
It is worth noting that some areas of inequity and power imbalance received more 
attention than others. This was often due to funder stipulations. For example, gender 
inequity was highlighted by funders and hence received more attention in consortia 
decisions. On the other hand, the funders’ emphasis on excellence led to a preference for 
partners who could perform (in delivering programme outputs) more than less-capacitated 
partners, and more resources were directed to the former. In effect, less attention was 
given to addressing the capacity inequities within consortia. This demonstrated the role 





6.6 Perceptions of Research Capacity as a Key Influence on 
Management Strategies  
Tension management processes and the management strategies adopted by consortia 
revealed the different perceptions and priorities of consortium actors regarding research 
capacity. These perceptions appeared to be both a source of tensions and a significant 
influence on management decisions. I discuss these perceptions and their drivers next. 
  
6.6.1 Conceptualisation and prioritisation of research capacity 
Research capacity meant different things to different consortia actors. As a result, the way 
research capacity was conceptualised and the research capacity components that were 
prioritised varied across individuals, institutions and consortia. The influences of these 
different perceptions were evident as tensions emerged and decisions on various 
management processes were made. For example, during the development of consortia 
goals and activities, varying interests within consortia originated from actors’ perception 
of what research capacity entailed. While some actors interpreted research capacity 
narrowly, focusing on the training of researchers, others had a broader perception which 
encompassed both researchers and their environments. Even regarding individual 
training, many focused on the technical training, but some advocated for a more holistic 
researcher training, including aspects such as management and grant writing. Perceptions 
of what constituted the environment also differed. Some consortia members focused 
mainly on physical research infrastructure such as laboratories and internet facilities; 
others expanded their interpretation to include support functions such as librarians, 
research administrators and accountants, and research management systems such as 
policies, processes and software. Second, emphases were placed on different research 
capacity components by different actors. Priorities differed among partners, and 
sometimes between partners and consortia leaders. Some partners preferred to focus on 
individual-level capacity strengthening over an institutional-level focus and vice versa. 
Some partners also preferred some of the DELTAS strategic areas over others.  
The tendency of attraction is more to the first two and less to the last two [of the 
DELTAS strategic areas]. The last two being where there’s capacity development of 
research administration and then the one on scientific citizenship. But the other two 
[scientific quality and research training], that’s where the, call it natural drift is… I 
do recall one of the partners, who in the first year put it bluntly, it is waste of time to 
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spend on scientific citizenship…maybe waste of time is putting it too strongly but not 
so valuable place to put emphasis. (Consortium B, Lead Institution, R2)     
I will speak as a scientist … what we prioritize more is to build research focused 
laboratories. Because for all my postdocs, and even for my PhDs, I had to go out and 
look for a very strong lab because we don’t have laboratory capacity here to do some 
of the experiments. So, I believe that in my university, we can strengthen the capacity 
of early scientists by building more research focused laboratories. (Consortium A, 
Partner Institution, R2) 
Additionally, there appeared to be different perceptions of how research capacity was 
strengthened. It seemed, for some consortia members, that conducting research was 
equivalent to research capacity strengthening. Indeed, the production of research outputs 
appeared to be ranked higher than other capacity strengthening activities and outputs by 
some consortia actors. This was evident when consortia had to address tensions between 
excellence and equity. Excellence in capacity strengthening was often likened to excellent 
research, a reasoning which sometimes led to preferences for research-oriented decisions 
over capacity-strengthening-oriented ones.  
So, I run a consortium that we’ve also got PhD students, but it’s around a research 
area… We’ve got students who are embedded in that research program, and what I 
see from there is that it’s much more directed towards a goal. So, the research 
students, we’re not only interested in them and how they are doing, but we’re also 
interested in their output. It’s like those outputs are also part of us a senior 
researcher, our deliverables, so it’s like we have a stake in this. We are more 
committed to ensuring that the deliverables are actually attained.  If there are papers, 
our focus is usually around, “when is the data going to be ready” … “we must put 
them together we are going to present them to WHO or ERG. While Consortium A 
does not have that pipeline or that goal... not really interested in what’s been 
published or whether it’s in a high-impact journal… It’s more of have they completed 
that milestone (Consortium A, Partner Institution, R5) 
Irrespective of the different research capacity interpretations and priorities, each 
consortium appeared to have worked out their RCS philosophy, which then shaped their 
management focus. For example, Consortium A focused on training of individual 
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researchers, while Consortia B and C opted for a broader scope which focused on both 
individual and institutional capacity. Consortium A’s approach to RCS was underlain by 
the ideology that individuals are key drivers of research excellence and agents of 
institutional capacity development. Consortium B however, subscribed to the philosophy 
that the best approach to RCS was to simultaneously tackle individual and institutional 
capacities. For Consortium C, individual capacity strengthening was only possible within 
strong institutional environments, and thus the programme focused on strengthening the 
technical research capacity of stronger partner institutions to serve as platforms for 
training individuals from across the consortium. 
For me, it’s strengthening people, and people will strengthen systems. That’s the first 
thing… you give skills to the person, that person will look for funds, will look for 
grants, will do a, b, c, d, and will strengthen and bring in all the other capacities 
around research. (Consortium A, Partner Institution, R5)  
It’s a broad spectrum. I know there are organizations that just focus on PhDs, “that’s 
the training we are offering, and that’s the research that we want to strengthen”. You 
go there, get your thesis and get your award. But for [Consortium B], it’s really 
broad, so it spans from the administrators being trained, the finance people being 
trained... (Consortium B, Partner Institution, M4) 
There is the strengthening of the research environment… and that environment when 
created needs people with a certain level of capacity to take advantage. So, you then 
go on to the individual capacity… It’s a kind of pyramid… beginning to deal with the 
research environment and making sure that this capacity is built at the individual 
level (Consortium C, Partner Institution, R4) 
These leanings, to a large extent, informed consortia’s management strategy decisions. 
To illustrate, Consortium A’s decision to focus on training individuals while holding off 
on institutional enhancements, and Consortium B’s broad-range interpretation and 
decision to address both levels simultaneously aligned with the choice of their respective 
centralised and decentralised partner management approaches. The quote below evinces 





Resources are limited, so you have to prioritise. But you prioritise at a risk because 
when there are pieces which are vital to research and they remain unattended to, the 
strengths or the degree to which you build your research capacity would be very 
much influenced by the weakest link, so to speak. And if the weakest link is concerning 
item X which you are not paying attention to, it might very much influence what else 
is happening. (Consortium B, Lead Institution, R2) 
Various factors informed individual and consortia perceptions of research capacity and 
the thinking behind the RCS philosophies. These are presented in the next section.  
 
6.6.2 Drivers of research capacity perceptions 
Across all the consortia, several factors influenced actors’ interpretation of research 
capacity and determined their priorities. These included the DELTAS objectives and 
evaluation requirements from the funder, the value individuals and institutions assigned 
to the different research capacity components, and the level of research capacity of partner 
institutions. I discuss these in turn. 
The objectives of the DELTAS initiative and the evaluation indicators stipulated by the 
funder significantly influenced how consortia interpreted RCS and the research capacity 
areas that were prioritised. For example, indicators such as the number of students 
completing their training and the number of research publications produced directed 
consortia's focus towards achieving those outputs. Evaluation indicators appeared to have 
had the most influence on consortia’s approach to RCS and their decisions to allocate 
substantial resources to the training of researchers. As realized earlier, the desire to be 
competitive, considerably shaped consortia decisions. Thus, in defining and prioritising 
research capacity components, consortia were extremely mindful of impending 
evaluations and how their performance would be assessed by funders.  
DELTAS has got those pillars of theory of change… Of course, there’s a lot of 
emphasis on numbers; you know publications, amount of funding, and so forth… I 




Some consortia leaders admitted that the focus on evaluation indicators was sometimes 
maintained at the expense of other capacity needs.   
There’s pressure sometimes to move things from skills-building to real research work 
and publications… There’s a lot of pressure on the whole system; the students and 
the PIs alike, to make sure that certain boxes are ticked. Because you know that these 
are the evaluation pillars and the milestones that they are expecting us to achieve. 
(Consortium C, Partner Institution, R4) 
Another factor which influenced RCS perceptions was the ranking of research capacity 
components. Consortia actors seemed to assign values to the different components, and 
these perceived values determined the level of attention given to each component. The 
weightings appeared to have two bases. Components that were considered valuable to 
funders were prioritised, as these were expected to increase consortia’s competitiveness 
for donor funding. Evaluation indicators were used as markers of funder priorities. This 
value system also appeared to be influenced by what was valuable to Consortia Directors 
and Partner Leads, who were primarily researchers and hence appeared to prioritise RCS 
components with a relatively higher academic value. For example, publications in high 
impact journals were generally ranked higher than other research outputs. 
I think when you talk to some of the partners, they are even less interested in the 
scientific citizenship because their interpretational thinking is that, it is not going to 
buy you a lot of mileage if you focus on that goal or on that aspect. It is not going to 
buy you a lot of mileage in terms of being competitive. But if you focus on the quality 
of science, quality of training, and again quality defined as the technical professional 
skills then oh yes, that’s going to be very competitive. (Consortium B, Lead 
Institution, R2) 
Consortium actors’ level of research capacity also influenced their approach to RCS. Each 
actor’s perception of research capacity and their own capacity needs were shaped by the 
maturity of the research enterprise in their contexts. These perceptions consequently 
informed partners’ and consortia’s RCS focus areas. Stronger institutions tended to 
advocate for strengthening a broader range of individual training and institutional 
capacity strengthening while less capacitated institutions focused more on individual 




Five to ten years ago, there would be no research support per se. The scientist would 
basically do everything… I think it was out of the infancy of the research culture on 
the continent. Now we are increasingly realizing that there should be proper 
research support for the activities that we do which means admin support; it means 
financial support; it means ethics regulatory and… legal support to properly run a 
research enterprise. (Consortium C, Lead Institution, R1) 
If you come to this institution, you will find that almost 80% of staff now have PhDs. 
So, more PhD funding from consortia doesn’t help. We have reached critical mass… 
So, I think these consortia should now bring in refresher courses, not necessarily 
PhD training. Because for the staff here, there are some skills that we need 
(Consortium A, Partner Institution, R2) 
As prevalent capacity needs were met, research environments became more advanced, 
and understanding of research capacity was expanded, other needs were brought to light, 
and new priorities emerged.  
 
6.7 Chapter Summary 
This chapter examined the tensions consortia leaders encountered as they determined and 
implemented strategies for key management processes. I identified factors that influenced 
those decisions and the perspective of different consortia members on the outcomes as 
decisions were implemented. A summary of the tensions encountered by the three 
consortia and the management strategies adopted is presented in Table 6.2. 
In some cases, consortia leaders sought to balance the options rather than choosing one 
extreme or the other. In others, consortia made distinct decisions, accepting the risks and 
sacrifices associated with those decisions. Multiple categories of measures were adopted 
in determining management strategies, and a strategy could be formed from merging 
multiple measures from the different categories. It also became clear that consortia actors’ 
varying interpretations of research capacity and pathways to its strengthening contributed 
to the emergence of management tensions and the type of adopted strategies. This chapter 
has drawn out the intricacies involved in consortium management and the complex 
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decision-making processes required. In the next chapter, I discuss the role and effect of 
these management processes on the RCS aim of consortia. 
Table 6.2: Tensions encountered by consortia and strategies adopted 
Tensions 
Consortia Strategies 





• Individual training of 
researchers 
Two-level goals 
• Collective + Partner-
specific 
• Individual + 
Institutional 
Goal menu 
• Range of goals for 
tailoring by partners 




Selection of partners 
with higher levels of 
capacity 
 
Focus on one research 
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with varying levels of 
capacity 
 
Focus on multiple 
research capacity levels 








Selection of partners 
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Focus on multiple 
research capacity levels 
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Steering board and 




















Combination of both 
aspects but more 
reliance on tangible 
than intangible 
Combination of tangible 
and intangible aspects 
Combination of both 
aspects but more 








CHAPTER 7: THE ROLE OF MANAGEMENT IN RESEARCH 
CAPACITY STRENGTHENING 
 
7.1 Introduction    
In the previous chapter, I presented the intricacies of decision-making processes in 
consortium management.  In this chapter, I consider the position and role of these 
management processes in the RCS agenda based on the findings from the case study. I 
examine how management features in research capacity strengthening efforts. To do this, 
I draw out the mechanisms through which management experiences translate into 
individual and institutional research-related capacities and the factors that facilitate these 
mechanisms. I also outline some of the capacity gains consortia members derived from 
these management processes.  
 
7.2 The Position and Role of Management in RCS Programmes 
One of the four strategic areas of the DELTAS programme centred on research 
management and environment, which indicates a recognition of the managerial aspects 
of RCS by the funder. According to funder documentation, this strategic area covered 
securing sustainable funding, physical infrastructure to support research, and functional 
consortium governance and management structures. These were expected to inform 
programme components and consortia activities. However, the interpretation of the 
strategic area varied across consortia. Consortium A appeared to interpret it as the 
provision of infrastructural and management support for the consortium’s activities. 
Consortium B and C participants interpreted it as the strengthening of research 
infrastructure and management support for the consortium and participating institutions. 
Consortium B focused more on enhancing research management capacity, and 
Consortium C focused more on enhancing research infrastructure.   
When it comes to research environment… we are dealing with aspects that touch on 
the environment provided for the fellows for them to be able to excel as doctoral 
fellows, and not in terms of the environment that we have provided for them to carry 
out research. (Consortium A, Lead Institution, M1) 
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We don’t want to stop at training researchers, but we also want to build systems for 
these health researchers in the different locations that they are in… so it is a very 
good idea to build not only the research aspects, the science, but also the 
environment within which the researcher is working… we are not thinking short term 
but long term (Consortium B, Lead Institution, M2) 
For the research management objective, we hold some workshops on writing, ethics, 
and others. The building permits us to improve research capacity for DELTAS and 
for all the university because some other people can come and do research in our 
laboratory if there is no workshop. (Consortium C, Lead Institution, M1) 
Regarding the role of consortium management, it emerged from participants’ descriptions 
of management functions that management played two roles across consortia: 
coordinating and capacity strengthening. The aims of the two roles differed. The former 
focused on running the consortium while the latter focused on enhancing the managerial 
capacity of individuals and institutions. There appeared to be more references to 
management in a coordinating role than in a capacity strengthening role. I discuss these 
roles next.   
 
7.2.1 Management in a coordinating role 
Management processes were described as essential for facilitating the implementation of 
consortia programmes and the delivery of expected outputs. Through these processes, 
consortia decisions on strategic direction and programmes of action were taken, 
implemented and monitored. Established management structures such as consortium 
management boards were considered instrumental in attaining buy-in from individual and 
institutional stakeholders, ensuring representativeness during decision-making, and 
garnering feedback from partners. 
They [management processes] play an important role… The processes that I have 
been involved in included curriculum development, the development of the DELTAS 
proposals… decision-making about fellows, strategic direction… Even in this last 
meeting, we spent a lot of time talking about… “What’s the new direction?”, “Is it 
enough just training PhDs?”, “What else do we need to do?” (Consortium A, 
Partner Institution, R1) 
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We need it [management] for decision-making. We need it for coming to a consensus. 
We need it for transparency (Consortium B, Partner Institution, R3) 
Consortium management processes also enabled the monitoring and measurement of 
programme results and helped demonstrate capacity changes in consortia. Monitoring 
processes helped leaders and managers to keep a close eye on risks and ensured that 
consortia stayed on track. 
The management processes have a very key role. In fact, I think if it is not for the 
strong processes, then we would lose a lot in terms of the capacity strengthening and 
being able to monitor what every fellow is doing… Putting a structure where they 
have to report has kept them on their toes. (Consortium A, Lead Institution, M1) 
Additionally, some participants pointed out that a management set-up ensured that 
consortia leaders, who were mainly researchers, received adequate support from the right 
management personnel. Leaders could then focus on the strategic and scientific aspects 
of the consortia’s activities.   
It’s very effective if you have those lower units being strengthened. It reduces the 
pressure, and you are able to sit and think about more ideas and plans… more 
developmental ideas rather than spending time on operations and routine work 
(Consortium B, Partner Institution, M1) 
Research capacity begins with… building a management team and executing the 
project so the science doesn't break down (Consortium C, Partner Institution, R4) 
A few consortia actors also recognised the role of management processes in linking 
consortia to institutional resources without which programme implementation would 
have been greatly challenged. Inputs from institutional units such as research offices, 
finance, procurement, and legal units were coordinated through consortium management 
processes to ensure that programmes were adequately supported in both lead and partner 
institutions. 
As these management processes were deemed essential for programmes to thrive, leaders 
ensured that the processes required for consortia performance and grant accountability 
were duly executed. Consortium A supported partners who received activity funds to 
prepare and submit accurate reports. Consortia B and C, as part of their sub-award 
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monitoring processes, also conducted series of training for researchers and managers in 
partner institutions to ensure accurate reporting.  
We have had a chance to attend one or two financial management workshops, which 
were okay. It helped us to get a sense of how AESA wants things done (Consortium 
C, Partner Institution, R4) 
We carry out training on what we need them to work on like finances. The DELTAS 
report is a really complicated report, so you have to take them through what is 
needed and how to go about it. So, we’ve been able to build their capacity…  they’ve 
been able to improve the way they do the reports, account to us, and make requests 
and approvals. (Consortium A, Lead Institution, M5) 
Generally, management processes appeared to be perceived only as a means to an end. 
As long as programme outputs were being delivered, little attention was given to these 
processes.  
If I look at the steering committee, they are mainly very technical; the management 
thing doesn’t seem to be part of that… They do not look at how the thing is going but 
what quality is coming out. When the PI is talking about scientific citizenship for 
instance, he asks, “how many community public engagements have we had” and 
“what impact has it had”? So, he doesn’t say, “Was there a problem with organizing 
it” or things like that; it’s not part of that. So, we are sort of looking at the output bit 
of things (Consortium B, Partner Institution, R1) 
I know there are some things which can be improved… I understand why some of the 
things do not go as fast or as well as it is supposed to be. But if students are trained 
and the annual objectives according to the student training are achieved, it’s ok. 
(Consortium C, Partner Institution, R1) 
I am not sure they are part of that [RCS processes]. I think… the primary role is that 
the grant is administered and therefore we need to have those sort of processes 




Although the value of management was generally recognised, some Partner Leads were 
reported to have found the processes extraneous. This periodically caused difficulties for 
the Secretariat in ensuring compliance with the required managerial tasks.  
We can put in place tools, and people will not work with them. Because they are 
scientists, they think that some tools are not important. They have a lot of work; they 
don’t see the importance of some tools. But for management, it’s necessary to put in 
place some tools… but for them, it’s not necessary (Consortium C, Lead Institution, 
M1) 
Overall, management was considered necessary for coordinating consortia activities and 
ensuring programmatic and fiscal accountability to funders. The primary aim of 
management processes such as recruitment and training of managerial staff and provision 
of administrative support to participating institutions was to facilitate the delivery of 
consortia outputs and not necessarily to strengthen participating institutions. Focusing on 
the consortium's management needs and not those of the participating institutions was the 
basis for setting up parallel managerial processes which sidestepped and compensated for 
institutional weaknesses. This approach was intended to minimise any adverse effect of 
institutional challenges on the consortium’s performance. Such an approach also meant 
that little attention was paid to the capacity strengthening implications for partner 
institutions. Thus, in its coordinating role, management appeared to be directed towards 
the short-term performance of consortia and not on the longer-term capacity of members. 
 
7.2.2 Management in a capacity strengthening role 
Management was rarely recognised as a capacity strengthening component of consortia’s 
programmes. Only Consortium B had a stated objective pertaining to strengthening the 
research management capacity in participating institutions. This involved training 
research administrators and strengthening institutional grant management systems. 
Although some management content was included in the training of fellows and 
administrative staff, it appeared the primary aim was to enhance fellow and consortium 
performance respectively. These efforts were neither designed nor recognised as capacity 
strengthening components.  
Consortium A leaders acknowledged that current efforts were inadequate, and a more 
purposeful effort would be required to build substantial management capacity. 
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Training financial managers for two or three days, and exposing them to different 
things is not enough to elevate the system if it is already terrible. In the next phase, 
we are thinking about being a bit more deliberate (Consortium A, Lead Institution, 
R2) 
Also, capacity strengthening activities mainly focused on the training of scientists. Very 
little investments were made in enhancing the capacity of other stakeholders involved in 
the research enterprise. Some managers shared their concerns about this disparity: 
In terms of actually acquiring skills and building capacity for support staff, not 
much… we have just attended one workshop for faculty and administrators because 
I think it’s like we are not serious partners I may say that; so not really much. The 
capacity is still at minimal levels (Consortium A, Partner Institution, M2) 
For capacity building, at least the financial management staff should be sponsored 
for, let’s say a master programme. If not the entire programme, let’s say you can 
cover a percentage of the cost… or get them to go to institutions with a lot of 
experience in research; to go and learn from their financial management processes… 
I believe when we start working on these programmes, it’s not always the 
researchers; financial management is also important, so they should remember us 
(Consortium C, Partner Institution, M3) 
Even for the scientists, a greater emphasis was placed on technical research training and 
very little on management training. As noted in the previous chapter, the concept of RCS 
for many consortia actors prioritised the technical aspects over the managerial, and this 
was demonstrated in consortia’s programmes.  
Maybe the management doesn’t really influence it [RCS] that much, but it’s more of 
I think the technical people, the experts, the partners that you have, I think that what’s 
drives that bit. (Consortium A, Partner Institution, R5) 
The significance of research management and institutional level research capacity was 
largely under-appreciated. Besides, most Consortia and Partner Leads are researchers and 
naturally emphasized the technical aspects of research over the managerial. While many 
of these leaders admitted to gaps in their managerial knowledge and skills, strengthening 
of their managerial capacity was not prioritised in consortia programming. There were no 
reports of any careful considerations of what consortium management entailed, or the 
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gaps in leaders’ managerial capacities, or the knowledge and skills they would require in 
their roles. One Partner Lead noted: 
When these consortia are being formed, and you propose in applications that we’ll 
have these levels of management… there is no follow up to see, “what is the 
management skillset of these people”, ‘can anything be done to improve their skill 
set”; because we are scientists, we are not managers. (Consortium C, Partner 
Institution, R4) 
Also, the evaluation indicators for the DELTAS management objective may have 
influenced the marginal inclusion of management capacity strengthening activities at the 
programme level. Stated indicators included the amount of additional funding secured, 
existence of research facilities and the number of consortia management meetings. 
Consortia therefore appeared to focus their efforts on these stated areas to meet the 
expectations of funders. As a result, many management elements were left unaddressed, 
and very little investment was made in strengthening institutional research management 
and consortium management capacities across consortia. 
 
7.2.3 Management in both coordinating and capacity strengthening roles 
While the coordinating and capacity strengthening roles of management were considered 
separate, they were not mutually exclusive. Some consortia leaders broadly considered 
that participating in management processes such as consortium-level meetings and sub-
award processes would strengthen consortia actors' management skills. This was 
especially evident in Consortia B and C, where the decentralised partner management 
system had been adopted. Yet, this thinking was neither documented as part of consortia’s 
planned programmes nor actively tracked. Upon reflection and in hindsight, consortia 
members acknowledged that participation in management processes had resulted in 
several capacity gains, even when management was not explicitly put forward or 
recognised as a capacity strengthening avenue.  
To throw more light on the less-considered capacity strengthening role of management 
processes, I examined how learning occurred during management processes and how 
individuals’ and institutions’ capacities were strengthened in the process. I discuss these 
learning mechanisms next. 
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7.3 Mechanisms of Learning Inherent in Management Processes 
As consortia actors participated in management processes, learning and capacity 
strengthening occurred. Six mechanisms through which individual and institutional 
managerial learning occurred were distilled from the data (Figure 7.1). I discuss these in 
turn and how each one was operationalised in the case consortia. Although each of these 
mechanisms is singled out to demonstrate how they work, it is important to note that they 
often occur concurrently, are interrelated and interact with each other to produce the 
resultant learning and enhanced capacity.  
 
 
Figure 7.1: Managerial learning mechanisms emerging from the data  
 
7.3.1 Interaction and peer learning (through exposure, observation and learning 
from differences) 
Consortium management boards brought together people with different expertise and 
experiences. For some members of these boards, the experience of such high-level 
decision-making platforms was new; while for others, the current contexts differed from 
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their previous experiences. Consortium actors learnt from each other through observing 
deliberation processes and exposure to different perspectives brought to bear during 
interactions. Members acquired competencies, including communication skills such as 
negotiation and advancing one’s arguments, decision-making intricacies, behavioural and 
collaborative skills, and conflict resolution and problem-solving skills.    
It was an opportunity for learning, because if you are sitting on a management board, 
then you learn how a board operates and how the decisions are reached, and how 
the follow-up of these decisions is being done or not. So, that in itself is an important 
skill (Consortium C, Lead Institution, R1) 
I would cite the exposure itself, which obviously is at a high level for somebody who 
is quite junior trying to gain experience in terms of how those meetings would 
actually go, and how you should behave or communicate, and see to it that your voice 
is also heard. It’s a learning experience. (Consortium A, Partner Institution, R7) 
Learning sometimes is by observing or when a query comes, and it’s pointed out that 
we should have done this (Consortium A, Partner Institution, M2) 
…through those interactions, you can see people really growing. You know people 
who could not make decisions, you can see them making decisions that they wouldn’t 
have made because they have seen other people making decisions… So, the 
interaction is very important in capacity building... they learn a lot because some of 
them you can see that they are not really exposed, but then they meet these kinds of 
people who are making all these decisions… It’s an important component. 
(Consortium B, Lead Institution, M3) 
Learning through these means was reported by both scientists and managers. Scientists 
and managers gained primarily from participating in managerial and general meetings, 
and managers gained primarily from interactions with the staff at the secretariat. 
In addition, much of the learning from interactions emerged from the different 
experiences. Partner diversity in consortia implied differences in country and institutional 
contexts, levels of expertise, disciplines, and personal dispositions. Dealing with 
differences in outlooks, systems and procedures generated learning as partners were 
confronted with the need to consider new ways of thinking and operating.  
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Different learning environments are also important. Visiting different institutions 
which have got different areas of strengths I think is good because it adds value to 
the programme. It enhances the exchange of knowledge and exposure (Consortium 
A, Partner Institution, R7) 
The centre can say, “ok these guys did it this way so let’s do it this way, take what 
they’ve learnt and improve it”…You’ve learned your lessons, and you know what 
works and what doesn’t work in different contexts. (Consortium A, Lead Institution, 
M4) 
You usually look at… challenges we have faced, and then we are able to get 
recommendations on how we can resolve some of those difficulties. This is discussed 
at the higher level where different institutions are participating. So, you are able to 
learn from how other colleagues are solving theirs… it helps in building your 
systems. (Consortium B, Partner Institution, M1) 
Learning from differences was a key element of peer learning. Constructive comparison 
challenged the status quo and fuelled growth. As part of monitoring processes, consortia 
leaders visited partner sites to familiarise themselves with their operations and provide 
needed support. This practice provided a platform for learning from varying contexts. For 
instance, in Consortium B, leaders regularly invited one or two other partners to join the 
team from the secretariat on the scheduled partner visits for learning purposes. Visiting 
partners and secretariat teams were exposed to management approaches and resources in 
different contexts. These differences facilitated the exchange of ideas, experiences and 
best practice, and stimulated out-of-the-box thinking and growth.  
These are all people in institutions that have their ways of doing things and can 
actually teach you things. So, I personally learn each time I visit some of these 
institutions. (Consortium C, Lead Institution, R1) 
Beyond the differences within each consortium, opportunities to engage with a variety of 
consortia across the wider DELTAS Africa network existed. During annual initiative-
wide meetings, consortia shared experiences and started or strengthened relationships, all 
of which promoted learning across different consortia. Although both researchers and 
managers gained from this learning mechanism, researchers appeared to have had more 
opportunities to engage with peers than managers. In Consortium B, where managers such 
as Finance Officers/Accountants and M&E Officers across the partner institutions held 
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regular meetings, there were increased opportunities for peer learning. Such opportunities 
appeared to have been limited in other consortia. Researchers, on the other hand, had 
more opportunities to participate in management meetings, general meetings, partner 
visits and DELTAS initiative-wide meetings.  
 
7.3.2 Experiential learning 
One of the main mechanisms by which consortia actors gained research and consortium 
management knowledge and skills was through their own management experience. 
Learning occurred as actors participated in decision-making processes, worked in teams, 
coordinated activities and resolved challenges encountered. Researchers and managers 
alike enhanced their capacity through hands-on experiences and ‘learning by doing’. For 
example, in Consortium A, trainees were expected to gain management skills by being 
accountable for their fellowships through regular reporting to the secretariat. The 
decentralised partner management approach adopted by Consortia B and C was aimed at 
getting partner institutions to participate in management at their levels to build 
competencies in managing grants.  
They have to be involved not just as participants, but actually playing a more active 
role in running an aspect of the program. In that process, it improves their own 
capacity in various aspects; in the specific deliverables that they have to do but also 
in project management (Consortium C, Lead Institution, R1) 
The experience for the administrative staff, accountants, and focal persons involved 
in grants management, especially in the institutions where activities happen, builds 
their skills and capacity that are transferable to their research management 
situations. (Consortium A, Lead Institution, M2) 
When you get into consortium level type of management, you get to learn a lot of 
things… If I am going to request for anything to be bought… those days, I remember 
I didn’t really bother about certain details. But now I need to make sure that the line 
that I’m asking that something be bought from, I’m not exceeding that line by a 
certain amount; and I’m ensuring that the line has cash in it; and that the charge 
cannot be placed in any other line just arbitrarily by the accountants or the finance 
people. (Consortium C, Partner Institution, R4) 
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As noted earlier, consortium and partner leaders are mainly researchers, many of whom 
acknowledged limitations in management expertise. Though leaders drew on previous 
experiences, the unique characteristics of the consortia studied such as being an HRCS 
instead of a research consortium, or South-led instead of North-led, meant that leaders 
needed to ‘learn on the job’. Consortia actors built up management proficiency as 
processes unfolded, as challenges and unanticipated situations forced innovations, and 
mistakes were made and corrected. Learning occurred through the ‘growing pains’. Some 
participants pointed out that:  
These opportunities should be used to build our institutions, and you can only do that 
if you throw the institutions into the deep end and they learn to swim… When you 
give the resources to the prime institution, it will develop its capacity in managing 
others; but what are the others getting out of it as far as that capacity. So, to me, 
decentralize. (Consortium B, Lead Institution, R2) 
It’s good for me to be involved in such a programme, and the management, even the 
design, planning and implementation of a training project… I have learnt many 
things, and for me as an academic researcher, it’s important. It has improved my 
financial management of projects…  The queries which have been raised allowed me 
to improve the financial report and financial management of the research project. 
(Consortium C, Partner Institution, R1) 
 
7.3.3 Training sessions 
The use of training sessions was the most evident learning mechanism used by consortia. 
Through workshops, didactic methods were used to introduce or build upon consortium 
actors' management knowledge in specific areas. For instance, all the case consortia 
conducted financial reporting workshops for Partner Leads and Finance Officers. The 
PhD curriculum used by Consortium A included some research management topics, and 
Consortium B conducted workshops on research administration for the relevant 





We also have regular training as a consortium. As we interact with the different 
partner sites, we tend to realize where there are common problems, and if the budget 
allows, we see where we can organize training to assist in those weak areas. 
(Consortium B, Lead Institution, M2) 
We have had huge delays… Eventually, we met for the financial training, and I 
realized that I didn’t quite understand how to manage that part of it… I now 
understand that this is completely different, and also some of the justifications that I 
have to do. Now I think we have streamlined things (Consortium C, Partner 
Institution, R2) 
Many of the training sessions were reported to have focused on financial reporting 
processes. Moreover, whether the training was meant to address programme-level needs 
or broader, it still resulted in capacities that were useful for participants beyond the 
consortium. 
I have learnt quite a lot, and it has also had an impact on my centre… I handle grants, 
projects, and partnerships, and I have had an opportunity to be trained in 
[Consortium B]. They have the research administration network where they take us 
and train us on specific things; financial management, research management. 
(Consortium B, Partner Institution, M4) 
Knowledge has been acquired from the training in diverse ways. I can’t speak for 
others but for me, yes. Because in any case you have learnt something new, and that 
helps you in the future. Even if you are not doing [Consortium C] work, there could 
be another project (Consortium C, Partner Institution, M4) 
Although researchers participated in these types of training, these were mostly targeted 
at managerial staff. There were no reports on management training for Consortium and 
Partner Leads. 
 
7.3.4 Coaching and mentoring 
An important role of the lead institutions was to provide continuous support to partner 
institutions as they implemented their tasks. This was done through the secretariats and 
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was especially crucial for partners with sub-awards as they navigated their 
implementation and reporting processes. Partners consulted the secretariat for support in 
working through challenges and devising appropriate solutions. A combination of e-
mails, telephone calls, meetings and site visits facilitated regular communication between 
the secretariat and partners. Coaching did not occur in a single direction; partners also 
coached lead institutions and other partners where a partner had more experience in a 
specific issue. During these interactions, it was considered essential to strike a balance 
between meeting funder requirements and using locally relevant solutions. This process 
resulted in learning for both lead and partner institutions. Consortia actors, particularly 
the Secretariat, also received managerial support from the funding agency including 
training and troubleshooting.  
In addition, informal mentoring relationships were formed between individuals and 
institutions in some cases which were expected to continue beyond the consortium’s 
activities.  
I have gained a lot by participating in the management of the consortium… it has 
been a very well-structured mentorship programme… You can now play a part in 
managing other projects as well with the knowledge you have. So, it’s a kind of a 
growth process; people have grown over the period of time in the management of 
projects… When the director executes the site visits, that’s another level where you 
learn. Actually, we call it a learning visit, where we say we have been doing this and 
that, and you have time to reflect on how you did it… They also learn from us when 
they come to visit us, whether we have done things either the wrong way or the right 
way. So, I call it a kind of nice mentorship programme for both researchers and for 
research administrators and grants managers. (Consortium B, Partner Institution, 
M6) 
Activity and financial reporting processes appeared to be the main learning points around 
which coaching occurred. While these coaching processes were mainly informal, they 
provided valuable learning opportunities for both researchers and managers. 
 
7.3.5 Evaluation  
Monitoring and evaluation processes were built into consortia’s programmes and were 
conducted internally by consortia leaders and externally by the funding agency. Annual 
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reporting requirements compelled consortia to assess their performance and employ 
corrective measures where necessary. These formal assessments provided the opportunity 
for consortia to review their processes, an exercise which generated learning as actors 
reflected on what worked and what did not.  
When we write the annual report, we do a summary of our activities: what were the 
difficulties; what were the outcomes; and then we take some decisions to change. 
Every six months, I do an evaluation of our activities. (Consortium C, Lead 
Institution, M1) 
Often, evaluation processes were perceived as necessary to fulfil funder requirements, 
and more for appraisal than for learning. Evaluations were thus viewed as grading 
exercises, and consortia tended to only put their best foot forward. However, this appeared 
to be changing, and some consortia leaders are recognising the role of evaluation 
processes and results in capacity strengthening.   
People hate audits; when they hear about an audit, they start shivering. I said, for 
me, I would like to have that audit as long as my mistakes were not intentional 
because I didn’t know, and I commit to learning from that, and next time I’ll do better. 
For me, find whatever you’ll find that I’ve done wrong, but I’ll use that as a 
springboard. And so, some colleagues started also appreciating that audits are not 
bad, they are good… you learn from them. (Consortium B, Lead Institution, R2) 
They came for an audit, and they said well, where is your policy for doing this, where 
is your policy for doing that. We hadn’t written anything down. So, I think that has 
been helpful actually. We have written down things and sharing with everybody… 
these policies are actually being reviewed. (Consortium C, Lead Institution, R1) 
 
7.3.6 Translating and contextualising learning 
Consortium members had accrued knowledge and skills in management processes over 
time from various sources. Previous and ongoing experiences from other collaborations 
were continuously drawn on to fulfil current roles.  
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There is no school for that [managing a consortium]. I learnt that through sitting on 
previous boards and seeing how those boards operated, and then bringing that 
previous knowledge to bear in this consortium. (Consortium C, Lead Institution, R1) 
The recall and translation of previous learning into current contexts became a learning 
mechanism as it required selecting, transposing, tailoring and putting into practice the 
knowledge in a new context. These processes constantly occurred when consortia actors 
received recommendations or support from other members as they required 
contextualization to be effective. This involved innovation and new learning, although 
often implicit and unacknowledged. Consortia actors reported that they were 
continuously transferring and adapting learning derived from their management roles to 
other programme and institutional roles and vice versa.  
Sometimes you get stuck, and you don’t know what to do, but when you present it, 
the proposals come. It may not be a directive because what I have learnt is that they 
normally want you to find solutions which are consistent with your institutional 
guidelines… you are also learning how to come up with solutions in complex 
situations. (Consortium B, Partner Institution, M1) 
We learn a lot from our experiences in different consortia and different activities 
during our career. So, I think in terms of learning how to even run a network… How 
do you manage them? How do you make sure that it’s inclusive? You learn all these 
subtle skills when you are in these different consortia… So, I would like to think that 
that has shaped the way I think of running a consortium or the way I run my research 
centre… I do appreciate and hopefully, bring some of the principles of consortia and 
how they run them to the university and also sometimes what happens at the 
university level to the consortium. (Consortium A, Partner Institution, R5) 
Leaders and partners also needed to contextualize management processes by determining 
how existing institutional processes could be used to achieve consortia requirements, 
particularly for institutions with nascent research management systems. For example, 
sub-award management required inputs from legal, finance and research administration 
stakeholders or appropriate proxies within the institutions. Coordinating these efforts 
engendered learning for both researchers and managers. In addition to individuals, the 
process strengthened the capacity of the institutions as intra-institutional interactions were 
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enhanced and readied for future activities. Previous learning was also validated and 
reinforced in the process.  
Some of the member universities have started adopting some of the practices and the 
policies that we have in the consortium. But what happens is that they go back, look 
at what is happening at their home universities and say, “I think this might be difficult 
to apply in our case because of how we operate locally, or the rules, or our 
procedures and regulations. So, what is it that we need to change in our case?” 
(Consortium A, Lead Institution, M3) 
Apart from managing the [technical group], I deal with the accounting people, 
administration, and we have a research support department. You have to liaise 
everything. I am managing all these because I’m the PI of this grant here. 
(Consortium C, Partner Institution, R2) 
Establishing a consortium is quite a complex thing. It involves various offices. In our 
institution for example, it would involve developing MoUs, agreements; now that’s 
legal. It has to go through the Director General’s office. We have to look at whether 
being part of a certain consortium is beneficial… And those processes get 
strengthened even within the institution (Consortium B, Partner Institution, R2) 
 
7.4 Factors Facilitating Learning 
Across the case consortia, a number of factors emerged as facilitators of the learning 
processes described above. Factors such as the burden of responsibility, the process of 
time and intentionality set some of the learning mechanisms into action and promoted 
individual and institutional capacity enhancement. I discuss these in turn. 
 
7.4.1 Burden of responsibility 
The level of accountability required of lead and partner institutions put pressure on them 
to master the required management processes and deliver on expected outputs. The 
burden of responsibility forced learning as consortia leaders needed to effectively manage 
diverse partners and consortium activities in order to be accountable to the funders. For 
Partner Leads, the responsibility associated with being jointly accountable for consortia 
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performance necessitated learning and helped strengthen leaders’ management capacity. 
As a result of sub-awards, partner institutions learnt to manage local teams as well as 
activities and budgets, and took the initiative for troubleshooting when challenges arose. 
Partners ensured that they were accountable to both the lead and their own institutions. 
Partner Leads therefore learnt to engage other stakeholders within their institutions such 
as research, finance and regulatory offices to ensure that activities were implemented, and 
programme outputs were produced.    
By writing a contract with those institutions, you spell things out: this is what is going 
to happen, you are going to be responsible for that… that is already part of the 
capacity processes… That contract highlights the terms and conditions of the grant 
which otherwise the partners may not have fully appreciated… Putting them at their 
doorstep and saying these are the terms and conditions, and this is the piece of paper 
you’ll refer to all the time as you manage the grant, that is contributing to capacity 
strengthening. Then you put the money at their doorstep and say, “well, if the money 
is misused, if it is misallocated, if it is misappropriated, you, institution X are 
responsible, and we expect accountability… the same accountability requirements 
that the funder expects from us”. (Consortium B, Lead Institution, R2) 
I have learnt a lot through my involvement in the processes. I have got to know how 
donors demand their reports, and sometimes I have to sit and take my time to read 
the conditions to also make sure I don’t do anything contrary to the conditions. 
(Consortium C, Partner Institution, M3) 
The advantage of this [decentralised] structure is that it’s helping me as a leader or 
as an aspiring leader to learn how to manage my own grant. So here, I am called the 
PI, and I basically run this grant. It helps me to learn. (Consortium C, Partner 
Institution, R2) 
 
7.4.2 Process of time 
The passage of time played an essential role in many of the identified learning 
mechanisms as learning occurred and increased over time. Gaining experience, coaching 
and applying previous learning in current situations require time. Both consortia leaders 
and partners acknowledged that gaining the competence to play their respective roles 
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required time and their capacities grew as the consortia progressed. Though these times 
varied among partners, each individual and institution experienced their own learning 
curve. 
After second and third quarters, co-applicants became very good with our 
procedure… if you take the start of the program and now, there is a good 
improvement. In the first quarter, there were a lot of questions… But now, there are 
just one or two questions on the checklist. (Consortium C, Lead Institution, M2) 
By the time we end the five years of the programme, we will learn our lessons. The 
challenges can be corrected, and in the next phase or maybe in the future if there is 
any opportunity again from the funder, things will improve (Consortium C, Partner 
Institution, M3) 
Research capacity building takes time, and you are not sure whether this is working 
or not working fully, because you’ve not given it adequate time. If you give it 
adequate time, then you can learn what worked and what did not work. (Consortium 
B, Lead Institution, R1) 
Some consortia leaders acknowledged that the essence of time in enhancing capacity 
included flexibility, allowing for mistakes, and sometimes accepting less than ideal 
results both from themselves and from partners while learning occurred. 
In terms of M&E, that has been challenging, but slowly we are getting there, starting 
with the lead. We’re not used to this concept of M&E… so that has been a learning 
curve for us at the lead, and it’s now trickling down to the co-applicants (Consortium 
C, Lead Institution, R1) 
As we introduce new things, we first make sure that we have the blessing from the 
institutional management, and the institution as a whole appreciates what we are 
going to do. For the easier things, institutions have taken them on board. For others, 
we basically continue to persuade and make those small steps in the right direction, 
while appreciating that it doesn’t happen overnight. (Consortium B, Lead Institution, 
M2) 
The role of time also reinforced the advantage that longer standing consortia had with 
regard to management capacity, and the difference it made in their consortium 




Another factor that facilitated learning for some actors was intentionality. This refers to 
a purposive posture and actively analysing situations to generate learning. It required 
perceiving every aspect of one’s experience as a learning opportunity and constantly 
drawing out lessons from each experience. Some members noted that such intent was 
essential for learning to occur.   
As the youngest, sometimes I feel I’m not heard. But I keep going until it works. What 
I’m looking for is to learn, so I’m learning. Whatever it is, good or bad, I’m learning, 
and I’m able to sort out these things. (Consortium C, Partner Institution, R3) 
The need to be intentional about learning was not only recognised as important at the 
individual level but also at the consortium level. Consortia needed to take deliberate steps 
in assessing management skills and organizing training for researchers to address the 
capacity gaps. 
I think in the management of any consortium where PIs are involved, PIs shouldn’t 
always assume that they have the necessary skills. They can look for ways of 
improving their skills that will at the end of the day, improve the overall delivery of 
the grants… I think just like they [leaders] always anticipate workshops to improve 
the skills of say, financial managers and program managers, they could incorporate 
training for the management board to give them management skills. (Consortium C, 
Partner Institution, R4) 
I present how some of these learning mechanisms and facilitating factors were portrayed 
in practice next.  
 
7.5 Learning Mechanisms in Action and Resulting Capacity Gains 
As indicated earlier, the identified learning mechanisms were not mutually exclusive. 
Multiple mechanisms were often embedded in single scenarios, and several were usually 
combined in participants’ learning experiences. For instance, gaining experience also 
involved exposure, observation, interactions, and practice. Training sessions also 
involved interactions among consortium actors and exposure to different experiences.   
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The interplay of multiple mechanisms and facilitators is illustrated in the following 
example from Consortium B:  
Two members of a partner institution in Consortium B, the leader and the accountant, 
joined the team during the implementation phase. A sub-award was already in place. It 
took time for the team to grasp the intent of the work plans and budgets, overcome initial 
missteps, and effectively perform their roles.  
At the beginning we didn’t really understand… we came on board a year after it had 
started, so it took us time to pick up… In the first year of operation, I would say we 
spent most of the funds in some of the budget lines. We didn’t know much about what 
the proposal intended. It was only after some time that we picked up: from the 
numerous training sessions we had, consultations with the secretariat and also from 
the field visits, and email communication. We came to know more about how these 
funds should be used. So, now we are ok, we are at par. (Consortium B, Partner 
Institution, M3) 
Multiple learning mechanisms were at play in this process: experiential, interaction with 
and coaching by the secretariat, and training sessions. Learning was facilitated by the 
burden of responsibility (as the local team needed to deliver on their sub-award) and the 
process of time.  
Across the case consortia, although mechanisms such as training sessions and evaluations 
were actively planned, the majority were not and appeared to be mostly unintended 
consequences of coordinating processes. Besides, learning was primarily aimed at 
ensuring programme performance more than institutional capacity strengthening, though 
capacity gains were expected to be useful beyond the programme period. Both researchers 
and managers reported having gained management capacity through these identified 
mechanisms, and capacity gains were produced at both individual and institutional levels. 
These include management expertise, professional growth, mentorship, and expanded 
networks. Participants reported improvement in various skills such as communication, 
people management, negotiation, seeking and gaining consensus, and identifying and 




You are able to know multiple systems… increasing my capacity in terms of working 
with multiple schemes. So, that is one area which I could say clarifies my being 
different from when I came. And then when you attend these meetings, you learn a 
lot from some of the senior personnel because you may not have them in your setting. 
So, the way you see them analysing things in a meeting and somebody is reasoning; 
there is a lot to learn from that. So, I think I am also able now to analyse in a 
satisfactory way and then also be able to come up with workable solutions. 
(Consortium B, Partner Institution, M1)  
The partnership has opened doors… Through the training, we were able to become 
a direct grantee of the Wellcome Trust and a direct grantee of NIH… (Consortium 
B, Partner Institution, M4) 
The knowledge and skills gained from consortia activities were transferable to other 
programmes and roles within participating institutions. Coupled with the strengthened 
infrastructural and managerial capacity, partners were able to source for funding and run 
research programmes of their own.  
I recently put in an application for an EDCTP grant, and I got it… I put there what 
I learnt from this consortium… It’s not magical. I have applied for other projects 
before for less funds, and I was not successful. But for this project, I knew exactly 
what the funders were expecting, and I was able to provide it because I have this 
experience… There is no way I can say that it’s coming from myself; it’s a result of 
this consortium and being in the management. (Consortium C, Partner Institution, 
R3) 
Discussions among partners and sharing experiences also provided members with 
comparators and facilitated self-evaluation and identification of institutional gaps. 
Partners were consequently motivated to address identified gaps and strengthen their 
institutional research and management systems. Partners had a frame of reference when 
proposing initiatives and requesting for support from their institutional leaders. 
The steering committee is a very useful platform because all the members contribute. 
And then as you sit and listen, you can also evaluate your performance, while 
learning from what other people are doing. And then from the PI, you get where the 




The cross-fertilisation has allowed for consortium partners to look at different 
elements. When you look at research governance within universities, we are able to 
provide examples from different consortium partners, and this I think is something 
that enriches some of the universities especially the younger, less developed 
universities. (Consortium A, Lead Institution, R1) 
Interactions between partner representatives on management boards and in partner forums 
forged closer individual and institutional working relationships that went beyond the 
consortium’s activities. New collaborations sprung up; and partners continued to share 
research, training and funding opportunities among themselves. Engagement with other 
consortia and across the DELTAS Africa community widened the networking 
opportunities even further for consortia actors and institutions.  
It’s quite clear through the consortium meetings that networking is happening, and 
collaborations are being built… not only at the level of the fellows but the supervisors 
as well, and not only in Africa but including the northern partners. (Consortium A, 
Partner Institution, R7) 
There were also opportunities for continuous learning even beyond the current DELTAS 
programmes as participants had formed networks within which other opportunities were 
shared and pursued. 
 
7.6 Chapter Summary 
In this chapter, I presented the findings on the role of consortium management processes 
in RCS. Across the three case consortia, consortium management activities were mainly 
perceived to facilitate rather than substantially contribute to RCS objectives. Activities 
for strengthening management capacity were not as deliberately planned for and tracked 
as those for strengthening technical research capacity. These programmatic choices 
indicated that management in RCS was rarely given its own space and attention, and only 
perceived as a means to an end. Irrespective of this status quo, it emerged that consortium 
management processes still resulted in individual and institutional gains in managerial 
capacity. These gains appeared to be knock-on effects of routine management processes 
as they were neither planned for nor reported on. I discussed the mechanisms through 
which learning and capacity strengthening occurred and the factors that facilitated these 
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learning processes. It is evident that management's role in RCS is understated and 
opportunities for developing essential research management capacity are underutilised. 
In the next chapter, I will discuss these findings in the light of established capacity 




CHAPTER 8: DISCUSSION AND RECOMMENDATIONS 
 
8.1 Introduction 
This study aimed to critically examine how the management processes and practices of 
health research capacity strengthening (HRCS) consortia feature in and contribute to 
broader capacity goals. To achieve this aim, I set out to: 1) identify the management 
processes used by HRCS consortia and factors that influence these processes; 2) examine 
the key management processes with a capacity development lens; 3) explore how 
consortium management features in research capacity strengthening goals and 
mechanisms; and 4) recommend strategies for managing HRCS consortia and the 
implications for their evaluation. In the last three chapters, I presented the empirical 
findings from exploratory and case studies conducted with the DELTAS Africa consortia. 
This chapter presents a discussion of the findings in relation to the wider literature and 
recommendations. The chapter is divided into four main sections. Section 8.2 presents a 
summary of the main findings. This is followed by a discussion of the key emerging issues 
from the findings and their relevance, and how they relate to the wider literature in Section 
8.3. Finally, I draw from the emerging issues and lessons learned to revise the initial 
conceptual framework in Section 8.4; and make recommendations for policy, practice, 
and further research in Section 8.5. 
 
8.2 Summary of Findings  
The findings of this study have been presented in Chapters Five to Seven. Chapter 5 laid 
the groundwork for the subsequent chapters by describing the consortium management 
processes used by the studied consortia and factors that influenced these processes. Three 
consortium management phases were examined: pre-inception, inception, and planning 
and implementation. The management structures and processes used in these phases were 
similar across the consortia studied. Processes included: determining the nature, size, 
focus and leadership of consortia; selecting partners; determining goals and activities; 
assigning roles and responsibilities; instituting governance and management structures; 
allocating resources; establishing partner management structures; and coordinating and 
monitoring activities. Generally, the consortium management phases, structures and 
processes identified in the studied consortia were similar to those identified in the 
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literature. However, these operational consortium management processes and their role 
in the capacity strengthening pathway had been rarely examined in the literature. 
Relational issues regarding power relations, equity, leadership, and inclusion emerged as 
important cross-cutting concerns both in the literature and the consortia studied. It also 
emerged that in determining the approaches for carrying out managerial processes, 
decision-making was often complex as consortia leaders encountered tensions between 
different options. The findings in this chapter addressed Objective 1 of this study and 
highlighted areas of interest for the in-depth case study presented in Chapters 6 and 7. 
Chapter 6 presented findings from the in-depth investigation of the key management 
processes and approaches of three selected consortia. The key tensions between 
alternative management strategies that arise during decision-making processes across the 
different consortium phases were identified. Leaders often had to decide between 
individual or collective interests, efficient programme delivery or effective capacity 
strengthening, excellence or equity, and shared power or greater control. Underlying these 
tensions and consortia priorities were perceived definitions of research capacity and the 
capacity components that were deemed critical. These perceptions sometimes differed 
across consortia actors and were mostly shaped by programme evaluation requirements. 
Consortia leaders adopted a range of strategies in addressing these tensions. Although 
they often chose to maintain a balance between conflicting options, clear decisions were 
made in some cases. It was in the nuances of consortia’s decision-making processes and 
how tensions were handled that priorities and perceptions of research capacity, as well as 
relational challenges regarding power relations, equity, inclusion, and leadership in 
consortia dealings were revealed. It also became clear that tangible management 
structures and processes that were not facilitated by intangible managerial ‘software’ such 
as communication and inclusion did not adequately achieve the intent of the management 
strategies adopted.  
Chapter 7 explored how management processes featured in and contributed to individual 
and institutional capacity strengthening. Consortium management processes were 
observed to contribute to both programme coordination and capacity strengthening, 
although - importantly - their capacity strengthening opportunities and value were not 
actively recognised, planned for, resourced or tracked. Nevertheless, consortium actors’ 
participation in management processes resulted in diverse learning experiences. Learning 
occurred through interacting with peers, playing respective management roles, 
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participating in training sessions, coaching and mentoring each other, learning from 
programme evaluations, and translating and contextualising learning for local use. 
Capacity gains made included strengthened operational and relational management skills, 
ability to determine appropriate management strategies, individual and institutional 
management of programmes, expanded professional networks, and opportunities for 
continuous learning. The findings in this chapter addressed Objective 3 of this study. 
In the subsequent sections, I build upon these findings by drawing out the key emerging 
issues and their interrelatedness to determine implications of consortium management 
processes on the RCS agenda. Four critical issues with implications for capacity-oriented 
management of consortia have emerged from this study. The first relates to the emergence 
and handling of tensions during consortium management processes. The second examines 
if and how the strategies adopted by consortia in addressing tensions align with 
consortia’s capacity strengthening aims. The third highlights the need to blend both 
tangible and intangible dimensions of selected management strategies to attain the desired 
results. These three interrelated issues address Objective 2 of this study. The fourth 
emerging issue considers how the three issues culminate in management-induced capacity 
gains, addressing Objective 3 of this study. I discuss each of these emerging issues next. 
 
8.3 Key Emerging Issues 
8.3.1 The existence and management of tensions in consortium management 
It has become evident that the emergence and handling of tensions are central features of 
managing HRCS consortia. The existence of dilemmas and tensions in decision-making 
has also been discussed in the organisational management literature 315-319, and more 
specifically regarding networks and inter-organisational transactions 320-322. Tensions 
similar to those experienced in the study cases have also been reported by management 
actors outside of the HRCS domain. Tensions between self and collective interests 318, 323, 
centralised and decentralised partner management models 165, 322, short-term and long-
term interests 324, 325, and efficiency and effectiveness 322 have been found to be inherent 
in different types of collaborations including North-led consortia.  
Tensions in decision-making often indicate misalignments between elements of consortia 
transactions, with the magnitude of the tension determined by the degree of divergence 
between these elements 319. It is evident from the literature and studied cases that tensions 
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reveal the underlying drivers of consortia challenges. For instance, Koelle and colleagues 
165 pointed out that discussions on whether to use centralised or decentralised financial 
management models in consortia revealed power struggles. The study findings of this 
study suggest that the resulting management decisions do not only shed light on the 
underlying interests and priorities of consortium stakeholders, but also reveal the most 
influential factors and power sources in consortia decision-making. The findings indicate 
that challenges related to inequities and power imbalances continue to exist in consortia 
because leaders are forced to make compromises when faced with tensions between 
competing priorities. For example, sharing power and granting levels of autonomy to 
partners is inextricably linked with decreased control over consortium delivery and an 
increased risk of sub-par performance. In many instances, leaders prioritised consortium 
performance and thus retained enough control to ensure programme outputs are delivered. 
Relatedly, leaders sometimes had to sacrifice collaborative principles such as equity to 
ensure that the expected results were produced. The situation was exacerbated when 
partners perceived as weak were involved. In such cases, capacitated partners were 
responsible for more activities and were allocated more resources compared to less-
capacitated partners to ensure consortia performance. Tensions and trade-offs have thus 
become inescapable features of consortium management. However, such tensions and 
trade-offs are (or should be) of particular significance in the RCS context as they reveal 
the perceptions of RCS, how different capacities are valued, who/what determines what 
is valued, and how all of these affect the overall capacity strengthening outcome. 
Compared to research consortia, whose primary goals are often the delivery of research 
outputs and hence can afford to be more programme-oriented, the goals of RCS consortia 
have broader and systemic implications. Therefore, closer attention needs to be paid to 
emerging tensions and the subsequent decisions and trade-offs in the RCS context to 
ensure that capacity aims are not undermined.   
Although tension management is a crucial component of consortium management 
practice 322, this is not always consciously or explicitly recognised. Consortia leaders did 
not follow a prescribed set of strategies or framework for managing tensions, but the range 
of strategies observed throw light on factors that require consideration during decision-
making by consortia. The identified tensions appear to be common across the study cases 
and even beyond the HRCS field; however, tensions have been observed to be 
contextually nuanced and must be interpreted within the specific contexts within which 
they occur 315, 318. As a result, tension management can “neither be formulaic nor 
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reductionist” 318. Nevertheless, highlighting potential tensions and providing clear HRCS-
specific guidance for consortia leaders on where priorities should be placed will facilitate 
decision-making processes and ensure management decisions are weighted towards the 
overarching RCS goals. 
Tension management has been extensively discussed in the wider organisational and 
management literature, particularly in relation to the pursuit of corporate sustainability 
326-330. Three common approaches to addressing tensions have been adopted by 
organisational actors: win-win, trade-off, and paradox approaches 328, 329, 331. The win-win 
approach avoids the tension by focusing on areas of alignment between the competing 
elements, the trade-off approach eliminates the tension by weighing the pros and cons of 
the competing elements and making a choice, and the paradox approach (also labelled as 
the integrative approach by some authors such as Hahn 326 and Juniarti 327) accepts the 
tensions by embracing the contradictory demands and making continuous efforts to 
resolve them 328, 330. These different approaches to addressing tensions were used across 
the consortia, albeit implicitly as opposed to explicitly. The win-win approach was 
observed in consortia’s primary focus on the common need for trained researchers across 
partners, the trade-off approach was observed in the choice of stronger partners over less 
capacitated ones, and the paradox approach was observed in the acknowledgement of the 
tension between excellence and equity and the incorporation of measures to balance out 
the effect of choosing one over the other. It has been noted that tensions can be 
contradictory and even mutually exclusive, or different but not in clear contrast, or form 
a continuum of different gradations of the elements in question 315, 318. Although different 
approaches may be suited to different types of tensions, there appears to be a convergence 
in the literature towards the fact that although the win-win and trade-off approaches have 
been dominant in practice over the years, the paradox approach offers more promise and 
appears to be better-suited for attaining sustainability 326, 328, 329. This is because the first 
two approaches have been reported to only work in the short-term and tensions resurface 
over time whereas the paradox approach pushes actors to continuously explore the 
tensions and come up with creative and sustainable solutions 328, 330. Thus, consortia 
appear to be better positioned if they accept and determine ways to resolve emerging 
tensions. Research capacity strengthening efforts will also be better served if the reality 
of tensions is proactively and explicitly raised, and some guidance, probably indicating 
boundaries, for resolving potential tensions are made available. As English 318 points out, 
one requires a strong sense of tensions to respond with the right action. Thus, 
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continuously raising and seeking ways to resolve tensions will increase actors’ awareness 
of and ability to address tensions in HRCS consortia.     
Specific capabilities at both individual and organisational levels have been identified as 
crucial when managing tensions 329, 330, 332. Individual capabilities include possessing the 
cognitive and behavioural ability to perceive, differentiate, connect, and act on the 
multiple dimensions of an issue 329, 330, 332. Organisational capabilities include dynamic 
abilities that enable effective responses to constantly shifting environments 329, 330. 
Further, the adoption of guiding principles or philosophy has been highlighted as essential 
in tension management 326, 333. This is because tension management has been shown to be 
more about underlying interests and values than just stakeholder positions 318. From the 
literature and this study, two sets of principles related to collaborations and capacity 
development respectively have been deemed crucial to the success of HRCS consortia 
and should guide decision-making in tension management. The first is the importance of 
adhering to collaborative principles such as equity and balanced power relations 12, 131, 132. 
The increasing number of LMIC-led initiatives are examples of efforts being made to 
operationalise these principles. It is worth noting that even for LMIC-led consortia, 
similar issues regarding inequity and power imbalances still emerged, highlighting the 
fact that these issues transcend HIC-LMIC collaborations and require close attention in 
every collaborative setting. The second set of principles crucial to the success of HRCS 
consortia pertain to capacity development. These include principles such as emergence 
and self-learning, although these have rarely been operationalised in RCS practice 69, 125. 
In the next section, I will focus on the latter and examine the key management strategies 
used in the studied cases from the capacity development perspective to give an indication 
of their suitability for consortia’s HRCS aim.   
 
8.3.2 HRCS consortium management: are the strategies fit for purpose? 
The literature review in Chapter 3 indicated that very little connection is made between 
consortium management strategies adopted and capacity outcomes. While consortium 
management challenges such as power imbalances and inequity have been reported to 
undermine capacity benefits 12, 14, the extent to which each management process and 
adopted strategy enables or hinders capacity development is not well understood. To 
ascertain whether adopted consortium management strategies are fit for purpose, it is 
essential to establish what research capacity strengthening entails. The literature and 
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study findings indicate diverse interpretations of and approaches to research capacity 
strengthening in practice. However, the essence of capacity and the mechanism through 
which it is developed has been reasonably established in the literature 69, 71, 73, 77, 86. As 
discussed in Chapter 2, capacity is a systems phenomenon which relies on the interaction 
between its multiple dimensions and levels. Thus, strengthening research capacity is a 
complex, holistic and long-term process requiring interactions between individual, 
organisational and environmental levels as well as its multiple dimensions such as skills, 
leadership, infrastructure, management systems, collaborations, resource flow and 
applicability to be effective and sustainable 98, 115, 116, 119. The mechanism through which 
capacity is developed has been pointed out to be more emergent than planned, more of an 
“inside-out” process than an “outside-in” one, more long-term than short-term, and more 
systemic and synergistic than compartmentalised.  
In addition, this study has established consortium management processes as capacity 
strengthening mechanisms in their own right. For HRCS consortia, decisions on 
management processes and strategies need to be made in the light of their capacity 
strengthening aims. Although it may be impractical to propose normative management 
strategies due to the varying contexts involved, assessing the strategies identified in this 
study with a capacity development lens will indicate the extent to which the strategies 
engender or hinder capacity development. I therefore assess the four main tension areas 
and the selected strategies in those areas – prioritisation of interests, efficiency and 
effectiveness, excellence and equity, and power – in turn. 
First, the extent to which consortia prioritisation, whether in determining goals or 
allocating resources, aligns with capacity development principles significantly influences 
the degree and strength of the resulting capacity changes. When tensions between 
individual and collective interests are encountered during goal development for instance, 
strategies that place greater emphasis on each institutional partner’s needs and on a 
broader range of research capacity components are likely to serve capacity development 
aims more effectively. This is because partners vary, and sustainable research capacity is 
contextual and reliant on interactions between multiple capacity dimensions within local 
systems. To illustrate, if a partner institution needs both technical and managerial 
capacities, addressing both needs will produce more sustainable local research capacity 
as the interaction between the two is essential for research performance. Focusing on only 
technical capacities as a collective consortium interest is likely to have less impact on the 
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overall local research capacity. Additionally, prioritising some capacity dimensions such 
as training researchers (due to their tangibility for instance) will produce partial capacities 
if not embedded in broader and more holistic institutional capacity development plans. 
Consequently, due to the gaps in other parts of the local system, even the strengthened 
capacities may not be as fully expressed as expected.  
Second, management efficiency seeks to attain the most outputs with the least inputs 334. 
Due to scarce resources, managers are required to be both effective (doing the right 
things) and efficient (doing things right) 335. This holds true in consortium management 
as well. However, there are tensions between efficiency and effectiveness, and consortia’s 
placement along the efficiency-effectiveness spectrum reflects their capacity 
development value. An emphasis on efficient programme delivery to the detriment of 
effectiveness defeats the purpose of holistic capacity development. Efficiency is 
predicated on the reductionist approach to capacity development which has led to the 
compartmentalization of research capacity components such as focusing on the training 
of individuals. This reductionist approach takes little account of the complexity of RCS, 
although it is evident that research capacity is systemic, and its development is neither an 
amalgam of its components or a simple input-output process. For example, when a 
consortium focuses on only the consortium's management needs and not the needs of the 
participating institutions by creating parallel processes to facilitate efficient consortium 
performance, capacity strengthening within the local system is undermined. On the other 
hand, partners significantly appreciated capacity gains that resulted from increased 
management responsibilities, use of local management systems, and the intra-institutional 
interactions associated with the decentralised partner management approach. While the 
latter approach may appear to be less efficient due to the risks to performance, it aligns 
with the internally driven self-organisation that drives effective and sustainable capacity 
development. Indeed, a similar argument could be made for the selection of partners with 
greater or less capacity for research or grant performance, as well as choosing goals that 
are easier or more challenging to deliver, produce short-term or long-term and tangible 
or intangible outputs. Capacity strengthening calls for options that promote research 
capacities that will be more holistic, relevant, and self-sustaining in the local contexts, 
even in the face of short-term risks.     
Third, excellence has been widely used as a key criterion for granting funding support to 
enable high-performing researchers to undertake high-quality research, and this has 
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permeated HRCS practice 336. As reinforced by the study findings, consortia often opted 
for high-performance strategies in almost all management processes including partner 
selection, assignment of roles and responsibilities, resource allocation and partner 
management. The hinging of HRCS decisions solely or heavily on excellence as currently 
conceptualised connotes a results-based ideology more than the need-based and 
relevance-driven thinking that undergirds research capacity development. Indeed, some 
funders have raised the need to consider equity without necessarily sacrificing excellence 
in HRCS decision-making, and to revisit what ‘excellence’ means and how it is measured 
336, 337. However, unless such calls are backed by explicit statements in funder policies or 
programme strategies and guidelines, and subsequently operationalised in funding 
application review processes, the status quo is likely to remain. Consortia leaders will be 
inclined to maximising programme performance based on the planned paradigm, and 
capacity strengthening will continue to be undermined. Similarly, if RCS initiatives 
explicitly or implicitly advance excellent science as a goal, tensions will emerge, and 
trade-offs will continue to occur. Clear policies and guidance will facilitate how these are 
managed and what needs to be prioritised.          
Fourth, issues regarding power relations in research and capacity strengthening 
collaborations have consistently been raised 197, 199, 338, 339. Shared power engenders 
ownership, and both the positive and negative effects of different ownership levels on 
partner engagement and capacity development were demonstrated in the cases studied. 
The significance of self-organisation and adaptation in capacity development requires that 
all partners possess the power to self-organise and adapt RCS activities to their own 
contexts. For instance, greater responsibility in the decentralised systems was established 
as a key learning mechanism for partners at both individual and institutional levels. This 
was due to the opportunity it gave partner actors to self-organise. However, the reality 
that all stakeholders may have to accept is that the more distributed the power across the 
consortium, the greater the risk to accountability. As demonstrated by the study findings, 
consortia leaders frequently contended with reporting challenges such as timeliness and 
accuracy, particularly when less-capacitated partners were involved. Such challenges 
often inform decisions by some consortia to centralise power and maintain greater control. 
However, considering that time facilitates capacity strengthening, these risks and 
challenges can be expected to diminish over time. It is important to note that at the heart 
of capacity development is empowerment 70, and centralising power means that those that 
these initiatives aim to empower, receive little power and less capacity. The increasing 
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number of LMIC-led HRCS initiatives point to some recognition of the interaction 
between power and capacity development. DELTAS Africa demonstrates this recognition 
at the highest level as HIC funders have handed over substantial control of the initiative 
to the AAS due to the capacity strengthening intent. However, the same principle is not 
necessarily demonstrated within all consortia. The interaction between power and 
capacity is often not apparent or explicitly laid bare in consortium management. 
Promoting shared power in consortia as a vehicle for capacity development, similar to 
other more accepted mechanisms such as training, will contribute to the consideration of 
power as a mainstream tool in HRCS initiatives.  
As indicated earlier, all these tensions described above and how they are addressed are 
significantly influenced by consortia actors’ interpretation of research capacity and its 
development. The centrality of research capacity conceptualisation in consortium goals 
and practices has strongly emerged throughout this study. It is also evident that a holistic 
definition and characterisation of research capacity, and the mechanisms by which it is 
developed, have not been fully incorporated into HRCS practice. The thinking and 
management processes of research-oriented programmes appear to have been largely 
reproduced for RCS programmes. Thus, a research and grant culture which promotes 
delivery of outputs such as publications in high impact journals has increasingly 
dominated consortia operations and appears to drive the adoption of management 
strategies that enhance competitiveness. Relatedly, consortia strategies such as 
sidestepping bureaucratic institutional structures and creating consortium-specific 
management structures in order to expedite the delivery of outputs are driven by the 
research culture. As noted above, this approach tends to be results-driven and reductionist 
and does not fully align with the systemic and emergent nature of RCS. A recent survey 
of researchers by Wellcome Trust raised concerns about the effect of such a culture, 
pointing out that although competition is a necessary component of research, it is 
becoming aggressive and harmful and resulting in a loss of quality and impact due to the 
narrow set of priorities 159. This call to streamline the research field to enhance the quality 
and impact of research indicates the need to evaluate and enhance RCS approaches. 
Taking a step back to redefine research capacity and explicitly delineate its dimensions 
and development pathways is likely to result in more effective and sustainable capacity 
changes. It is important to point out that a holistic HRCS agenda does not entirely exclude 
performance goals (such as publications). Performance is an indication that the required 
capacity exists, and capacity development is expected to eventually result in performance 
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125. Thus, RCS without any consideration of performance could result in losing track of 
the need to produce results or engagement in endless re-organisation without tailoring the 
capacity development to the needed performance 69. Nonetheless, it is important to note 
that although performance indicates the presence of capacity, it does not necessarily 
indicate capacity changes and should be cautiously used as a metric for RCS 69. Health 
research capacity strengthening consortia will require dialectical thinking in shaping their 
practice while still being guided by fundamental capacity development aims. In doing 
this, a shared understanding of performance within the RCS context among all 
stakeholders is critical. Additionally, consideration of different evaluation timelines for 
capacity and performance outcomes, appropriate indicators, and seeking a balance 
between capacity changes and performance will be essential elements of a more holistic 
capacity-oriented practice.  
Consequently, balancing options such as complementing the emergent capacity 
development approach with elements of the planned approach or complementing capacity 
changes with performance elements may be necessary for developing pragmatic 
programme and management strategies. Capacity gains can still be optimized if funders 
and practitioners are equipped with knowledge of the capacity development benefits and 
opportunity costs of various options. Admittedly, programmatic limitations of RCS 
initiatives (such as funding and time) may necessitate prioritisation of some capacity 
dimensions over others. However, embedding the selected area(s) of focus within wider 
RCS plans particularly at institutional and continental levels, and an awareness of the 
interconnectedness with other parts of the targeted systems will better address the overall 
capacity needs of participating stakeholders26. From the findings, prevailing RCS 
thinking drives consortium management practice; thus, HRCS management practices that 
are fit for their capacity development purpose will require a consensus on the definition, 
approaches to and evaluation of RCS.  
 
8.3.3 Blending tangible and intangible elements of management  
It emerged from the literature review and empirical findings that a fusion of tangible and 
intangible elements is essential in consortium management. It was also observed that the 
connection between these two management elements is not always taken into account. 
Integrating tangible elements such as management structures and operational processes, 
and intangible elements such as actor agency and relationships is crucial. Although efforts 
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by funders and practitioners such as the use of LMIC-led consortium structures to balance 
power relations have been made, the significance of the tangible-intangible interaction 
and its influence on capacity outcomes have not fully suffused management practice. For 
example, consortia commonly use representative governance structures to ensure 
inclusion and power-sharing; but without addressing intangible barriers such as feelings 
of inadequacy which disempower some partners, and lack of ownership which 
disincentivize others, full inclusion and power balance are not achieved. This 
management outcome undermines the capacity strengthening process. Equally, having 
representative governance structures or decentralised partner management structures 
without a proactive and explicit commitment to values such as openness and learning is 
likely to result in missed capacity strengthening opportunities. Another area where 
combination of tangible and intangible measures is required is in promoting gender equity 
in HRCS consortia efforts. In addition to measures that will increase women trainees and 
leaders in research and in consortia, it is essential to be mindful of and take measures to 
address some of the inadequacies that may be felt by women consortia actors as a result 
of long-standing gender inequities such as limited experience in global health and 
research leadership 340, 341. Overall, it is imperative that tangible structures and processes 
are combined with intangible aspects of management to fully achieve the capacity 
development intent of consortia. Indeed, the importance of this interdependency has been 
recognised in business partnerships where emphasis is placed on going beyond formal 
governance structures to fostering collaborative relationships and behaviour in order to 
attain the desired goals 342, 343.  
Ensuring that these dual dimensions are appropriately tackled will require the relevant set 
of skills. Many of the requisite skills relevant to the more tangible functions such as 
instituting systems and executing processes have been commonly labelled as 
‘management skills’ while those relevant for the more intangible functions such as the 
ability to empower have been commonly labelled as ‘leadership skills’ 344-346. There are 
many overlaps between leadership and management, and the terms and associated skills 
are commonly used interchangeably 347. Several authors have advanced that high-
performing organisations require leader-managers who demonstrate both sets of skills, 
each of which are exercised based on the specific activity or situation 346, 348, 349. Different 
roles warrant different degrees of leadership and management skills 346. The exigencies 
of HRCS require leadership styles such as distributed and transformational leadership 
which prioritise shared power and stakeholder development respectively, as opposed to 
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styles such as transactional leadership which focus on execution of management tasks 350-
352. A distributed perspective on leadership acknowledges that all individuals and 
organisations within the system contribute to leadership irrespective of those formally 
designated as leaders 350, 353. Transformational leadership treats each individual as unique 
and needed in achieving the collective results while empowering and helping individuals 
achieve their fullest potential 351, 352, 354. The principles underlying these two leadership 
styles align with capacity development thinking, and their practice in HRCS consortia 
would be expected to be valuable for their capacity outcomes. Attention to developing 
the appropriate leadership skills will enhance leaders’ crucial skills such as emotional 
intelligence which enables picking up partners’ unvoiced feedback, and empowering 
skills that reinforce partners’ self-expression and active participation in consortia and 
their local systems. It is clear that not only are high levels of both management and 
leadership skills required for effective consortium management, they are crucial 
components of research capacity and their incorporation as capacity strengthening goals 
in consortia programmes would be beneficial. 
 
8.3.4  Management-induced research capacity outcomes 
The literature review and study findings indicate that the conceptualisation of research 
capacity by HRCS consortia has often been too narrow. Indeed, this narrow perception is 
also prevalent in the broader RCS arena 355. Research capacity strengthening has been 
widely perceived as synonymous with research skills training for individuals for many 
years, and this perception appears to still hold in many cases. The exploration into the 
essence of research capacity in Chapter 2 demonstrated the range of capacity dimensions 
spanning the tangible and intangible, technical and managerial, and strategic and 
operational required to work together for research capacity to fully exist. Hence, it is 
essential to make use of all opportunities to strengthen the full range of capacities. As 
discussed in Chapter 7, consortium management processes and practices lead to multiple 
individual and institutional capacity gains that are essential for the research system. 
Unpacking the mechanisms through which learning occurred in consortia increases 
consortia actors’ awareness of the multiple and often overlooked ways through which 
capacity is strengthened, which can in turn inform managerial strategy decisions. For 
example, consortia leaders become increasingly conscious of the fact that participating in 
consortia-level deliberations, hands-on consortium management experience, and higher 
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levels of responsibility are crucial for research capacity strengthening. Similarly, an 
awareness that translating knowledge from one context into another is essential for 
sustainable capacity strengthening and self-reliance highlights the importance of allowing 
partners to contextualise management processes instead of creating ‘ideal’ parallel 
structures to manage grants.      
Many of the management-induced capacity gains reported by participants in the cases 
studied strengthened both individual and institutional capabilities. They also strengthened 
many of the less-considered research capacity dimensions, particularly the strategic, 
managerial and intangible dimensions. For example, new and strengthened relationships 
with consortium partners and other DELTAS stakeholders provide platforms for new 
research collaborations and access to research resources. Indeed, some consortia cases 
reported that they had already leveraged and experienced these benefits. Consortium 
coordinating and reporting requirements strengthened local research management 
systems and workflows as well as intra-institutional relationships that are expected to 
continue supporting local research. Leadership skills gained by consortia actors in areas 
such as goal and strategy development, negotiation, and communication feed into 
capacity dimensions such as the ability to develop local research aims, translate these into 
strategic and operational goals, and relate with internal and external stakeholders to attract 
resources and deliver on goals. Flexibility and dynamic management skills gained from 
managerial experiences have been found to be essential in managing constantly changing 
local contexts and stakeholders. For example, the COVID-19 pandemic clearly 
demonstrated the need for such leadership and management skills. In such emergencies, 
prompt mobilisation of the multiple actors and elements of research systems is a crucial 
part of the required multi-level response efforts; making management processes and skills 
an integral part of health emergency preparedness 59. Hence, identifying and working 
towards capacity gains such as those discussed above, and linking them to research 
capacity dimensions, will ensure that research capacity developed is not limited to 
technical research skills but aims for strengthened contextual and strategic bases on which 
local research enterprises thrive. Thus, incorporating management-induced capacity goals 
into consortia plans will contribute to developing research leaders and advancing the 




8.4 Revised Conceptual Framework 
In Chapter 4, I presented a conceptual framework based on the literature reviewed, which 
elicited the consortium management phases and activities and served as a guide for the 
study (Figure 4.1). Here I present a restructured conceptual framework (Figure 8.1) that 
takes into account the critical issues emerging from the empirical findings of this study 
as well as the literature I have shared throughout this thesis. This is a normative 
framework to support consortium management decision-making which promotes 
capacity strengthening. While the revised conceptual framework still presents the 
consortium management processes and outcomes, it places greater emphasis on: 1) the 
capacity strengthening purpose of consortia; 2) the need for stakeholder consensus on 
what RCS entails; 3) the centrality of taking the essence of capacity and its development 
into account when deciding on management strategies; 4) both tangible and intangible 
aspects of consortium management; 5) ‘how’ the management processes are executed and 
not just ‘what’ processes are to be followed; and 6) the capacity strengthening value of 
consortium management processes and practices as well as some of the resulting capacity 
outcomes.  
The framework lays out the steps and factors that should be considered in managing 
HRCS consortia to promote their capacity strengthening aim. First, it is essential to clearly 
establish consortia’s capacity strengthening purpose which will then provide the fulcrum 
around which managerial decisions are made. This should be done through the collective 
formulation of programme goals based on a holistic definition of research capacity, and 
the framework that will be used to assess the performance on these goals. Thus, a 
consideration of the multiple levels (individual, institutional and environmental) and 
dimensions (tangible and intangible) of research capacity is crucial when determining 
consortia goals. Second, management decisions need to be guided by the collaborative 
and capacity development values that undergird HRCS consortia.  
The RCS purpose can then be operationalised by vetting consortia’s management strategy 
options for alignment with these goals and values. For instance, consortia goals should 
be need-based and take into account ways in which equitable capacity benefits would be 
attained across partners. In determining management strategies, consortia need to 
consider both the tangible and intangible aspects to ensure that the intents of the strategies 
are achieved. While implementing the selected strategies, consortia will need to actively 
track the outcomes of the strategies and the effect on learning goals in order to maximise 
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the resulting management-driven capacity outcomes. Tracking both planned and 
unplanned as well as explicitly and implicitly communicated consequences of the 
implementation of the various strategies is essential during this process. Additionally, 
monitoring the outcomes of management strategies and feeding them back into decision-
making will ensure that capacity opportunities are not missed.  
This conceptual framework represents a ‘theory of change’ and maps out a fresh approach 
to consortium management to optimize the research capacity gains that are derived from 
management processes. It draws out issues underlying the tensions encountered in 
consortium management to facilitate their consideration throughout the consortia’s 
lifecycle. I acknowledge that while this framework puts forward an evidence-informed 
consortium management approach for effective capacity strengthening, its 
implementation would not be without challenges. The factors that have precipitated the 
need for such a framework such as the nature of some funder requirements may still 
dominate decision-making. Nevertheless, the aim of the framework is to continuously 
draw attention to managerial influences and their capacity implications as well as to 
highlight management-related gaps and areas that require greater attention for 
consideration in HRCS policymaking, practice and research. It is intended to promote 
transparent discussion of these issues, informed decision-making, and an awareness of 
the capacity implications of decisions made. Thus, the questions raised in the framework 
are not meant to promote dichotomous strategy choices but to provide a spectrum of 
options for consideration during decision-making in alignment with consortia’s capacity 
goals.    
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Figure 8.1:  Steps and Factors that Should be Considered in Consortium Management to Promote Capacity 
Strengthening   
Goals 
• Holistic definition of research capacity 
drawing out multiple levels and dimensions 
(tangible and intangible) 
• Establish programme goals informed by 
holistic research capacity definition (by 
funders and implementing institutions) 
Values 
• Collaborative: Equity, power balance, 
inclusion 
• Capacity Development: Emergent, long-
term, systemic, synergistic, internally-







Strategy Outcomes to Track and Feed Back into Decisions 
Outcomes of strategy implementation (planned and unplanned; explicit and implicit) 
Alignment or deviations from goals and values 
Effect on management-driven learning goals 
Individual and Institutional Research Capacity Outcomes 
Research and capacity strengthening leadership skills 
Programme and consortium management skills (hard and soft) 
Intra and inter- institutional and individual interactions 
Enhanced institutional research and management systems 
 
Factors to Consider in Aligning Consortium Management Strategies with 
Capacity Strengthening Goals and Values 
Tangible 
• Partner selection:  
Are criteria driven by ability to perform or capacity 
needs? 
• Consortium goals:                                                              
Do they fit into partners’ wider RCS goals? 
Is a wide range of capacity goals captured and 
tracked? (tangible and intangible, technical and 
managerial, and product- and process-driven) 
• Governance:  
Are structures and processes inclusive?  
Do partners have adequate decision-making 
power? 
• Roles and participation:  
Are roles driven by ability to perform or equity and 
inclusion?  
Do partners have adequate authority to fully 
execute their roles and responsibilities? 
Are partners fully engaged in consortia activities? 
What factors enable or hinder involvement? 
• Partner management:  
Is the selection of centralised or decentralised 
partner management approach driven by 
efficiency, inclusion or learning opportunities? 
•  Resource allocation:  
Is allocation driven by ability to perform or equity? 
• Learning opportunities:  
Are opportunities identified and prioritised when 
determining strategies for management processes?  
Intangible 
• Ownership and participation:  
Do partners demonstrate ownership of consortium 
goals and activities?  
Are there any expressed or unvoiced hinderances to 
full partner participation? 
• Power:  
What are the power relations among partners?  
What decision-making power do partners have in 
reality?  
How empowered (enabled or hindered) do partners 
feel in executing their governance and management 
roles?  
What factors contribute to the enabling or 
hinderances? 
• Communication:  
How open is communication in the consortium in 
practice from the perspective of all partners? 
• Learning:  
• How intentional are leaders and partners in 
incorporating learning into each process? 
Is time and support allowed for learning curves? 
• Feedback:  
Are leaders sensitive and responsive to partner 














8.5 Implications for Policy, Practice and Research 
Drawing from the reported findings and emerging issues, I address the study’s fourth 
objective by making recommendations for policy, practice, and further research 
specifically for HRCS consortia management and the broader HRCS agenda. 
 
8.5.1 Policy implications 
The policy context within which consortia operate, particularly concerning funders, 
significantly influences how capacity strengthening initiatives are shaped and consortia’s 
latitude in management 122. A paradigm shift in the HRCS domain towards facilitating 
greater and more sustainable capacity gains from initiatives will require policy 
adjustments that reflect the emerging evidence. To begin with, it is crucial to reach a 
consensus on what research capacity and its development entail among HRCS 
stakeholders, including funders, consortia and institutions. Considering the pivotal role 
funders play in HRCS practice, it is essential for funders to not only clarify the primary 
capacity strengthening aim of initiatives, but to ensure that it permeates through 
programme design and reporting requirements. For instance, some funders could better 
recognise that consortium management is a capacity strengthening mechanism in its own 
right, and management processes that prioritise capacity development require adequate 
resources and time. This has been demonstrated by a UK funder’s example of impelling 
the incorporation of consortium management into programme theories of change 28. 
Funders can play a crucial role in driving the prioritisation of consortium management 
and ensuring it receives adequate support in its operationalisation and evaluation through 
their programme stipulations. In addition, it is important for funders to realize that 
management tensions are significantly heightened in capacity strengthening programmes, 
and consortia leaders often make trade-offs based on their perception of what the funder 
expects. As a result, strategy decisions that optimize capacity strengthening are often less 
favoured as they do not always optimize programme efficiency. Funders would have to 
be more willing to accept the performance risk inherent to processes that optimize 
capacity strengthening. Consequently, such commitments would have to be accompanied 
by specific guidelines with clear emphases on the capacity strengthening intent of 
programmes to give implementers the latitude to choose the appropriate consortium 
strategies. Considering that consortia leaders are usually research experts (as opposed to 
RCS experts), these guidelines will be both instructive and empowering for consortia in 
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their decision-making processes. Such guidance will also be useful for reviewers of 
funding applications for HRCS programmes, who will prioritise RCS principles and not 
just ‘good science’. 
Relatedly, the performance evaluation of HRCS programmes requires further attention. 
This study highlighted the influence of current RCS evaluation requirements on 
consortium management decisions. Evaluation indicators were mainly research products 
such as publications and grants won by trainees. Funders’ focus on research product goals, 
as opposed to RCS goals, has consistently created tensions in RCS programmes 15, 69, and 
as demonstrated by this study, often led to compromises on both capacity strengthening 
and collaborative principles. Therefore, it is crucial that the research capacity that is 
mandated must match what is measured, and this intention needs to be accepted and 
advanced from the policy level. A shift towards more RCS-specific programme 
evaluations will be an important step in that direction. Such a shift will require 
acknowledging that capacity strengthening is not straightforward and does not always fit 
the input-output structure; it is contextual and emergent over time, and RCS results are 
often intangible and difficult to measure. Capacity changes must not only be measured in 
single research capacity components but in changes to system behaviour 69. Thus, in 
evaluating RCS programmes, it will be useful to assess changes in multiple capacity 
dimensions at all three levels (even when the interventions were focused on only some 
dimensions or levels); and if and how changes in one dimension or level affect broader 
local research systems. Evaluations should take cognizance of the fact that research 
capacity is both a means and an end, and should therefore reflect both the ‘means’ and 
‘end’ assessments. These will require employing both quantitative and qualitative 
indicators and methodologies to capture both tangible outcomes such as research 
productivity changes and intangible outcomes such as behavioural and cultural changes 
26. Additionally, the element of time in the capacity development process suggests that 
RCS programme evaluations will provide a better picture of outcomes and impact when 
conducted at time points beyond implementation. As Brinkerhoff and Morgan 88 pointed 
out, there are situations where what may initially appear to be a failed intervention could 
often contribute to subsequent successes. Similarly, unanticipated results or insights, in 
many cases, may prove more important to capacity development effectiveness than what 
was planned 92. Thus, it will be valuable for funders and programme evaluators to 
consider a broader range of evaluation approaches such as outcome mapping, outcome 
harvesting, contribution analysis, and realist evaluation; and the use of methodologies 
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such as case studies and reflective practices 68, 356, 357 in assessing programmes. These 
approaches may help unpack the capacity development process and draw out any causal 
or contributory links between different aspects of RCS interventions and capacity 
changes. Subsequently, such evidence would contribute to improved programme theories 
of change that are likely to lead to better capacity outcomes. Basically, it is imperative 
for RCS stakeholders to redefine performance and excellence and how these are 
measured. Excellence in RCS need to be considered more as excellence in developing the 
means to research performance than as excellence in research performance. Funders may 
be best placed to both initiate as well as be receptive to and support such discussions 
initiated by HRCS practitioners and researchers.     
Furthermore, to promote effective and sustainable RCS, increased institutional leadership 
and ownership of RCS programmes is essential. While funders generally award grants for 
RCS programmes to institutions, the study findings indicated that programmes were led 
by individual researchers, and the levels of institutional embeddedness and ownership, as 
well as the resultant benefits, varied. Similar to research grants, consortium participation 
appeared to be more at the individual level than at the institutional level. Thus, it would 
be beneficial for RCS programmes to place greater emphasis on institutional consortium 
membership and closer alignment of consortia activities with institutional goals. It will 
be necessary for participating institutions to have RCS plans which are actively tracked, 
and which consortium programmes can fit into. Such an approach to developing consortia 
goals will also inform and facilitate tailored evaluation of consortia programmes.     
Finally, capacity strengthening outcomes of HRCS initiatives can be optimized if more 
attention is paid to HRCS implementation science to inform policy and practice. 
Deliberate efforts to increase the generation and use of empirical evidence on HRCS 
practice will provide the learning required to consistently improve guidelines, design, and 
implementation of HRCS programmes and ensure the aims are achieved. While research 
in this area is emerging, it is still an under-developed area, and so the empirical bases for 
building the HRCS practice appears to be weak 21. Currently, many health research 
funders demonstrate their commitment to capacity strengthening by requiring applicants 
to include their capacity strengthening strategies as part of funded programmes. This 
could be taken a step further by including HRCS research as an important scientific area 
in both research and HRCS programmes. The HRCS agenda will significantly benefit 
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from a well-supported research component that will drive more effective and sustainable 
RCS and ensure that returns on investments are optimized.  
 
8.5.2 Recommendations for HRCS consortium management practice 
The findings of this study form the basis for proposing some strategies for consortium 
management practice. First, as demonstrated in both the literature review and study 
findings, similar management processes were used by most HRCS consortia during their 
inception, planning, and implementation phases. The differences among consortia lay in 
the strategies adopted for each process. As such, there is no ‘one size fits all’ formula for 
the management strategies used as contexts vary. However, it is essential for the capacity 
development ethos of HRCS consortia to be at the forefront of management decisions. 
This would require deliberate discussions and a consensus among consortia stakeholders 
on what holistic research capacity comprises as well as programme priorities at both 
initiative and consortium levels. All partners would then assess their research capacity 
contexts and map out their respective strengths and gaps. Management decisions are then 
shaped by these agreements and factors unique to consortia stakeholders’ contexts. For 
example, goal development processes should recognise the short, medium and long-term 
capacity strengthening goals of participating institutions which have been determined by 
a holistic research capacity definition.  
Second, the assessment of consortia’s performance, including the tools and indicators 
employed, must be suited to measuring the changes in the multiple dimensions of research 
capacity at the different levels (individual, institutional, environmental). The contextual 
baseline of different partners also needs to be taken into account when assessing capacity 
changes. Additionally, consortium evaluations need to cover a wide range of capacity 
changes: quantifiable and unquantifiable, tangible and intangible, technical and 
managerial, strategic and operational, programme-oriented and institution-oriented, 
short- and long-term, and whether wholly or partially attributable to the programme. The 
use of such a wide lens will increase the awareness and maximisation of capacity 
strengthening opportunities. 
Third, capacity gains from management processes and practices need to be planned for, 
resourced, tracked and evaluated. As illustrated in the conceptual framework, a conscious, 
explicit and consistent detailing of management strategy options for each process and 
their implications on capacity development is required to ensure that management 
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practices are aligned to consortia’s capacity aims. In doing so, it is crucial for consortia 
leaders and managers to recognise that management strategies are made up of both 
tangible and intangible dimensions, particularly when the aim is to capitalize on their 
capacity strengthening opportunities. Instituting the tangible management structures and 
processes alone do not always achieve their purposes unless they are powered by 
intangible elements such as proactiveness, perception of power dynamics, sensitivity to 
management outcomes, and responsiveness. The use of frameworks or guidance, such as 
the above conceptual framework (Fig 8.1) will help leaders draw out and consider both 
tangible and intangible strategies required to successfully manage HRCS consortia. 
Fourth, this study's findings have highlighted the significance of monitoring, 
responsiveness and dynamism in consortium management to ensure that the desired 
results and capacity changes from those experiences occur. Continuous tracking of 
tensions, contextual influences, interactions between programme and institutional 
elements, and the effect of all these on capacity strengthening efforts is crucial. This will 
not only facilitate timely responses to any developments by leveraging opportunities and 
addressing hindrances but will ensure that the capacity being developed is more 
embedded in the local systems; thus, improving its sustainability.  
Fifth, two important means of enabling consortia leaders in their leadership and 
management roles are training and mentorship. Leaders need to plan for and access 
training and other resources for themselves and other consortia actors to enhance their 
leadership and management skills and practice. It is crucial for HRCS consortia funders, 
designers and implementers to recognise that there is a science to capacity strengthening 
that should inform programme implementation including management practice. Training, 
particularly for consortia leaders, will increase the awareness of a broad range of tangible 
and intangible capacity strengthening and management elements, and enhance leaders’ 
skills in managing HRCS consortia. For example, discussions on the cognitive and 
behavioural skills required for tension management during such training sessions will 
enhance awareness and increasing use of those skills. Such training will provide the 
opportunity to explicate and strengthen the required leadership and management skills. 
The need for deliberate training is even more crucial considering that management 
practices are often transferred from one consortium to the other, and in many cases, 
without the benefit of evaluation of these management practices and outcomes. Making 
deliberate efforts to strengthen the management skills of consortia leaders will therefore 
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promote the replication of knowledge-based management practices across consortia and 
in the broader RCS domain.  
Finally, consortia leaders should endeavour to provide comprehensive feedback to 
funders, including elements that are not stipulated in reporting and evaluation 
requirements. For example, sharing the reality of management tensions and trade-offs and 
how different decisions enable or hinder capacity strengthening in their contexts will 
increase stakeholder awareness of a broad range of implementation outcomes. Consortia 
feedback will then serve as evidence and sources of learning for funders and designers of 
programmes. 
 
8.5.3 Areas for further research  
This study has led to insightful findings regarding the interaction between consortium 
management and capacity development. It has also highlighted a number of issues that 
warrant further investigation. First, this study focused on one Africa-based HRCS 
initiative (DELTAS Africa) and only examined consortia from this initiative. Conducting 
a similar study with consortia from other HRCS initiatives, geographical settings, and 
disciplines will contribute towards determining the transferability of these findings to 
different contexts. This study also focused on South-led consortia, and an examination of 
management processes and practices of North-led HRCS consortia may draw out 
different contextual influences and unique issues for consideration in such consortia.  
Second, it would be worth examining the management processes and practices of research 
consortia to better understand how the experience differs when capacity strengthening is 
not a primary objective. Many research consortia may still have embedded capacity 
strengthening goals, and it would be insightful to ascertain if and how those goals 
influence their management processes and strategies. 
Third, it would be valuable to examine the power relations among consortia members in 
greater depth, drawing out the different forms and sources of power and how they are 
channelled or expressed throughout the consortium lifecycle. This will increase the 
awareness of the power dynamics among consortia stakeholders and help improve our 
understanding of the underlying causes of inequity and power asymmetries. Also, it 
would be useful to consider a deliberate application of a gender lens in examining 
consortia operations to draw out any gendered influences and implications of current 
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management practices. Highlighting these factors will promote management strategies 
that address power challenges and promote more equitable capacity benefits across 
consortia. 
Fourth, it will be necessary to validate and build upon the presented conceptual 
framework (Fig 8.1) through empirical testing with RCS consortia in similar and different 
contexts. This would involve applying the conceptual insights that have emerged from 
this study  and captured in the conceptual framework to other cases and contexts. The 
framework can thus be used to understand and further examine the management processes 
and strategies of both similar and different RCS consortia and their influence on the 
capacity outcomes.   
Finally, several potential areas of research on RCS more broadly have been highlighted 
as a result of this study. The highlighted characteristics and dimensions of capacity 
provide a conceptual basis for empirically identifying the full range of research-specific 
capacity dimensions. The investigation of multiple RCS initiatives can contribute to an 
evidence-based and unified definition and characterisation of research capacity to guide 
RCS practice. Another key area for research is an institutional-level investigation to 
identify the different research capacity components, as well as the interfaces and 
interactions between RCS activities and other institutional structures and activities and 
their effects. Additionally, research that seeks to draw out RCS-specific evaluation 
strategies and indicators will contribute towards addressing this long-standing gap in the 
RCS field. Also, conducting impact evaluation of RCS programmes several years after 
completion to assess all the research capacity levels and dimensions will identify factors 
that influence the capacity development pathway. Impact evaluations will also draw out 
enablers and hindrances to the capacity development process and suggest more effective 
and sustainable approaches to capacity development.   
 
8.6 Chapter Summary 
In this final chapter, I presented a summary of the study findings and discussed the 
emerging issues, how they fit in the existing literature and their relevance to the HRCS 
field. I highlighted the reality of tensions in consortium management and ascertained how 
they are managed from the broader management literature. I advocated for the paradox 
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approach of tension management, which promotes confronting and resolving the conflicts 
underlying tensions, and which aligns with consortia's capacity strengthening aims. I then 
examined the management strategies adopted by the studied consortia using a capacity 
development lens to ascertain their fitness for the capacity development aim of HRCS 
consortia. It also emerged that it was essential to blend both tangible and intangible 
elements of management to ensure that the intended consortia outcomes are achieved. It 
became clear that there are several essential management-induced research capacity 
outcomes that require giving consortium management the necessary attention to ensure 
those capacities are realized. Finally, based on the study findings, I present a revised 
conceptual framework that can guide capacity-oriented consortium management, and 
recommendations for policy, practice and further research. Summaries of key 
recommendations for HRCS funders and consortia leaders and managers are presented in 




Box 8.1: Summary of Recommendations for HRCS Funders 
1) Recognise that consortium management is a capacity strengthening 
mechanism in its own right, and management processes require adequate 
resources, time, and training 
2) A holistic (multi-level and multi-dimensional) approach to research capacity 
strengthening is essential to maximise the capacity outcomes  
3) Clarify the capacity strengthening aim of initiatives and ensure it permeates 
programme design and reporting requirements 
4) Recognise the existence of tensions in consortium management and the 
capacity implications of the resulting compromises and trade-offs that are 
often made to meet funder requirements 
5) Embrace the risks inherent in RCS and its management 
6) Back capacity strengthening commitments with clear guidelines to give 
implementers the latitude to make appropriate management decisions even 
when it appears ‘risky’ 
7) Redefine performance and excellence and how these are measured; and ensure 
evaluation indicators are RCS-specific to promote the prioritization of 
capacity strengthening in management decisions 
8) Promote increased institutional leadership and ownership of RCS programmes 
as well as closer alignment of consortia activities with institutional goals to 
ensure more sustainable capacity outcomes 
9) Appreciate that there is a science to capacity strengthening which should 
inform programme implementation; and endeavor to advance the generation 












Box 8.2: Summary of Recommendations for HRCS Consortia 
1) Establish a consensus on what holistic research capacity and its development 
entails among stakeholders including funders, consortia and partner institutions 
to guide consortia activities  
2) There is no ‘one size fits all’ formula for consortium management strategies as 
contexts vary, but it is essential to ensure that decisions are guided by a holistic 
capacity development ethos 
3) Recognise that consortium management is a capacity strengthening mechanism 
in its own right; leverage the RCS opportunities it presents, and assign the 
required resources, time and training 
4) Identify the tensions that emerge when making consortium management 
decisions and ensure constant awareness of the capacity implications of the 
different strategy options 
5) Align consortia activities with institutional goals of partners to ensure the 
attainment of more relevant and sustainable capacity outcomes 
6) Continuously track tensions, how management decisions unfold during 
implementation, contextual influences, interactions between programme and 
institutional elements, and the effect of all these on capacity strengthening 
efforts; make adjustments where necessary, and share experiences as learning 
7) Integrate tangible management structures and processes with intangible 
management ‘software’ such as such as perception of power dynamics, and 
sensitivity to both expressed and unvoiced feedback to help achieve the 
intended capacity outcomes 
8) Employ programme evaluation approaches including tools and indicators that 
consider the contextual baseline of different partners and measure a wide range 
of research capacity changes (quantifiable and unquantifiable, tangible and 
intangible, technical and managerial, strategic and operational, programme-
oriented and institution-oriented, short- and long-term) at the different levels 
(individual, institutional, and environmental) 
9) Provide comprehensive feedback covering a broad range of implementation 
outcomes to funders including elements that are not stipulated in reporting and 
evaluation requirements to enhance policy and future programmes 
10) Draw on and contribute to empirical evidence on HRCS practice and 
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Appendix 3: Included Papers (55) in Systematised Literature Review 
Empirical papers (18)  












Ager & Zarowsky 2015  Retrospective, 
summative, qualitative 
Common challenges and their key 
drivers of HRCS 
South, East & 
West Africa 
 
RCS Multiple External *** 
Anderson et al. 2014 Retrospective, 
formative, qualitative 
Evaluating the initial effects of a 
charter for collaboration 






Birch et al. 2013 Prospective, formative, 
qualitative 
Self-evaluation of partnership using 
an identified assessment measure 
Africa - Malawi Clinical care 
Research 
Nursing Internal ** 
Dean et al. 2015 Retrospective, 
summative mixed 
methods 
Lessons for establishing and 
maintaining successful research 
collaborations 








Elmusharaf et al. 2016 Retrospective, 
summative, qualitative 
Achievements and outcomes of 
partnership 
Africa - Sudan RCS Health systems Internal and 
external 
** 
Farnman et al. 2016 Retrospective, 
summative, qualitative 
Successes, challenges and lessons 
learned 





Asia - China, 
India, Oman, 
Vietnam 
RCS Health systems 





Jentsch & Pilley 2003 Retrospective, 
summative, qualitative 







Multiple Internal ** 
Larkan et al. 2016 Retrospective, 
qualitative 
Characteristics of successful research 
partnerships 
Africa & Asia Research 
RCS 
Multiple Internal *** 
Mafigiri et al. 2014 Prospective, formative, 
qualitative 
Experiences, successes and 
challenges of collaboration 



















Marjanovic et al. 2013 Retrospective, 
formative, mixed 
methods 
Experiences of consortia actors Africa - East, 
West and South 
Africa 
RCS Multiple External Not 
scored 
Mayhew et al. 2008 Retrospective, 
summative, mixed 
methods 
Successes and challenges, and 
lessons learned 
Africa - South 
Africa 
Asia - Thailand  
RCS 
Research 
Health Economics External * 
Murphy et al. 2015 Retrospective, 
qualitative 







Multiple Internal ** 





Outputs and outcomes including 
project’s eventual failure and lessons 
learnt 
















RCS Nursing Internal **** 




Obstacles for southern institutions 
RCS & perceptions of southern 
researchers on capacity transfer 












Varshney et al. 2016 Retrospective, 
formative, qualitative 
Understand challenges of 
collaborations, whether collaboration 
result in capacity building, and 
requirements for sustainable 
collaborations 
Africa - South 
Africa  






Not stated *** 




characterized as higher-value for 
building the capacity of four 
universities and identify why they are 
so considered 






Multiple External ** 
Yassi et al. 2016 Retrospective, 
summative, qualitative 
Determine the partnership model 
used, success factors and lessons 
learnt 











(H)RCS – (Health) research capacity strengthening 
1Specific countries or regions are listed if named in the publication 
2MMAT scoring metrics: * = one criteria met (25%) to **** = all criteria met (100%); Not scored= did not fulfil screening criteria, thus not eligible for full appraisal 
 
Commentary papers (37)  
Paper Reference Commentary 
informed by 






Airhihenbuwa et al. 
2011 
Personal experience Present partnership that led to 
training, and make recommendations 
for capacity building for health 
researchers in Africa 
Africa - South 
Africa 
RCS HIV/AIDS 
Ali et al. 2012 Personal experience Report on implementation, outputs 
and challenges of partnership 
Asia - India Research 
RCS 
Cancer 
Asirwa et al. 2016 Personal experience Describe programme content, 
outcome measures and challenges 






Atkins et al. 2016 Personal experience Describe the activities of two 
consortia 




Asia - China, 
India, Oman, 
Vietnam) 
RCS Health systems and 
services & Social 
determinants of health 
Breuer et al. 2018 Personal experience Reflect on the history, formation, 
challenges and achievements of the 
partnership 











Paper Reference Commentary 
informed by 






Cash-Gibson et al. 
2015 
Personal experience Description of a collaborative RCS 
project 
















RCS Public health research 
Dalmar et al. 2017 Personal experience Outline reasons and motivations for 
re-launching research cooperation 
programme 
Africa - Somalia RCS Health research 
de-Graft Aikins et al. 
2012 
Personal experience Review the partnership’s 
achievements and challenges 










Eckerle et al. 2017 Personal experience Describe evolution of novel global 
health partnership 










RCS Population and public 
health 
Fischer et al. 2017 Personal experience Describe steps taken and key factors 
in establishing a successful 
collaborative consortium, and 
challenges 






Paper Reference Commentary 
informed by 






Greenwood et al. 
2012 






Greenwood et al. 
2018 
Personal experience Describe programme activities and 
lessons learnt 





Gureje et al. 2018 Personal experience Describe the partnership, programme 
components, and challenges 
Africa - Nigeria, 
South Africa, 





Kaddumukasa et al. 
2014 
Personal experience Describe partnership initiative Africa - Uganda RCS 
Education 
Neurology 








MacLaren et al. 2015 Personal experience Provide an example of an RCS model Pacific - Solomon 
Islands 
RCS Nursing 
Mathai et al. 2018 Personal experience Describe a South-North collaboration  Africa - Kenya RCS 
Research 
Mental health 
Miiro et al. 2013 Personal experience Outline the initial experiences of the 







HIV/, TB, Malaria and 
NTDs 
Miranda et al. 2018 Personal experience Explore features of existing 
partnerships  






Nakabugo et al. 2010 Personal experience Illustrate potential mutual benefits 
from partnerships, challenges and 
strategies for achieving a mutual and 
sustainable partnership 
Africa - Malawi, 
Mozambique, 
Tanzania, Uganda 
RCS Health and education 
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Paper Reference Commentary 
informed by 






Noormahomed et al. 
2017 
Personal experience To describe programme outcomes, 
compare main features with 
traditional collaboration models; and 





Health education and 
research 




Ogden & Porter 2000 Personal experience Recount the unfolding of two related 
international research 
collaborations 






Personal experience Examine the experience of the 
partnership and outlining successes 
and challenges 





O’Sullivan et al. 2017 Personal experience Describe the approach used to 
develop a collaborative and 
sustainable partnership, and initial 
project outcomes 
Africa - Uganda Education 
RCS 
Physiotherapy 
Pinto et al. 2012 Personal experience Using the International Participatory 
Research Framework (IPRF) to build 
a partnership 
Latin America & 




Reddy et al. 2002 Personal experience Discussion of challenges and 
opportunities for capacity building 
and collaboration strategies 
Africa - South 
Africa 
RCS HIV/AIDS 
Sanchez at al. 2013 Personal experience Describe the implementation, 
challenges, and lessons learned of an 
RCS project 
Latin America & 
Caribbean - 
Honduras 
RCS Infectious diseases 
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Paper Reference Commentary 
informed by 



















Silva et al. 1994 Personal experience Review the results of the programme 
from the angle of cross-fertilization 
of disciplines through their 
collaboration 
Asia – Sri Lanka RCS 
Research 
Health social science 
Spiegel et al. 2006 Personal experience Summarize how collaboration was 
pursued, identify outputs, and 
highlight mutual benefits gained 
Latin America & 





Stillman et al. 2006 Personal experience Describe the approach, main 
outcomes and challenges of a 
partnership 
Asia - China, 






Tierney et al. 2013 Personal experience Describe partnership, challenges and 
value created 






Van Teijlingen et al. 
2018 
Personal experience Highlight reasons for, considerations, 
and procedures around development 
of partnerships and key challenges 




Vasquez et al. 2013 Personal experience Highlight major challenges to the 
HRCS enterprise and make 
recommendations 
Asia - Vietnam RCS HIV/AIDS 
(H)RCS - (Health) research capacity strengthening 
1Specific countries or regions are listed if named in the publication 
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Appendix 4: Document Review Checklist 
Date: 
Reviewer: 
Inquiry Source Document 
Background to Consortia 
Formation • Call for applications for DELTAS Africa programmes 
Funder Influences 
• Notice of Award 
• Funder Terms and Conditions 
• DELTAS Africa M&E Strategy 
• Consortium Reporting Templates 
Consortia Characteristics 
• List and Details of Consortia 
• Current Consortia Leadership and Management Team 
Consortia Management 
Structures and Processes 
• Proposals submitted by consortia 










Appendix 5: Template for Collection of Consortia Data 
Consortium Management Study - Learning Research Programme 




1. List of Partners 
No. Partner Institution 
Designation of 









of partner  
Estimated level of 
research capacity of 
institution 
(low, medium, high) 
*includes infrastructure, 
HR, number of projects, 
research outputs 
How long 






1       
2       
3       
 
2. Period of existence of this consortium (in years) 
 




4. Governance and management structures (including boards, committees, secretariat) 
• Governance bodies 
• Composition (number of persons and description, and not individual names) 
• Terms of reference/functions  
• Frequency of meetings 
 
 
5. Consortium goals 
 
 





Appendix 6: Informed Consent Forms for Participants in Consortia 
KEMRI Wellcome Trust Research Programme: Information Sheet and Consent Forms for 
Consortia Directors and Managers 
 
Study Title: Examining the process of establishing and managing health research capacity 
strengthening consortia 
 
Lay Title: Understanding how health research capacity strengthening consortia are established 
and managed 
Institution Investigators 
KEMRI Wellcome Trust 
Research Programme 
Ms Nadia Tagoe, Prof. Sassy Molyneux, Dr Sam Kinyanjui 
Liverpool School of 
Tropical Medicine  
Dr Justin Pulford 
 
Introduction for Participants: 
This study is part of the Learning Research Programme (LRP), which is working alongside 
DELTAS Africa consortia to produce research-based learning about how to train and develop 
world-class researchers, foster their careers and collaborations, and promote research 
uptake.  This study is being implemented through a collaboration involving the LRP, led by the 
Liverpool School of Tropical Medicine and IDeAL hosted by the KEMRI Wellcome Trust 
Research Programme with the support of the African Academy of Sciences (AAS).   
Who is carrying out this study and what is this study about?  
This study is being carried out by KEMRI in collaboration with the Liverpool School of Tropical 
Medicine (LSTM), UK, with the support of AAS.  
The study seeks to draw on the collective experience of the DELTAS Africa initiative to generate 
and share evidence towards promoting collaborative health research capacity strengthening 
efforts. We want to learn more about: 
• the processes used in establishing and managing health research capacity strengthening 
consortia and what influences these processes 
• capacity strengthening goals from the perspectives of different actors within the consortia  
• how processes used by consortia influence the achievement of their goals  





Why do you want to talk to me and what does it involve?  
We feel that your experience as a leader or member of the DELTAS consortium, and your 
involvement in health research capacity strengthening initiatives can contribute to our 
understanding and knowledge of consortia processes.  We would like to hold a discussion with 
you to listen to your experiences in the DELTAS consortia as well as other consortia-based 
programmes. We would also like to hear your ideas on consortia processes and achieving capacity 
strengthening goals. 
• I would like to ask you a number of questions about how the consortium was established, 
what goals it intends to achieve, how the consortium is managed, what influences consortium 
processes, what successes have been achieved and what challenges have been encountered. 
If you do not want to answer any of the questions, you may say so, and I will move on to the 
next question. The discussion will take place at a location that is convenient for you, and no 
one else will be present unless you would like someone else there.  
• The discussions will be audio recorded to assist later in fully writing up the information.  No 
one will be identified by name in the recording.  
 
Are there any risks or disadvantages of taking part?  
• The discussions should take approximately one hour.   
 
Are there any advantages of taking part? 
The study is expected to contribute to new learning with respect to consortium management which 
can immediately be fed back to the DELTAS community. This can help strengthen management 
processes in the current and future consortia. This study will also contribute to knowledge that 
will help researchers, programme leaders, funders, policymakers and other stakeholders in 
improving collaborative initiatives for strengthening health research capacity in low and middle-
income countries, especially in Africa. 
 
Who will have access to the information I give? 
• We will not share individual information about you or other participants with anyone apart 
from those closely involved in this study. The knowledge gained from this research will be 
shared in summary form, without revealing individuals’ identities. 
• All our documents and audio recordings are stored securely in locked cabinets and on 
password-protected computers.  
• Audio recordings of interviews will be destroyed at the end of the study. 
• Data collected during this study will not be shared with other researchers in the future. 
 
Who has allowed this research to take place? 
All research at KEMRI and collaborating centres have to be approved before commencement by 
several national committees who look carefully at planned work. They must agree that the 
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research is important, relevant to Kenya and follows nationally and internationally agreed 
research guidelines. This includes ensuring that all participants’ safety and rights are respected. 
 
What will happen if I refuse to participate?  
All participation in research is voluntary.  You are free to decide if you want to take part or not.  
If you do agree, you can change your mind at any time without any consequences.   
 
What if I have any questions? 
You are free to ask me any question about this research. If you have any further questions about 
the study, you are free to contact the research team using the contacts below:  
 
Ms. Nadia Tagoe, KEMRI Wellcome Trust Research Programme, P.O. Box 230, Kilifi.  
Telephone: +254 791626310 or +254 722 203417, +254 733 522063, +254 41 7522063; Email 
address: ntagoe@kemri-wellcome.org 
 
If you want to ask someone independent anything about this research, please contact: 
Community Liaison Manager, KEMRI Wellcome Trust Research Programme, P.O. Box 230, 
Kilifi.  Telephone: +254 41 7522 063; Mobile +254 723 342 780 or +254 705 154 386 
 
The Secretary, KEMRI Scientific and Ethics Review Unit, P. O. Box 54840-00200, Nairobi; 





I have had the study explained to me. I have understood all that has been read/explained and had 
my questions answered satisfactorily.  
  Yes (please check) I agree to take part in this research 
  Yes (please check) I agree for the interview/discussion to be audio recorded  





Participant Name:  Time:  
 (please print name)  
 
Information/consent provided by: _______________________   _______________________ 




KEMRI Wellcome Trust Research Programme: Information Sheet and Consent Forms for 
AAS Participants  
 
Study Title: Examining the process of establishing and managing health research capacity 
strengthening consortia 
 




KEMRI Wellcome Trust 
Research Programme 
Ms Nadia Tagoe, Prof. Sassy Molyneux, Dr Sam Kinyanjui 
Liverpool School of 
Tropical Medicine  
Dr Justin Pulford 
 
Introduction for Participants: 
This study is part of the Learning Research Programme (LRP), which is working alongside 
DELTAS Africa consortia to produce research-based learning about how to train and develop 
world-class researchers, foster their careers and collaborations, and promote research uptake. This 
study is being implemented through a collaboration involving the LRP, led by the Liverpool 
School of Tropical Medicine and IDeAL hosted by the KEMRI Wellcome Trust Research 
Programme with the support of Alliance for Accelerating Excellence in Science in Africa 
(AESA). 
   
Who is carrying out this study and what is this study about?  
This study is being carried out by KEMRI in collaboration with the Liverpool School of Tropical 
Medicine (LSTM), UK, with the support of AESA.  
The study seeks to draw on the collective experience of the DELTAS Africa initiative to generate 
and share evidence towards promoting collaborative health research capacity strengthening 
efforts. We want to learn more about: 
• capacity strengthening goals from the perspectives of different actors within the consortia  
• the processes used in establishing and managing health research capacity strengthening 
consortia and what influences these processes 
• how processes used consortia influence the achievement of their goals.  






Why do you want to talk to me and what does it involve?  
We feel that your role can contribute to our understanding and knowledge of the management and 
capacity building activities of the consortia.  We would like to hold a discussion with you to listen 
to your views and experiences regarding the DELTAS consortia. We would also like to hear your 
ideas on consortia management and achieving capacity strengthening goals. 
• I would like to ask you a number of questions about the background and goals of DELTAS, 
how it is strengthening capacity, what successes have been achieved and what challenges 
have been encountered. If you do not want to answer any of the questions, you may say so, 
and I will move on to the next question. The discussion will take place at a location that is 
convenient for you, and no one else will be present unless you would like someone else there.  
• The discussions will be audio recorded to assist later in fully writing up the information.  No 
one will be identified by name in the recording.  
• In some cases, I may also silently observe your participation in a DELTAS related meeting 
or forum. 
 
Are there any risks or disadvantages of taking part?  
• The discussions should take approximately one hour.   
 
Are there any advantages of taking part? 
The study is expected to contribute to new learning with respect to consortia management which 
can immediately be fed back to the DELTAS community. This can help strengthen management 
processes in the current or future consortia. This study will also contribute to knowledge that will 
help researchers, programme leaders, funders, policymakers and other stakeholders in improving 
collaborative initiatives for strengthening health research capacity in low and middle-income 
countries, especially in Africa. 
 
Who will have access to the information I give? 
• We will not share individual information about you or other participants with anyone apart 
from those closely involved in this study. The knowledge gained from this research will be 
shared in summary form, without revealing individuals’ identities. 
• All our documents and audio recordings are stored securely in locked cabinets and on 
password-protected computers.  
• Audio recordings of interviews will be destroyed at the end of the study. 
• Data collected during this study will not be shared with other researchers in the future. 
 
Who has allowed this research to take place? 
All research at KEMRI and collaborating centres have to be approved before commencement by 
several national committees who look carefully at planned work. They must agree that the 
research is important, relevant to Kenya and follows nationally and internationally agreed 
research guidelines. This includes ensuring that all participants’ safety and rights are respected. 
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What will happen if I refuse to participate?  
All participation in research is voluntary.  You are free to decide if you want to take part or not.  
If you do agree, you can change your mind at any time without any consequences.   
 
What if I have any questions? 
You are free to ask me any question about this research. If you have any further questions about 
the study, you are free to contact the research team using the contacts below:  
 
Ms. Nadia Tagoe, KEMRI Wellcome Trust Research Programme, P.O. Box 230, Kilifi.  
Telephone: +254 791626310 or +254 722 203417, +254 733 522063, +254 41 7522063; Email 
address: ntagoe@kemri-wellcome.org 
 
If you want to ask someone independent anything about this research, please contact: 
Community Liaison Manager, KEMRI Wellcome Trust Research Programme, P.O. Box 230, 
Kilifi.  Telephone: +254 41 7522 063; Mobile +254 723 342 780 or +254 705 154 386 
 
The Secretary, KEMRI Scientific and Ethics Review Unit, P. O. Box 54840-00200, Nairobi; 





I have had the study explained to me. I have understood all that has been read/explained and had 
my questions answered satisfactorily.  
   Yes (please tick) I agree to take part in this research 
   Yes (please tick) I agree for the interview/discussion to be audio recorded  





Participant Name:  Time:  
 (please print name)  
 
Information/consent provided by: _______________________   _______________________ 







Appendix 7: Topic Guide Used in Key Informant Interviews  
Consortia Directors 
Inception 
1) What is your role in the consortium?  
• When and how did you take it on?  
• What are your main responsibilities, and how have they changed over time? 
 
2) What motivated the formation of the consortium (why the consortium model)? 
• How was it established? Who initiated and why? 
• What determined the structure and size of the consortium? 
• What makes it a ‘consortium’ rather than a network/partnership? 
 
3) What criteria was used in selecting the partners?  
• Why stated criteria? 
• Previous relationship (and how long)? Funding? Topic/technical capacity? 
• Why these partners and not others who meet or may have met the same criteria? 
 
4) What are the differences between co-applicants and collaborators? 
• How were partner roles determined? 
 
5) How were the goals, focus areas and partner responsibilities determined? 
• Who was involved? 
• What influenced the selection?  
• Was it easy to agree across partners?  
• Have they changed over time? Why? 
 
6) How was resource allocation done? 
• How is trainee support awarded? 
 
7) Did your consortium have an establishment/inception/partnership development phase?  
• What were the easiest and hardest parts?  
• At what stage is the consortium now? 
242 
 
• At what point did you consider the consortium established? Why?  
• What type of agreement was used, and why? 
 
8) What was your experience during the consortium start-up phase? 
 
Implementation 
9) How was the leadership and/or management structure developed? 
• Do you distinguish between leadership and management? How? 
• What determined/influenced structure (requirements from funders, host 
institution)? 
• How do they function in practice (including planning, decision-making, 
coordinating, reporting)? 
• Differences between instituted and how they function in practice and why?  
• How do the different management levels/arms relate to each other? 
• What are the enablers and challenges of leadership/management functions across 
levels? 
 
10) How do the partners relate to each other, and how has that developed over time? 
• How are equity and inclusivity promoted? 
• Any conflicts? Competition? How do you respond? 
• What are the differences between partners?  
• How different are the levels of engagement among partners? Why? 
 
11) What makes it a research capacity strengthening (RCS) consortium vs a research 
consortium? 
• What are the differences between managing an RCS consortium such as this and 
a research consortium? 
12) Have there been any critical incidents (e.g. unintended occurrences or changes, e.g. 
personnel), and how did the leadership respond? 
 
13) How does the consortium relate to the host institution? 
•  Active institutional role? 
• Influence of institutional policies, procedures and practices 
 
14) How does the consortium relate to the funder (AAS/AESA)? 
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• What has your experience been with requirements, influence, support? 
• What will be helpful for funders to do in addition to and/or differently?   
 




16) How have you developed your expertise in leading/managing a consortium? 
• Any previous experience leading or participating in a research or RCS consortium? 
• How does this experience compare to the previous one(s)? 
• Do you draw on any training, resources (e.g. tools, frameworks) in managing the 
consortium?  
o What are they? 
o What training, resource or other support would you consider to be 
helpful/recommend? 
 
17) How will you describe a successful consortium? Enablers and barriers? 
 
18) How does excellence drive what the consortium does? 
 
19) What aspects of consortium management helps or challenges the achievement of 
consortium goals? 
 
20) If you have to do this again, what will you do differently? 
 
21) As a consortium, what are some of the overall successes and challenges to date? 
 








1) What is your role in the consortium?  
• When and how did you take it on?  
• What are your main responsibilities, and how have they changed over time? 
 
2) Tell me about how the consortium was set up (if applicable) and how it operates. 
• What makes it a “consortium” rather than a network/partnership? 
• What indicates that it is an established consortium? 
• What were the criteria for inclusion? 
 
3) Tell me more about the partners 
• Type of institution, expertise, type of institution, size, level of research intensity, 
prior working relationship (if data not already provided) 
 
4) What are the differences between co-applicants and collaborators? 
• How were partner roles determined? 
 
5) How were the goals, focus areas and partner responsibilities determined? 
• Who was involved? 
• What influenced the selection?  
• Was it easy to agree across partners?  
• Have they changed over time? Why? 
 
6) How was resource allocation done? 
• How is trainee support awarded? 
 




8) How was the leadership and/or management structure developed? 
• How do they function in practice (including planning, decision-making, 
coordinating, reporting)? 
• Differences between instituted and how they function in practice and why? 
• How do the different management levels/arms relate to each other? 
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• What are the enablers and challenges of leadership/management functions across 
levels? 
 
9) How do the partners relate to each other, and how has that developed over time? 
• How are equity and inclusivity promoted? 
• Any conflicts? Competition? How do you respond? 
• What are the differences between partners? 
• How different are the levels of engagement among partners? Why? 
 
10) What makes it a research capacity strengthening (RCS) consortium vs a research 
consortium? 
• What are the differences between managing an RCS consortium such as this and 
a research consortium? 
 
11) Have there been any critical incidents (e.g. unintended occurrences or changes, e.g. 
personnel), and how did the leadership respond? 
 
12) How does the consortium relate to the host institution? 
•  Active institutional role? 
• Influence of institutional policies, procedures and practices 
 
13) How does the consortium relate to the funder (AAS/AESA)? 
• What has your experience been with requirements, influence, support? 
• What will be helpful for funders to do in addition to and/or differently?   
 




15) How have you developed your expertise in consortium management? 
• Path to project management? 
• Previous experience with a consortium?  
• How does this experience compare to the previous one(s)? Better/worse, and why? 
• Have you drawn on any training, resources or other support?  
o What are they? 
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o What training, resource or other support would you consider to be 
helpful/recommend? 
 
16) How will you describe a successful consortium? Enablers and barriers? 
 
17) How does excellence drive what the consortium does? 
 
18) What aspects of consortium management helps or challenges the achievement of 
consortium goals? 
 
19) As a consortium, what are some of the overall successes and challenges to date? 
 







AESA Director and AAS Advisor 
 
1) What is AESA’s current role (overall and with respect to DELTAS)? 
• How has that role with respect to DELTAS evolved over time? 
 
2) Why was the DELTAS initiative developed, and what was the thinking behind it? 
• How has that evolved? 
• Which stakeholders were involved? 
• Role of previous initiatives? 
 
3) What processes went into developing the initiative and what determined/informed 
the design requirements given in the call? 
 
4) Why the preference for consortia/collaborations?  
5) Did AESA (together with its funding partners) provide any support to applicants 
during the application process? 
 
6) What are the challenges faced by AESA in administering DELTAS Africa? 
 
7) What are your thoughts on how the DELTAS consortia were formed and how they 
are managed? 
• Any patterns, similarities, differences? 
• Examples of successes and challenges 
• What can be improved to better facilitate the achievement of DELTAS goals? 
 
8) Which aspects of how consortia are established and managed are important to 
AESA?  
• Why? 
• What will be important to follow-up on during this study? 
 
9) Having gone through the experience of establishing the DELTAS programme, what 
will you do differently in a subsequent initiative? 
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• In terms of supporting the formation and management of consortia  
• Generally? 
 
10) Generally, has the initiative unfolded in the way you expected?  
• Any unexpected experiences or things that have naturally emerged?  
 
11) What will you say are the main successes and challenges of the initiative so far? 
 
12) What will a successful DELTAS look like for AESA? 
• What do you expect consortia to achieve (in addition to research capacity) in the 
area of research/consortium management? 





DELTAS Programme and M&E Managers at AAS 
1) What is your current role, and what are your responsibilities? 
• When and how did you take this role on? 
• How have your responsibilities changed over time? 
 
2) What is your understanding of the overall thinking behind the DELTAS initiative? 
 
3) What are your thoughts on how the DELTAS consortia were formed and how they 
are managed? 
• Any patterns, similarities, differences? 
• Examples of successes and challenges 
• What can be improved to better facilitate the achievement of DELTAS goals? 
  
4) What is the role of AESA with respect to DELTAS? 
• In general, and in how consortia are managed (across board + individual 
consortia)? 
 
5) What are the challenges faced by AESA in administering DELTAS Africa? 
 
6) What requirements are consortia expected to comply with regarding how they are 
established and managed?  
• Why? 
• How prescriptive is AESA in the following and why? 
o Formation of consortia 
o Management structures 
o Management procedures and operations 
o Coordination 
o Reporting 
• What has the experience been with consortia in complying with these 
requirements? 




7) What kind of support does AESA offer to the programmes to facilitate the 
management of the consortia? 
• Proactive vs reactive? 
 
8) Which aspects of how consortia are established and managed are important to 
AESA?  
• Why? 
• What will be important to follow-up on during this study? 
 
9) Having gone through the experience of establishing the DELTAS programme, what 
will you do differently in a subsequent initiative? 
• In terms of supporting the formation and management of consortia  
• Generally? 
 
10) Generally, has the initiative unfolded in the way you expected?  
• Any unexpected experiences or things that have naturally emerged?  
 
11) What will you say are the main successes and challenges of the initiative so far? 
 
12) What will a successful DELTAS look like for AESA? 
• What do you expect consortia to achieve (in addition to research capacity) in the 





Appendix 8: In-Depth Interview Guides 
Consortia Directors 
Understanding of HRCS 
1. How would you personally interpret the term/concept ‘research capacity 
strengthening’? What comes to mind? 
2. What are your institutional research capacity strengthening priorities?  
• Any tensions between them, e.g. does developing one type take away from the 
other? 
3. To what extent does this thinking align with the DELTAS approach? 
• Activities? Expected outputs? Practices?  
• Are there other areas of capacity that require attention? 
 
Influence of HRCS thinking on key management processes 
4. Why did the consortium choose a centralised/decentralised approach? 
5. Are there any differences in the way the consortium is managed because of the 
focus on HRCS?  
Any dilemmas? 
6. Are there any differences in the way the consortium is managed because of this 
specific initiative or funder or compared to any others you’ve managed? How? 
Why? 
 
Effect of management processes on capacity development 
7. What is your perception of the theory of change/LFA approach to 
measuring/evaluating capacity strengthening? How can it be improved? 
8. Are there other ways that capacity strengthening happens that are not recognised? 
How are you able to identify that capacity strengthening is happening?  
9. Do consortium management processes play any role in the capacity strengthening 
process?  
10. What is the effect of consortium management processes on individual and 
institutional capacity?  
• Which aspects enable and which ones hinder? 
• Examples? 
11. To what extent are consortium management processes embedded in the institution? 
252 
 
• Partner selection, goal development, governance, programme and financial 
management 
 
Recommendations for HRCS models and management approaches   
12. Based on your thinking and experience, what kind of HRCS programme design will 
you propose for an initiative like this if given the opportunity? 
 
13.  What kind of management approach will you propose that supports capacity 
development? 









Managers at Lead Institutions (Programme, M&E, Finance) 
Programmatic management processes 
1. When did you join the consortium, and what are your responsibilities? 
2. What processes are used to manage the programmatic aspects of the consortium, 
i.e. activity planning, coordination and monitoring 
• What influenced the choice of these processes? 
• What benefits and challenges have you encountered in using these processes? 
 
Understanding of HRCS 
3. How would you personally interpret the term/concept ‘research capacity 
strengthening’? What comes to mind? 
4. Which areas should your institution prioritise in strengthening its research 
capacity? 
5. What do you think are the best ways by which these capacity areas can be 
developed?  
• Approaches? Activities? Practices? Types of resources? 
6. How does your personal and/or institutional thinking align with the DELTAS 
approach? 
• Activities? Expected outputs? Practices?  
• Are there other areas of capacity that require attention? 
7. What are some of the dilemmas that you have encountered due to your institutional 
thinking on HRCS and that of DELTAS, if divergent? 
 
Influence of HRCS thinking on key management processes 
8. How have adopted management strategies worked?  
i) Governance structures and processes (Boards, committees, secretariat) 
ii) Financial management 
iii)  Resource allocation/trainee award strategy 
iv) Reporting and evaluation 
 
9. Are there any differences in the way the consortium is managed because of the 
focus on HRCS?  
v) Selecting partners  
vi) Deciding on consortium goals 
vii) Determining partner roles and responsibilities 
viii) Establishing governance structures and practices 
ix) Allocating resources (funds) including trainee awards 
x) Financial management structures and processes 
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xi) Programmatic management structures and processes 
Any dilemmas encountered? 
10. Are there any differences in the way the consortium is managed because of this 
specific initiative or funder or compared to any others you’ve managed? How? 
Why? 
 
Effect of management processes on capacity development 
11. What is your perception of the theory of change/LFA approach? Is it adequate, 
and how can it be improved? 
12. Are there other ways that capacity strengthening happens that are not recognised? 
How are you able to identify that capacity strengthening is happening? 
13. Do consortium management processes play any role in the capacity strengthening 
process?  
14. What role have the consortium management processes played in individual and 
institutional capacity development?  
• Which aspects enable and which ones hinder? 
• Examples? 
15. To what extent are consortium management processes embedded in the institution? 
• Partner selection, goal development, governance, programme and financial 
management 
 
Recommendations for HRCS models and management approaches   
16. Based on your thinking and experience, what kind of programme design will you 
propose for an HRCS initiative if given the opportunity? 
• Model, implementer, goals, activities? 
17.  What management approach will you propose? 










Leaders at Partner Institutions 
Partner perception of consortium management processes 
1. What are your responsibilities? 
2. What motivated your institutions’ participation in this consortium? 
3. How were the consortium goals determined and agreed upon?  
• How are your institutional goals represented?  
• Are there others that you would have wanted to be represented? 
4. I understand the consortium has/uses X (management structure and processes) … 
• How has it functioned? How can they be improved? Can anything be done 
differently? 
5. I understand consortium resources are allocated based on X (including trainee 
award strategy), how has this worked so far? 
6. I learnt from my first phase of interviews that … (financial management approach) 
… what are the advantages and disadvantages of this approach? 
7. What are your thoughts on partner relationships in the consortium? 
•  How are equity, power balance, and inclusivity promoted? 
8. What is your general perception of how the consortium is managed? 
9. What influences are exerted by the lead/partners on consortium processes and 
interactions?  
10. Are there any differences in the way the consortium is managed compared to others 
you’ve participated in? 
 
Understanding of HRCS 
11. How would you personally interpret the term/concept ‘research capacity 
strengthening’? What comes to mind? 
12. What are your institutional research capacity strengthening priorities?  
13. How does this thinking align with the DELTAS approach/the consortium? Are 
there any divergences?  
14. Were these needs and approaches brought up during DELTAS discussions, and 
how were they incorporated into the consortium’s goals? 
15. Are there other HRCS approaches or activities you would have proposed? 
 
Effect of management processes on capacity development 
16. Are there any differences in the way the consortium is managed because of the 
focus on RCS? 
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17. What is your perception of the theory of change/LFA approach? Is it adequate, 
and how can it be improved? 
18. Are there other ways that capacity strengthening happens that are not recognised or 
reported?  
19. Do consortium management processes play any role in the capacity strengthening 
process (i.e. contribute or a toll on)? How does the way the consortium is 
managed affect capacity strengthening?  
20. What is the effect of consortium management processes on: 
• Individual capacity  
• Institutional capacity 
21. To what extent are consortium management processes embedded in the institution? 
• Partner selection, goal development, governance, programme and financial 
management 
 
Recommendations for HRCS models and management approaches   
22. Based on your thinking and experience, what kind of programme design will you 
propose for an HRCS initiative if given the opportunity? 
• Model, goals, activities? 
23. What will be the best way of approaching the following management processes for 
an HRCS consortium and why? 
i) Selecting partners 
ii) Deciding on consortium goals 
iii) Determining partner roles and responsibilities 
iv) Establishing governance structures and practices 
v) Allocating resources (funds) including trainee awards 
vi) Financial management structures and processes? 
vii) Programmatic management structures and processes? 





Managers at Partner Institutions (Programme, M&E, Finance) 
Partner perception of consortium management processes 
1. What does your role entail? 
2. I understand the consortium has/uses X (management structure and processes, 
including programmatic management) … 
• How has it functioned? 
• What is your perception (has been your experience) with the management 
processes adopted?  
• How can they be improved? 
3. I understand consortium resources are allocated based on X (including trainee 
award strategy), how has this worked so far? 
4. I learnt from my first phase of interviews that … (financial management approach) 
… what are the strengths and challenges of this approach? 
5. What are your thoughts on partner relationships in the consortium? 
•  How are equity, power balance, and inclusivity promoted? 
6. What is your general perception of how the consortium is managed? 
 
Understanding of HRCS 
7. How would you personally interpret the term/concept ‘research capacity 
strengthening’? What comes to mind? 
8. Which areas should your institution prioritise in strengthening its research 
capacity? 
9.  What would you propose as the best ways of developing these capacities?  
• Approaches? Activities? Practices? Types of resources? 
10. How does this thinking compare to the DELTAS approach? Are there any 
divergences? 
• Activities? Expected outputs? Practices?  
11. Are these needs and approaches brought up during consortium discussions, and 
how are they incorporated into the consortium’s activities? 
 
Effect of management processes on capacity development 
12. Are there any differences in the way the consortium is managed because of the 
focus on HRCS? 
13. What is your perception of the theory of change/LFA approach? Is it adequate, 
and how can it be improved? 
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14. Are there other ways that capacity strengthening happens that are not recognised? 
How are you able to identify that capacity strengthening is happening?  
15. Do consortium management processes play any role in the capacity strengthening 
process?  
16. What role have the consortium management processes played in the development 
of individual and institutional capacity?  
• Which aspects enable and which ones hinder? 
• Examples? 
17. To what extent are consortium management processes embedded in the institution? 
• Partner selection, goal development, governance, programme and financial 
management 
 
Recommendations for HRCS models and management approaches   
18. Based on your thinking and experience, what kind of HRCS programme design will 
you propose if given the opportunity? 
• Model, implementer, goals, activities? 
19. What will be the best way of approaching the following management processes and 
why? 
i) Selecting partners 
ii) Deciding on consortium goals 
iii) Determining partner roles and responsibilities 
iv) Establishing governance structures and practices 
v) Allocating resources (funds) including trainee awards 
vi) Financial management structures and processes? 
vii) Programmatic management structures and processes? 





Other Institutional Stakeholders at Lead and Partner Institutions 
Participation and goals 
1. What is your role in the consortium? 
2. What motivated your institution’s participation in this consortium? 
3. To what extent are your institutional goals represented in the overall consortium 
goals?  
• Are there others that you would have wanted to be more represented? 
4. What is your perception of partner relationships in the consortium? 
•  How are equity, power balance, and inclusivity promoted? 
5. Have there been any critical incidents (e.g. unintended occurrences or changes, e.g. 
personnel), and what was the effect and response? 
Understanding of HRCS 
6. How would you personally interpret the term/concept ‘research capacity 
strengthening’? What comes to mind? 
7. Which areas does your institution need to prioritise in its bid to strengthen its 
research capacity? 
8. How does your personal and/or institutional thinking compare to the DELTAS 
approach? 
• Has it been explicitly discussed? Are there any divergences? 
• Are there other areas of capacity that require attention or being addressed but not 
recognised? 
9. How does this thinking compare to the DELTAS approach? 
• Activities? Expected outputs? Practices?  
• Are there other areas of capacity that require attention, or being developed but 
not recognised/rewarded? 
Influence of HRCS thinking on key management processes 
10. Are there any differences in the way the consortium is managed because of the 
focus on HRCS? 
i) Selecting partners 
ii) Deciding on consortium goals 
iii) Determining partner roles and responsibilities 
iv) Establishing governance structures and practices 
v) Allocating resources (funds) including trainee awards 
vi) Financial management structures and processes? 
vii) Programmatic management structures and processes? 
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Any dilemmas encountered? 
 
Effect of management processes on capacity development 
11. What is your general perception of consortium management processes? 
12. What role have consortium management processes played in the development of 
individual and institutional capacity?  
• Which aspects enable and which ones hinder? 
• Examples? 
13. What is your perception of the theory of change/LFA approach? Is it adequate, 
and how can it be improved? 
14. Are there other ways that capacity strengthening happens that are not recognised? 
How are you able to identify that capacity strengthening is happening? 
15. To what extent are consortium management processes embedded in the institution? 
• Partner selection, goal development, governance, programme and financial 
management 
 
Recommendations for HRCS models and management approaches   
16. Based on your thinking and experience, what kind of programme design will you 
propose for an HRCS initiative if given the opportunity? 
• Implementer, goals, activities? 
17.  What management approach will you propose? 





Leaders at High-Income Partner Institutions 
Partner perception of consortium management processes 
1. What is your role in the consortium, and what does it entail? 
2. What motivated your participation in this consortium? 
3. How were the consortium goals determined and agreed upon?  
• How are your institutional goals represented?  
• Are there others that you would have wanted to be represented? 
4. What is your general perception of how the consortium is managed? 
5. I understand the consortium has/uses X (management structure and processes) … 
• How has it functioned so far? 
• What is your perception (has been your experience) with the management 
processes adopted?  
• How can they be improved?  
6. I understand consortium resources are allocated based on X (including trainee 
award strategy), how has this worked so far? 
7. What is your perception of partner relationships in the consortium? 
•  How are equity, power balance, and inclusivity promoted? 
8. Have there been any critical incidents (e.g. unintended occurrences or changes, e.g. 
personnel), and what was the effect and response? 
 
Understanding of HRCS 
9. How would you personally interpret the term ‘research capacity strengthening’? 
What comes to mind? 
10. How does this thinking compare to the DELTAS approach? Are there any 
divergences? 
• Activities? Expected outputs (any intangible or unrecognised)? Practices?  
11. Does participation in this consortium strengthen your institution’s research 
capacity? How?  
12. Were these needs brought up during DELTAS discussions, and how were they 
incorporated into the consortium’s goals? 
13. Did/do you encounter any dilemmas as this programme was being developed or 
implemented? 
 
Effect of management processes on capacity development 
14. What is your perception of the theory of change/LFA approach to 
measuring/evaluating capacity strengthening? How can it be improved? 
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15. Are there other ways that capacity strengthening happens that are not recognised? 
How are you able to identify that capacity strengthening is happening?  
16. Do consortium management processes play any role in the capacity strengthening 
process (i.e. contribute or a toll on)?  
17. What is the effect of consortium management processes on individual and 
institutional capacity?  
• Which aspects enable and which ones hinder? 
• Examples? 
18. To what extent are consortium management processes embedded in your 
institution? 
• Partner selection, goal development, governance, programme and financial 
management 
 
Recommendations for HRCS models and management approaches   
19. Based on your thinking and experience, what kind of HRCS programme design will 
you propose if given the opportunity? 
• Implementer, goals, activities? 
20. What will be the best way of approaching the following management processes and 
why? 
i) Selecting partners 
ii) Deciding on consortium goals 
iii) Determining partner roles and responsibilities 
iv) Establishing governance structures and practices 
v) Allocating resources (funds) including trainee awards 
vi) Financial management structures and processes? 
vii) Programmatic management structures and processes? 























RCS conceptualisation and prioritisation  
a) Conceptualisation of RCS 
b) Factors influencing RCS priorities/focus 
c) Alignment in conceptualisation and prioritisation 
d) Challenges with conceptualisation and 
prioritisation 
e) Changes in RCS conceptualisation and 
prioritisation 
Monitoring and evaluating RCS progress and 
achievements 
a) Views on DELTAS Theory of Change 
o Value / What is measured 
o Limitations / What is not or cannot be 
measured 
b) Changes in RCS evaluation 
c) Recommendations  
 
Setting up of 
consortia  




Factors influencing management strategies 
a) Partner selection 
b) Determination of consortium activities and goals  
c) Determination of roles and responsibilities 
d) Governance structure 
e) Management processes used 
f) Partner management 








Perceptions of management structures and 
approaches and experiences 











Differences Differences in governance and management compared 
to other consortia 
 
Role of management 
processes in RCS 
 






Learning about management processes 
 
Role of management processes in RCS 
 
Embedding management processes into the institution 
 
Recommendations Recommendations on RCS initiatives 
a) Programme design 
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Appendix 14: DELTAS Theory of Change and Evaluation Indicators 
Strategic 




oversight is available 
Number of scientific advisory board 
meetings held 
Increased capacity for 
Trainees to attract new 
funding 
Number (and monetary value) of new 
grant awards won by researchers and 
fellows/students associated with 
programme 
Trainees / Researchers get 
appropriate supervision 
Overall average primary 




Diversity of training courses 
offered by Programme 
Number training courses (technical and 
soft skills) offered by the Programme 
High training completion 
rates 
Proportion of students who completed 
their training successfully and on 
schedule 
Researchers publishing in 
high-quality Scientific 
journals 
Number of high impact publications 
where the first author is based at an 




Researchers and programmes 
engage with and influence 
policymakers 
Number of formal policy processes 
participated in (policy briefings and 
debates; advisory groups, etc.) 
Researchers collaborate with 
other institutions 
Number of new and significant 
collaborations developed through the 
DELTAS Africa programme during the 
reporting period 
Researchers and programmes 
engage with the public to 
raise awareness and interest 
Number (and type) of public engagement 
activities held during reporting period 
Programme disseminates 
research findings to the 
relevant stakeholders 
Number of media communication and 





Sustainable funding is 
secured and harmonised 
Amount of additional funding secured 
from other partners / non-DELTAS 
Africa sources for enhanced support to 
the programme activities 
Appropriate physical 
infrastructure is available to 
support Research 
Existence of well-maintained supporting 
equipment including ICT, libraries, labs 
Functional management and 
governance support structures 
Number of management board or 
consortium advisory group meetings held 
 
